Mar 2014 Summary Tables
-
Upload
dennis-armando-valvert-gamboa -
Category
Documents
-
view
25 -
download
1
Transcript of Mar 2014 Summary Tables
Summary Tables by Region,
Health Area, Country and Product
POPULATION SERVICES INTERNATIONAL
CYPs, Cases, and Deaths by Region
1/2014 - 3/2014
Cases CYP*
HIV & TB Reproductive Health
Maternal
Deaths
Unintended
Pregnancies
Malaria
Cases
Malaria
Deaths
Diarrhea
Cases
Diarrhea
Deaths
Malaria Control Child Survival
Sum of
All Deaths
Pneumonia
Cases
Pneumonia
Deaths
STI
Deaths
TB
Deaths
Nutrition
Deaths
IDU
Deaths
West and Central Africa 6,643 1,180,947 1,390 373,264 - 71,694 555 - 73,750 - 111 - - - -
East Africa 12,408 1,111,748 818 355,376 - 15,567 658 - 17,404 - 348 14 - - -
Southern Africa 34,146 711,361 458 160,368 - 20,195 223 - 21,125 - 225 23 - - -
Americas 352 191,475 47 35,663 - 12 37 - 96 - - - - - -
Asia and Eastern Europe 705 1,078,588 452 224,211 - 177 227 - 1,810 - 201 17 662 - 75
54,254 4,274,120 3,165 1,148,882 - 107,644 - 1,700 114,185 Total - 885 54 662 - 75
3001 - 4/18/2014 4:43:37PM Page 1 of 1
* Using USAID CYP conversion factors
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Region
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
GRAND TOTAL 29% 64% 41,567,649 4,656,557 7,257,549 11,929,599
West and Central Africa 114% 100 % 36% 17,924,629 3,027,840 6,477,337 2,513,966
HIV & TB 129,281 19% 1,808,760 5%(22)% 352,036 448,976
Reproductive Health 190,655 21% 2,899,916 9%(5)% 597,358 630,076
Malaria Control 2,173,647 42% 12,990,333 84% 211% 5,471,154 1,758,204
Child Survival 20,382 25% 225,619 1%(70)% 56,789 190,584
East Africa 39% 100 % 25% 10,013,716 1,837,147 2,548,000 1,265,040
HIV & TB 351,990 23% 3,225,623 29% 36% 728,342 535,827
Reproductive Health 279,768 24% 2,339,108 22% 15% 550,125 477,630
Malaria Control 579,695 29% 4,144,291 47% 59% 1,189,154 746,163
Child Survival 53,587 26% 304,693 3% 4% 80,380 77,528
Southern Africa 65% 100 % 24% 10,168,232 1,464,747 2,418,310 600,314
HIV & TB 428,772 21% 5,007,753 44% 1% 1,071,816 1,059,702
Reproductive Health 96,332 18% 1,379,559 10% 0% 249,096 249,894
Malaria Control 59,053 29% 3,647,125 44% 766% 1,062,683 122,759
Child Survival 16,157 26% 133,794 1% 7% 34,714 32,391
Americas 7% 100 % 22% 197,116 39,784 42,604 16,136
HIV & TB 7,307 26% 72,065 44% 35% 18,566 13,740
Reproductive Health 8,142 20% 101,536 48% 7% 20,455 19,054
Malaria Control - 19% 5,695 3%(68)% 1,065 3,298
Child Survival 687 14% 17,820 6%(32)% 2,518 3,692
Asia and Eastern Europe (50)% 100 % 14% 3,263,957 888,031 443,348 261,102
HIV & TB 34,206 12% 704,066 19%(29)% 85,972 120,622
Reproductive Health 206,806 14% 2,225,970 69%(51)% 306,693 622,621
Malaria Control 7,337 10% 135,932 3%(87)% 13,552 103,969
Child Survival 12,752 19% 197,989 8%(9)% 37,131 40,819
3007 - 4/18/2014 4:40:35PM Page 1 of 1
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Health Area
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
GRAND TOTAL 29% 64% 41,567,649 4,656,557 7,257,549 11,929,599
HIV & TB 951,557 21 % 10,818,268 100% 4% 2,256,732 2,178,867
West and Central Africa (22)% 16 % 19% 1,808,760 129,281 448,976 352,036
East Africa 36% 32 % 23% 3,225,623 351,990 535,827 728,342
Southern Africa 1% 47 % 21% 5,007,753 428,772 1,059,702 1,071,816
Americas 35% 1 % 26% 72,065 7,307 13,740 18,566
Asia and Eastern Europe (29)% 4 % 12% 704,066 34,206 120,622 85,972
Reproductive Health 781,703 19 % 8,946,090 100%(14)% 1,723,727 1,999,276
West and Central Africa (5)% 35 % 21% 2,899,916 190,655 630,076 597,358
East Africa 15% 32 % 24% 2,339,108 279,768 477,630 550,125
Southern Africa 0% 14 % 18% 1,379,559 96,332 249,894 249,096
Americas 7% 1 % 20% 101,536 8,142 19,054 20,455
Asia and Eastern Europe (51)% 18 % 14% 2,225,970 206,806 622,621 306,693
Malaria Control 2,819,731 37 % 20,923,376 100% 183% 7,737,607 2,734,393
West and Central Africa 211% 71 % 42% 12,990,333 2,173,647 1,758,204 5,471,154
East Africa 59% 15 % 29% 4,144,291 579,695 746,163 1,189,154
Southern Africa 766% 14 % 29% 3,647,125 59,053 122,759 1,062,683
Americas (68)% 0 % 19% 5,695 - 3,298 1,065
Asia and Eastern Europe (87)% 0 % 10% 135,932 7,337 103,969 13,552
Child Survival 103,566 24 % 879,915 100%(39)% 211,533 345,014
West and Central Africa (70)% 27 % 25% 225,619 20,382 190,584 56,789
East Africa 4% 38 % 26% 304,693 53,587 77,528 80,380
Southern Africa 7% 16 % 26% 133,794 16,157 32,391 34,714
Americas (32)% 1 % 14% 17,820 687 3,692 2,518
Asia and Eastern Europe (9)% 18 % 19% 197,989 12,752 40,819 37,131
3005 - 4/18/2014 4:42:28PM Page 1 of 1
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Country
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
29%GRAND TOTAL 64% 41,567,649 4,656,557 7,257,549 11,929,599
West and Central Africa 114% 100 % 36% 17,924,629 2,513,966 3,027,840 6,477,337
Benin 27% 1% 213,903 24,826 40,404 58,291 44 %
HIV & TB 56% 23 % 0% 57,882 4,182 8,516 13,288
Reproductive Health 54% 27 % 1% 129,878 11,283 22,743 34,991
Malaria Control 372% 15 % 0% 3,130 128 100 470
Child Survival 5% 41 % 0% 23,013 9,233 9,045 9,541
C.A.R. -% -% - - 7,275 - (100)%
HIV & TB (100)% 0 % 0% - - 4,804 -
Reproductive Health (100)% 0 % 0% - - 2,471 -
Cameroon 18% 1% 525,246 30,820 151,733 93,254 (39)%
HIV & TB 17% 23 % 1% 185,912 14,685 36,710 42,830
Reproductive Health 4% 15 % 1% 215,029 12,566 32,006 33,318
Malaria Control (70)% 7 % 0% 88,573 3,193 20,133 5,954
Child Survival (82)% 31 % 0% 35,731 376 62,885 11,151
Congo-Kinshasa 35% 40% 7,450,480 40,424 457,125 2,621,918 474 %
HIV & TB (96)% 2 % 0% 149,024 - 73,055 2,882
Reproductive Health (66)% 12 % 0% 232,023 3,586 82,842 28,154
Malaria Control 1,122% 37 % 40% 7,033,527 34,182 211,753 2,586,574
Child Survival (95)% 12 % 0% 35,906 2,656 89,475 4,308
Cote d'Ivoire 76% -% 15,141 1,143 9,426 11,483 22 %
HIV & TB 37% 29 % 0% 5,003 639 1,041 1,427
Reproductive Health 196% 45 % 0% 1,923 405 294 870
Child Survival 14% 112 % 0% 8,216 99 8,091 9,187
Cote d'Ivoire (AIMAS) -% -% 22,116 - 73,043 - (100)%
HIV & TB (100)% 0 % 0% 9,697 - 38,065 -
Reproductive Health (100)% 0 % 0% 12,418 - 34,978 -
Guinea 41% 1% 160,201 35,937 36,213 65,293 80 %
HIV & TB 0% 31 % 0% 35,352 3,142 10,963 10,925
Reproductive Health 131% 32 % 0% 79,805 11,390 10,983 25,321
Malaria Control 0% 0 % 0% - 16,014 - 16,014
Child Survival (9)% 29 % 0% 45,044 5,391 14,267 13,032
Liberia 9% -% 8,482 306 947 804 (15)%
HIV & TB (85)% 2 % 0% 3,391 26 513 75
Reproductive Health 68% 15 % 0% 4,429 256 385 648
Child Survival 70% 12 % 0% 663 25 48 82
Mali 19% 6% 2,128,981 361,704 124,215 409,896 230 %
HIV & TB (54)% 9 % 0% 114,710 247 22,979 10,586
Reproductive Health (13)% 23 % 1% 300,675 36,886 77,979 67,900
Malaria Control 1,478% 19 % 5% 1,692,970 323,370 20,644 325,690
Child Survival 119% 28 % 0% 20,625 1,200 2,613 5,719
Nigeria 44% 49% 7,181,552 1,995,303 2,092,829 3,173,642 52 %
HIV & TB 4% 22 % 4% 1,138,071 92,903 239,940 248,400
Reproductive Health 14% 21 % 6% 1,846,792 107,067 343,173 390,919
Malaria Control 68% 61 % 39% 4,140,584 1,793,931 1,505,556 2,530,556
Child Survival (9)% 7 % 0% 56,104 1,402 4,160 3,767
3006 - 4/18/2014 4:38:21PM Page 1 of 6
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Country
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
Senegal 19% -% 78,172 6,633 10,762 14,996 39 %
HIV & TB 3% 22 % 0% 41,673 3,629 9,047 9,356
Reproductive Health 17% 23 % 0% 8,857 724 1,714 2,011
Malaria Control 0% 13 % 0% 27,325 2,281 - 3,629
Child Survival (10)% 0 % 0% 317 - 1 1
Togo 20% -% 140,355 16,870 23,868 27,760 16 %
HIV & TB 267% 18 % 0% 68,044 9,830 3,341 12,267
Reproductive Health (36)% 19 % 0% 68,087 6,492 20,509 13,227
Malaria Control 12,061% 54 % 0% 4,224 548 19 2,267
East Africa 39% 100 % 25% 10,013,716 1,265,040 1,837,147 2,548,000
Angola 17% 3% 384,172 29,957 13,617 66,889 391 %
HIV & TB 33% 21 % 0% 23,382 1,793 3,664 4,857
Reproductive Health 33% 21 % 0% 25,402 1,948 3,980 5,278
Malaria Control 2,591% 17 % 2% 326,041 25,376 2,001 53,844
Child Survival (27)% 31 % 0% 9,348 840 3,972 2,909
Burundi 10% 1% 165,479 5,919 27,056 16,851 (38)%
HIV & TB (23)% 21 % 0% 52,034 3,729 14,169 10,950
Reproductive Health (22)% 21 % 0% 23,632 1,694 6,403 4,981
Malaria Control (86)% 1 % 0% 89,814 496 6,483 920
Ethiopia 6% 1% 415,951 6,402 93,729 23,964 (74)%
HIV & TB (77)% 6 % 0% 216,370 3,172 52,570 12,030
Reproductive Health (79)% 5 % 0% 172,004 1,701 40,391 8,442
Malaria Control (100)% 0 % 0% - - 3 -
Child Survival 357% 13 % 0% 27,576 1,528 765 3,493
Kenya 28% 14% 1,223,019 136,149 231,855 345,731 49 %
HIV & TB 64% 33 % 5% 399,142 46,405 81,506 133,392
Reproductive Health 53% 27 % 6% 554,884 67,496 98,372 150,057
Malaria Control 34% 23 % 2% 240,704 19,689 41,584 55,709
Child Survival (37)% 23 % 0% 28,289 2,559 10,392 6,574
Malawi 21% 7% 873,469 56,030 253,311 181,055 (29)%
HIV & TB (23)% 22 % 2% 198,589 14,614 56,671 43,864
Reproductive Health (24)% 24 % 1% 73,793 6,124 23,298 17,710
Malaria Control (16)% 20 % 5% 585,267 34,250 137,410 115,676
Child Survival (89)% 24 % 0% 15,819 1,042 35,931 3,804
Mozambique 37% 19% 1,291,827 165,645 483,718 473,343 (2)%
HIV & TB 31% 24 % 3% 325,870 28,372 58,931 76,964
Reproductive Health 33% 23 % 1% 109,632 8,686 18,797 25,081
Malaria Control (8)% 44 % 14% 838,943 126,806 398,741 366,496
Child Survival (34)% 28 % 0% 17,383 1,780 7,249 4,803
Rwanda 36% -% 1,692 260 10,995 615 (94)%
HIV & TB (92)% 36 % 0% 1,692 260 7,725 615
Reproductive Health (100)% 0 % 0% - - 2,830 -
Child Survival (100)% 0 % 0% - - 440 -
SFH Rwanda 32% 2% 180,472 13,757 29,864 58,218 95 %
HIV & TB 44% 26 % 1% 114,485 9,158 20,234 29,221
Reproductive Health 53% 26 % 1% 54,916 4,442 9,341 14,298
Malaria Control 0% 161 % 1% 8,389 - - 13,544
3006 - 4/18/2014 4:38:39PM Page 2 of 6
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Country
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
Child Survival 299% 43 % 0% 2,682 157 289 1,155
Somaliland 9% -% 26,812 429 5,319 2,311 (57)%
Reproductive Health 28% 21 % 0% 2,050 128 333 424
Child Survival (62)% 8 % 0% 24,762 301 4,987 1,887
South Sudan 29% 24% 2,100,999 416,430 174,989 605,394 246 %
HIV & TB (65)% 0 % 0% - - 1,628 574
Reproductive Health (65)% 0 % 0% - - 2,156 761
Malaria Control 244% 28 % 22% 1,932,643 372,550 159,940 550,165
Child Survival 378% 32 % 2% 168,356 43,880 11,265 53,894
Tanzania 25% 17% 1,731,856 260,722 387,106 429,394 11 %
HIV & TB 30% 25 % 9% 889,147 147,470 172,113 224,381
Reproductive Health (5)% 24 % 8% 833,892 112,235 213,683 203,679
Malaria Control 0% 0% - - -
Child Survival 2% 15 % 0% 8,817 1,017 1,310 1,334
Uganda 21% 14% 1,617,968 173,342 125,589 344,235 174 %
HIV & TB 187% 19 % 8% 1,004,913 97,017 66,616 191,492
Reproductive Health 106% 24 % 5% 488,904 75,314 58,045 119,415
Malaria Control 11,813,100% 27 % 1% 122,491 528 - 32,800
Child Survival (43)% 32 % 0% 1,660 483 928 529
Southern Africa 65% 100 % 24% 10,168,232 600,314 1,464,747 2,418,310
Botswana 65% 1% 51,235 19,710 27,490 33,170 21 %
HIV & TB 21% 65 % 1% 44,493 17,117 23,873 28,805
Reproductive Health 21% 65 % 0% 6,741 2,593 3,617 4,364
Lesotho 37% 4% 251,773 27,115 37,861 93,617 147 %
HIV & TB 146% 37 % 3% 208,390 22,433 31,199 76,727
Reproductive Health 154% 39 % 1% 43,383 4,682 6,661 16,890
Madagascar 23% 10% 1,047,427 101,735 238,924 239,920 - %
HIV & TB 13% 22 % 1% 62,775 7,109 12,398 13,957
Reproductive Health 6% 23 % 4% 387,956 29,363 84,328 89,240
Malaria Control (10)% 22 % 5% 511,119 52,569 122,230 110,524
Child Survival 31% 31 % 1% 85,577 12,695 19,968 26,199
Namibia -% -% - - 8,858 - (100)%
HIV & TB (100)% 0 % 0% - - 6,973 -
Reproductive Health (100)% 0 % 0% - - 1,370 -
Malaria Control (100)% 0 % 0% - - 515 -
Child Survival (100)% 0 % 0% - - - -
South Africa 18% 19% 2,444,663 176,823 613,760 449,406 (27)%
HIV & TB (27)% 18 % 17% 2,224,527 161,373 557,192 408,953
Reproductive Health (28)% 18 % 2% 220,135 15,451 56,569 40,452
Swaziland 27% 3% 292,694 33,126 37,519 79,762 113 %
HIV & TB 101% 26 % 3% 271,865 29,496 35,210 70,939
Reproductive Health 282% 42 % 0% 20,829 3,630 2,309 8,823
Zambia 16% 15% 2,330,770 120,549 264,387 364,070 38 %
HIV & TB 9% 21 % 8% 944,739 79,888 185,054 201,207
Reproductive Health (6)% 12 % 3% 554,276 30,724 68,944 65,125
Malaria Control 639,244% 11 % 4% 783,538 6,484 14 89,455
Child Survival (20)% 17 % 0% 48,217 3,453 10,375 8,283
3006 - 4/18/2014 4:38:39PM Page 3 of 6
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Country
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
Zimbabwe 31% 48% 3,749,670 121,255 235,947 1,158,365 391 %
HIV & TB 31% 22 % 11% 1,250,964 111,357 207,803 271,226
Reproductive Health (7)% 17 % 1% 146,238 9,889 26,096 24,203
Malaria Control 0% 37 % 36% 2,352,468 - - 862,704
Child Survival (89)% 0 % 0% - 9 2,048 233
Americas 7% 100 % 22% 197,116 16,136 39,784 42,604
Belize 18% 1% 1,947 189 123 342 179 %
HIV & TB 173% 17 % 1% 1,754 168 112 305
Reproductive Health 251% 19 % 0% 193 20 11 37
Caribbean 15% 1% 1,655 63 3 244 8,300 %
HIV & TB 8,287% 15 % 0% 1,173 45 2 172
Reproductive Health 8,330% 15 % 0% 482 18 1 71
Costa Rica 21% 1% 1,252 82 301 259 (14)%
HIV & TB (5)% 23 % 0% 500 38 122 116
Reproductive Health (20)% 19 % 0% 752 44 179 143
Dominican Republic 26% 20% 33,241 3,921 5,247 8,549 63 %
HIV & TB 61% 25 % 14% 23,940 2,749 3,786 6,089
Reproductive Health 68% 26 % 6% 9,302 1,171 1,461 2,460
El Salvador 26% 5% 7,600 766 2,053 1,984 (3)%
HIV & TB 1% 25 % 2% 3,940 388 969 979
Reproductive Health (7)% 27 % 2% 3,660 378 1,085 1,005
Guatemala 17% 23% 56,774 4,497 7,337 9,819 34 %
HIV & TB 45% 24 % 8% 14,134 1,393 2,331 3,383
Reproductive Health 29% 15 % 15% 42,640 3,104 5,005 6,437
Haiti 21% 29% 59,538 3,769 17,011 12,319 (28)%
HIV & TB 6% 26 % 9% 14,063 1,342 3,458 3,652
Reproductive Health (23)% 23 % 12% 21,960 1,740 6,562 5,083
Malaria Control (68)% 19 % 3% 5,695 - 3,298 1,065
Child Survival (32)% 14 % 6% 17,820 687 3,692 2,518
Honduras 23% 4% 8,079 760 1,581 1,865 18 %
HIV & TB 18% 23 % 3% 5,021 472 983 1,159
Reproductive Health 18% 23 % 2% 3,058 288 598 706
Nicaragua 21% 5% 11,012 632 2,185 2,312 6 %
HIV & TB (7)% 28 % 1% 1,012 84 311 288
Reproductive Health 8% 20 % 5% 9,999 548 1,874 2,024
Panama 40% 7% 7,155 696 1,784 2,837 59 %
HIV & TB 59% 40 % 5% 5,565 541 1,388 2,200
Reproductive Health 61% 40 % 1% 1,590 155 396 637
Paraguay 23% 5% 8,863 761 2,160 2,074 (4)%
HIV & TB (20)% 23 % 1% 963 86 277 222
Reproductive Health (2)% 23 % 4% 7,900 676 1,883 1,852
Asia and Eastern Europe (50%) 100 % 14% 3,263,957 261,102 888,031 443,348
Cambodia 17% 8% 225,427 14,059 95,717 37,565 (61)%
HIV & TB 31% 15 % 1% 44,829 1,352 4,984 6,537
Reproductive Health (24)% 14 % 4% 125,334 4,854 23,362 17,838
Malaria Control (87)% 24 % 2% 34,119 6,338 63,654 8,291
3006 - 4/18/2014 4:38:39PM Page 4 of 6
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Country
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
Child Survival 32% 23 % 1% 21,146 1,515 3,717 4,898
China -% -% - - 281 - (100)%
HIV & TB (100)% 0 % 0% - - 232 -
Reproductive Health (100)% 0 % 0% - - 49 -
India 4% 8% 1,042,063 15,152 166,362 36,491 (78)%
HIV & TB (96)% 0 % 0% 340,773 595 36,255 1,338
Reproductive Health (78)% 4 % 6% 642,666 14,776 115,621 25,235
Child Survival (32)% 17 % 2% 58,623 (218) 14,487 9,918
Kazakhstan 98% 1% 2,941 104 141 2,896 1,954 %
HIV & TB 1,988% 99 % 1% 2,920 102 138 2,889
Reproductive Health 150% 30 % 0% 21 1 3 6
Kyrgyzstan 32% -% 40 - 3,211 13 (100)%
HIV & TB (100)% 32 % 0% 21 - 1,921 7
Reproductive Health (100)% 33 % 0% 19 - 1,290 6
Laos 16% -% 12,931 13 3,858 2,057 (47)%
HIV & TB (42)% 18 % 0% 5,644 13 1,800 1,043
Reproductive Health (51)% 15 % 0% 6,601 - 2,058 1,011
Malaria Control 0% 0 % 0% 686 - - 3
Myanmar 18% 19% 474,551 33,010 129,215 84,501 (35)%
HIV & TB (10)% 22 % 10% 202,794 16,544 50,445 45,301
Reproductive Health (26)% 21 % 3% 55,451 4,202 16,002 11,831
Malaria Control (87)% 5 % 1% 98,386 839 40,277 5,099
Child Survival (1)% 19 % 5% 117,920 11,425 22,491 22,270
Nepal 1% -% 114,501 809 6,136 1,560 (75)%
HIV & TB 0% 0 % 0% - - - 3
Reproductive Health (77)% 1 % 0% 113,475 650 6,097 1,398
Malaria Control 315% 16 % 0% 1,026 159 38 159
Child Survival (100)% 0 % 0% - - 1 -
Pakistan 20% 59% 1,332,684 189,942 466,278 261,241 (44)%
HIV & TB 17% 24 % 3% 53,603 7,979 11,114 13,018
Reproductive Health (45)% 19 % 56% 1,279,063 181,947 455,112 248,207
Child Survival (68)% 92 % 0% 18 17 52 17
Papua New Guinea 33% -% 5,812 443 927 1,903 105 %
HIV & TB 119% 47 % 0% 2,877 316 621 1,363
Reproductive Health 118% 47 % 0% 1,138 124 246 537
Malaria Control 0% 0 % 0% 1,715 - - -
Child Survival (95)% 4 % 0% 82 3 59 3
Tajikistan 28% 1% 12,107 296 2,598 3,406 31 %
HIV & TB 30% 29 % 1% 10,840 264 2,390 3,113
Reproductive Health 41% 23 % 0% 1,267 32 208 293
Thailand 33% 1% 16,684 3,209 3,575 5,520 54 %
HIV & TB 53% 33 % 1% 15,773 2,988 3,395 5,188
Reproductive Health 84% 36 % 0% 912 221 180 332
Viet Nam 26% 1% 24,215 4,064 9,731 6,196 (36)%
HIV & TB (16)% 26 % 1% 23,993 4,053 7,326 6,171
Reproductive Health (100)% 0 % 0% 23 - 2,394 -
3006 - 4/18/2014 4:38:39PM Page 5 of 6
POPULATION SERVICES INTERNATIONAL
Monthly DALY Report by Country
Period: 3
Year: 2014
DALY
3/2014
YTD DALY
2013
Percentage
Change
YTD DALY
2014
Percentage of
Category
Percentage
of Target
Achieved
Annual
DALY
Target
Child Survival 138% 13 % 0% 199 11 11 26
3006 - 4/18/2014 4:38:39PM Page 6 of 6
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Antiretroviral Treatment 151 457 365 482 236 4,050 32% 2,775 3,257
Asia and Eastern Europe 151 457 482 4,050 365 2,775 3,257 236 32%
Antiretroviral Treatment (Tablet) - - - - - - -% - 97,980
Asia and Eastern Europe - - - - - - 97,980 - -%
ARV Prophylaxis 28 wks (Mother and Baby) - - - - - - -% - 382
Asia and Eastern Europe - - - - - - 382 - -%
ARV Prophylaxis 28 wks (Mother Only) - - - - - - -% - 359
Asia and Eastern Europe - - - - - - 359 - -%
Basic Care Package 1,781,706 725,276 1,135,334 3,440,122 176,230 22,599,600 203% 17,924,339 51,799,447
West and Central Africa - - - 600 - 600 600 - -%
East Africa 1,781,706 725,276 3,440,122 22,599,000 1,135,334 17,923,739 51,798,847 176,230 203%
Cervical Cancer-VIA and Cryotherapy 282 204 114 537 166 3,456 371% 1,455 2,000
West and Central Africa 13 9 38 - 1 3 41 11 3,700%
East Africa 88 98 143 1,456 - 326 469 47 -%
Southern Africa 180 77 330 1,800 - 604 934 101 -%
Asia and Eastern Europe 1 20 26 200 113 522 556 7 (77)%
Clean Delivery Kit 11,134 4,415 21,202 16,778 1,453 76,100 (21)% 70,712 1,505,942
West and Central Africa 800 1,033 3,200 - 81 11,281 206,110 384 3,851%
East Africa 5,334 3,382 8,578 64,000 12,909 51,214 311,378 504 (34)%
Asia and Eastern Europe 5,000 - 5,000 12,100 8,212 8,217 988,454 565 (39)%
Condom 92,843,424 67,326,733 216,240,542 196,594,905 1,854,790 1,088,640,665 (9)% 1,001,445,629 18,145,488,074
West and Central Africa 20,901,222 20,551,483 58,252,146 311,107,980 64,139,299 310,685,161 4,836,110,051 561,478 (9)%
East Africa 25,882,286 11,467,616 50,581,134 200,814,705 41,502,189 187,958,221 2,527,533,073 613,565 22%
Southern Africa 15,064,654 11,594,460 34,083,224 149,365,174 35,162,030 148,066,830 1,585,083,778 517,355 (3)%
Americas 4,676,581 3,405,060 12,272,395 47,194,726 9,655,957 45,542,035 1,030,564,758 27,218 27%
Other Africa - - - - - - 14,310,880 - -%
Asia and Eastern Europe 26,318,681 20,308,115 41,406,006 380,158,080 65,781,067 309,193,382 8,151,885,534 135,174 (37)%
Deworming Tablets - - - - - - -% - 1,095,308
3004 - 4/18/2014 4:47:22PM Page 1 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
East Africa - - - - - - 978,174 - -%
Southern Africa - - - - - - 117,134 - -%
Diarrhea Treatment Kit 365,661 134,438 684,924 675,926 43,172 3,318,656 (1)% 2,260,014 9,388,375
West and Central Africa 263,904 72,561 460,034 2,073,933 393,653 895,712 4,039,306 31,939 17%
East Africa - 6,059 8,356 133,553 27,130 115,546 548,997 1,224 (69)%
Southern Africa 20,595 10,797 44,931 194,970 25,036 108,671 787,684 1,823 79%
Asia and Eastern Europe 81,162 45,021 162,605 916,200 239,105 1,140,085 4,012,388 8,185 (32)%
Early Infant MC (HIV-Negative) 39 52 151 134 1,007 1,200 (11)% 788 1,776
Southern Africa 39 52 134 1,200 151 788 1,776 1,007 (11)%
Early Infant MC (HIV-Unknown) 19 25 553 64 453 800 (88)% 957 1,817
Southern Africa 19 25 64 800 553 957 1,817 453 (88)%
Emergency Contraception 430,782 259,168 759,578 878,950 16,893 5,386,592 16% 3,252,968 25,876,905
West and Central Africa 94,680 104,654 280,427 1,580,000 203,682 935,598 9,226,426 7,291 38%
East Africa 7,840 5,850 21,710 42,320 3,600 37,920 1,233,181 542 503%
Southern Africa 8,728 7,915 14,354 118,272 14,864 123,332 518,133 267 (3)%
Americas 23,471 22,917 68,529 286,000 66,757 269,268 3,083,070 308 3%
Asia and Eastern Europe 296,063 117,833 493,930 3,360,000 470,675 1,886,850 11,816,095 8,485 5%
Female Condom 919,248 633,227 2,042,619 1,918,029 25,359 8,070,935 (6)% 8,797,045 60,923,667
West and Central Africa 113,158 205,266 345,093 3,260,711 991,072 3,205,990 17,848,385 3,233 (65)%
East Africa 293,908 121,855 508,038 1,441,005 337,788 1,843,651 7,584,531 6,052 50%
Southern Africa 492,346 271,944 990,068 3,092,019 599,932 3,393,608 28,839,816 15,710 65%
Americas - - - - 2,000 3,704 3,751,762 - (100)%
Asia and Eastern Europe 19,836 34,162 74,830 277,200 111,827 350,092 2,899,173 363 (33)%
Free Condom 14,252,402 15,763,490 43,767,335 36,876,950 466,354 182,482,681 (16)% 222,953,144 1,499,892,659
West and Central Africa 1,935,918 1,133,290 3,653,134 6,232,561 2,071,326 19,772,368 110,621,140 34,791 76%
East Africa 5,652,765 6,739,339 14,356,318 70,840,680 15,513,409 80,275,339 395,904,990 154,570 (7)%
Southern Africa 6,176,356 7,651,173 17,867,628 101,051,600 25,451,842 114,403,021 900,979,310 271,756 (30)%
Americas 100,339 81,218 263,398 1,559,800 190,660 1,361,846 50,805,983 557 38%
3004 - 4/18/2014 4:47:37PM Page 2 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Asia and Eastern Europe 387,024 158,470 736,472 2,798,040 540,098 7,140,570 41,581,236 4,679 36%
Free Female Condom 127,384 92,620 620,900 330,058 4,673 1,701,943 (47)% 2,687,167 6,570,025
West and Central Africa - 16,667 25,000 136,693 - 676,424 716,304 266 -%
East Africa 69,300 13,000 92,300 306,000 142,313 777,529 2,669,687 1,404 (35)%
Southern Africa 58,000 61,667 209,500 1,190,250 470,524 1,198,545 2,964,464 2,995 (55)%
Americas 84 1,194 3,038 4,000 133 4,255 83,922 7 2,184%
Asia and Eastern Europe - 93 220 65,000 7,930 30,414 135,648 1 (97)%
HAART (Mother and Baby) - - - - - - -% - 256
Asia and Eastern Europe - - - - - - 256 - -%
HAART (Mother Only) - - - - - - -% - 239
Asia and Eastern Europe - - - - - - 239 - -%
Implant 3 Distribution 28,386 1,325 2,390 30,059 35,080 25,600 1,158% 16,007 82,743
West and Central Africa - - - - - - (8,706) - -%
East Africa 28,609 1,306 30,770 22,550 2,766 16,401 65,495 35,696 1,012%
Southern Africa (128) 55 (554) 3,050 (80) 218 4,266 (564) -%
Americas (62) - (62) - - - (111) (22) -%
Asia and Eastern Europe (33) (36) (95) - (296) (612) 21,799 (29) -%
Implant 3 Insertion 3,307 1,999 4,909 7,162 9,360 27,900 46% 22,124 76,135
West and Central Africa - - - - - - 11,148 - -%
East Africa 1,744 1,565 4,742 27,000 3,973 17,755 48,685 7,667 19%
Southern Africa 462 398 1,257 - 640 3,699 12,042 1,362 96%
Americas 1,068 - 1,068 900 - 58 1,197 300 -%
Asia and Eastern Europe 33 36 95 - 296 612 3,063 31 (68)%
Implant 4 Distribution (2) 29 1,060 (277) (259) 600 (126)% 974 20,626
Southern Africa 138 172 154 600 1,375 2,300 19,857 201 (89)%
Asia and Eastern Europe (140) (143) (431) - (315) (1,326) 769 (460) -%
Implant 4 Insertion 161 325 517 997 1,455 - 93% 2,138 6,020
East Africa - 174 523 - - 188 711 906 -%
3004 - 4/18/2014 4:47:37PM Page 3 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Southern Africa 21 8 43 - 41 166 1,440 60 5%
Asia and Eastern Europe 140 143 431 - 476 1,784 3,869 489 (9)%
Implant 5 Distribution 7,753 (5,410) 13,316 8,173 10,132 262,719 (39)% 90,132 282,757
West and Central Africa (2,804) (6,457) (1,301) 95,251 15,005 54,314 136,017 (1,712)(109)%
East Africa 5,946 1,681 9,467 70,807 2,530 27,195 51,851 20,181 274%
Southern Africa (2,894) (625) (7,086) 72,698 (4,438) (5,360) 47,570 (16,622) -%
Americas 1,296 52 1,178 1,470 115 294 9,934 609 924%
Asia and Eastern Europe 6,209 (60) 5,915 22,493 104 13,689 37,385 7,675 5,588%
Implant 5 Insertion 21,775 20,084 45,057 64,836 130,938 114,335 44% 201,835 617,432
West and Central Africa 9,041 9,341 28,646 11,000 16,009 82,593 243,075 59,864 79%
East Africa 6,656 5,278 17,645 50,200 15,371 64,006 195,094 33,204 15%
Southern Africa 5,604 4,449 15,836 37,200 10,828 44,340 150,933 36,514 46%
Americas 84 463 1,053 8,040 1,006 5,187 11,041 532 5%
Asia and Eastern Europe 390 554 1,656 7,895 1,843 5,709 17,289 825 (10)%
Infant Fortified Food - - - - - - -% - 91,859
Asia and Eastern Europe - - - - - - 91,859 - -%
Injectable 1 40,594 14,376 69,506 69,842 1,385 320,050 -% 239,947 3,015,450
West and Central Africa - - - 30,000 8,400 44,523 224,928 - (100)%
Americas 13,989 6,654 31,054 55,050 11,006 49,438 240,197 349 182%
Asia and Eastern Europe 26,605 7,722 38,788 235,000 50,100 145,986 2,550,325 1,036 (23)%
Injectable 2 115,968 103,700 414,441 327,582 26,586 2,219,000 (21)% 1,528,871 17,398,944
West and Central Africa 71,808 88,737 265,419 1,439,000 263,961 995,089 11,593,015 22,984 1%
Americas - 3 3 - - 7 19 - -%
Asia and Eastern Europe 44,160 14,960 62,160 780,000 150,480 533,775 5,805,910 3,602 (59)%
Injectable 3 369,823 445,541 1,885,382 1,559,853 151,798 8,098,143 (17)% 7,287,500 60,679,111
West and Central Africa 4,374 50,172 494,138 2,849,234 637,679 2,141,419 20,187,804 65,921 (23)%
East Africa 31,686 55,813 106,184 796,098 329,710 980,711 10,417,056 12,801 (68)%
Southern Africa 130,849 156,916 443,649 1,901,111 402,119 1,818,024 11,745,836 47,028 10%
3004 - 4/18/2014 4:47:37PM Page 4 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Americas 17,200 17,605 49,110 245,000 84,100 234,118 3,039,259 1,916 (42)%
Asia and Eastern Europe 185,714 165,034 466,772 2,306,700 431,774 2,113,228 15,289,156 24,131 8%
Iron Folic Acid Tablet - - 192,000 - - - (100)% 1,109,910 48,233,970
Asia and Eastern Europe - - - - 192,000 1,109,910 48,233,970 - (100)%
ITN - - - - - - -% - 19,397,605
West and Central Africa - - - - - - 891,146 - -%
East Africa - - - - - - 18,226,857 - -%
Southern Africa - - - - - - 249,314 - -%
Americas - - - - - - 30,288 - -%
IUD 10 Distribution 21,379 1,335 6,153 24,925 70,103 403,095 305% 161,255 1,906,525
West and Central Africa 5,235 (4,013) 12,848 146,710 16,027 87,038 1,362,018 30,350 (20)%
East Africa 17,258 5,390 21,496 106,691 (7,791) 52,409 160,480 55,226 -%
Southern Africa 62 (152) (2,314) 47,900 (856) 2,117 27,529 (5,722) -%
Americas 179 49 (241) 22,760 720 (1,445) 184,419 (161)(133)%
Asia and Eastern Europe (1,356) 61 (6,864) 79,034 (1,947) 21,136 172,080 (9,590) -%
IUD 10 Insertion 28,614 24,388 94,639 79,088 164,845 244,509 (16)% 329,408 1,057,116
West and Central Africa 9,072 7,979 25,396 11,658 21,661 86,410 243,509 62,317 17%
East Africa 9,359 6,548 24,588 132,824 48,685 124,394 382,699 60,692 (49)%
Southern Africa 3,961 3,203 10,783 24,800 10,280 42,688 171,753 24,854 5%
Americas 2,326 2,056 6,618 27,760 5,683 29,532 101,698 3,584 16%
Asia and Eastern Europe 3,896 4,601 11,703 47,467 8,330 46,383 157,457 13,397 40%
IUD 5 Distribution 70,457 2,537 309,743 54,382 55,971 702,228 (82)% 650,771 3,761,995
West and Central Africa - - - - - - 3,726 - -%
East Africa 1,121 146 1,427 2,000 (994) (3,265) 8,676 2,876 -%
Southern Africa - - - - - - 937 - -%
Asia and Eastern Europe 69,337 2,391 52,955 700,228 310,737 654,036 3,748,655 53,095 (83)%
IUD 5 Insertion 18,981 19,028 41,477 57,043 67,987 8,392 38% 217,842 455,667
West and Central Africa - - - - - - - - -%
3004 - 4/18/2014 4:47:37PM Page 5 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
East Africa 431 348 1,257 6,700 1,229 6,461 18,040 2,695 2%
Southern Africa - - - - - - 2,921 - -%
Asia and Eastern Europe 18,550 18,680 55,786 1,692 40,248 211,382 434,706 65,292 39%
LLINs 3,447,104 4,745,948 1,656,897 8,311,551 5,842,629 20,182,557 402% 23,685,899 184,971,759
West and Central Africa 2,719,390 1,862,092 5,676,460 7,385,582 144,542 4,924,948 67,320,633 4,303,202 3,827%
East Africa 545,738 524,857 1,602,810 7,469,167 1,340,786 8,892,806 74,663,400 586,369 20%
Southern Africa 11,586 2,358,992 861,870 4,258,090 78,326 8,287,907 34,734,647 952,428 1,000%
Americas - - - - - - 3,396,535 - -%
Other Africa - - - - - - 22,408 - -%
Asia and Eastern Europe 170,390 7 170,411 1,069,718 93,243 1,580,238 4,834,136 629 83%
Lubricant A 576,486 (32,811,957) 100,969,871 (98,226,235) - 5,140,281 (197)% 106,001,685 46,140,102
West and Central Africa - 167 - 1,000 388 12,673 419,165 - (100)%
East Africa - 33,333 100,000 120,000 - 363,003 760,379 - -%
Southern Africa 128,400 (33,325,650) (99,858,750) - 100,244,620 100,524,109 1,140,064 - (200)%
Americas 58,586 51,023 192,850 395,249 137,017 485,851 2,689,459 - 41%
Asia and Eastern Europe 389,500 429,170 1,339,665 4,624,032 587,846 4,616,049 41,131,035 - 128%
Lubricant B 7,751 9,027 21,052 23,870 - 105,400 13% 109,089 583,721
Asia and Eastern Europe 7,751 9,027 23,870 105,400 21,052 109,089 583,721 - 13%
Lubricant C - - - - - - -% - 97,867
West and Central Africa - - - - - - 69,081 - -%
Americas - - - - - - 28,786 - -%
Lubricant D - - - - - - -% - 6,823
Asia and Eastern Europe - - - - - - 6,823 - -%
Lubricant E 42,418 36,330 89,960 143,664 - 300,191 60% 345,309 2,131,972
West and Central Africa 26,845 25,223 102,515 160,000 66,922 187,772 1,323,177 - 53%
Southern Africa 6,240 6,064 18,732 72,000 6,672 64,764 83,496 - 181%
Americas 9,333 5,043 22,417 68,191 16,366 92,773 725,299 - 37%
Malaria PPT (ACT) 2,165,953 614,267 3,891,871 3,302,186 1,890,670 14,346,393 (15)% 14,129,290 69,109,414
3004 - 4/18/2014 4:47:37PM Page 6 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
West and Central Africa 1,621,359 419,966 2,248,125 10,377,742 3,072,573 10,770,194 45,178,107 1,167,952 (27)%
East Africa 433,390 119,241 789,327 2,197,650 248,229 1,363,985 16,670,380 602,784 218%
Southern Africa 98,675 51,484 206,956 750,000 214,934 941,369 3,458,412 110,255 (4)%
Asia and Eastern Europe 12,529 23,576 57,778 1,021,001 356,135 1,053,742 3,802,515 9,680 (84)%
Malaria PPT (Non-ACT) - 11,967 38,700 12,500 1,065 66,825 (68)% 76,600 13,742,163
West and Central Africa - - - - - - 5,009,188 - -%
Southern Africa - - - - - - 8,462,175 - -%
Americas - 11,967 12,500 66,825 38,700 76,600 270,800 1,065 (68)%
Malaria PPT (Non-ACT) P - - 33,333 - - 40,095 (100)% 44,700 44,700
Americas - - - 40,095 33,333 44,700 44,700 - (100)%
Malaria RDK 185,127 180,813 377,154 408,260 - 5,416,622 8% 2,343,384 10,066,355
West and Central Africa - 60,900 - 2,172,714 56,497 262,809 1,594,132 - (100)%
East Africa 14,150 83 14,400 500,000 - 425 63,000 - -%
Southern Africa 115,669 72,084 278,968 1,064,908 157,547 1,196,873 3,075,327 - 77%
Americas - - - 360,000 - - 190 - -%
Asia and Eastern Europe 55,308 47,745 114,892 1,319,000 163,110 883,277 5,333,706 - (30)%
Male Circumcision 29,155 30,582 44,207 77,086 274,559 357,630 74% 342,501 814,227
East Africa 2,110 3,045 8,002 30,313 1,601 25,096 58,597 15,819 400%
Southern Africa 27,045 27,537 69,084 327,317 42,606 317,405 755,630 258,740 62%
Manual Vacuum Aspiration - - - - - - -% - 3,249
Asia and Eastern Europe - - - - - - 3,249 - -%
Medical Abortion 42,660 30,887 165,572 110,345 3,502 516,353 (33)% 506,434 1,667,462
Southern Africa - - - - - - 10,451 - -%
Asia and Eastern Europe 42,660 30,887 110,345 516,353 165,572 506,434 1,657,011 3,502 (33)%
Micronutrient Powder 343,280 83,077 477,750 549,570 - 3,900,000 15% 1,251,160 14,074,775
East Africa 312,200 45,767 449,460 1,500,000 - 960 450,420 - -%
Southern Africa 31,080 37,310 100,110 2,400,000 444,150 1,161,600 2,268,930 - (77)%
Americas - - - - - - 2,818,903 - -%
3004 - 4/18/2014 4:47:37PM Page 7 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Asia and Eastern Europe - - - - 33,600 88,600 8,536,522 - (100)%
Misoprostol for PAC (Oral) 1,406 1,327 166,671 4,606 40 1,253,464 (97)% 1,180,760 1,495,774
West and Central Africa 700 327 900 53,740 351 77,832 78,732 18 156%
East Africa 56 - 56 1,129,724 166,320 1,075,928 1,386,392 1 (100)%
Americas 650 1,000 3,650 30,000 - 7,000 10,650 21 -%
Asia and Eastern Europe - - - 40,000 - 20,000 20,000 - -%
Misoprostol for PPH 170,486 24,269 71,881 196,136 753 273,860 173% 521,974 2,848,468
West and Central Africa 2,000 5,067 11,600 - 3,640 56,210 73,210 74 219%
East Africa 168,486 19,200 184,536 267,600 62,860 328,124 2,164,989 679 194%
Southern Africa - - - - - 119,988 584,608 - -%
Americas - 2 - 1,260 377 1,092 3,446 - (100)%
Asia and Eastern Europe - - - 5,000 5,004 16,560 22,215 - (100)%
Multivitamin 203,400 204,070 651,930 667,650 64 2,880,300 2% 2,445,090 87,861,679
West and Central Africa 3,240 39,580 100,380 720,300 143,820 517,170 15,141,458 17 (30)%
Southern Africa - - - - - - 12,270,645 - -%
Americas 200,160 164,490 567,270 2,160,000 508,110 1,927,920 46,939,531 47 12%
Asia and Eastern Europe - - - - - - 13,510,045 - -%
Naloxone 80 3,102 1,932 3,104 4,216 7,246 61% 13,141 59,461
Asia and Eastern Europe 80 3,102 3,104 7,246 1,932 13,141 59,461 4,216 61%
Needle & Syringe 653,710 245,869 280,425 1,166,002 9,109 4,229,974 316% 1,611,855 6,080,927
Americas - - - - - 138,400 1,540,000 - -%
Asia and Eastern Europe 653,710 245,869 1,166,002 4,229,974 280,425 1,473,455 4,540,927 9,109 316%
Nevirapine - - - - - - -% - 11,442
East Africa - - - - - - 11,292 - -%
Americas - - - - - - 150 - -%
OCs 2,908,461 2,808,122 9,545,457 8,463,580 211,097 39,726,763 (11)% 49,904,400 483,530,572
West and Central Africa 1,057,700 721,302 2,657,642 12,888,424 2,431,951 12,508,630 131,866,687 86,976 9%
East Africa 545,105 612,546 1,854,691 6,185,098 1,697,428 6,528,861 51,023,767 55,889 9%
3004 - 4/18/2014 4:47:37PM Page 8 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Southern Africa 397,928 473,075 1,177,700 5,994,952 1,066,753 5,668,634 56,568,877 35,860 10%
Americas 143,888 132,698 428,475 1,693,289 453,054 1,549,950 31,291,044 3,330 (5)%
Asia and Eastern Europe 763,840 868,500 2,345,072 12,965,000 3,896,271 23,648,325 212,780,197 29,042 (40)%
ORS 592,338 329,715 913,702 1,256,067 42,507 3,416,550 37% 2,759,237 427,410,832
West and Central Africa 7,622 99,050 230,825 496,000 328,225 516,506 63,587,941 6,361 (30)%
East Africa 493,979 29,595 558,245 563,050 169,202 893,844 21,055,304 24,016 230%
Southern Africa - - - - - - 1,999,000 - -%
Americas 19,440 19,120 63,600 311,500 80,400 253,680 8,798,096 740 (21)%
Other Africa - - - - - - 6,127,779 - -%
Asia and Eastern Europe 71,297 181,950 403,397 2,046,000 335,875 1,095,207 325,842,712 11,389 20%
Pneumonia PPT 61,302 32,477 261,670 134,338 75,690 561,643 (49)% 1,135,465 2,854,266
West and Central Africa - 4,120 12,360 45,030 151,619 225,124 498,457 9,478 (92)%
East Africa 26,338 3,792 37,715 190,613 42,802 634,661 1,165,040 29,765 (12)%
Southern Africa 19,105 7,656 39,979 96,000 22,816 49,924 189,954 19,247 75%
Asia and Eastern Europe 15,859 16,909 44,284 230,000 44,433 225,756 1,000,815 17,200 -%
Pregnancy Test 6,984 13,472 10,441 27,525 - - 164% 101,440 841,773
West and Central Africa - 167 500 - 1,315 3,526 5,175 - (62)%
Americas - - - - - 2,760 129,873 - -%
Asia and Eastern Europe 6,984 13,305 27,025 - 9,126 95,154 706,725 - 196%
PUR 7,346,107 2,098,198 23,577,125 10,905,904 1,754 37,417,319 (54)% 54,952,909 313,727,906
West and Central Africa 222,720 350,400 1,135,440 5,166,009 864,737 6,293,607 29,064,562 373 31%
East Africa 7,123,387 1,747,798 9,770,464 32,251,310 22,702,831 47,701,985 216,084,832 1,382 (57)%
Southern Africa - - - - 9,557 10,037 4,694,784 - (100)%
Americas - - - - - 947,280 21,231,358 - -%
Asia and Eastern Europe - - - - - - 42,652,370 - -%
Retreatment - - - - - - -% - 46,984,114
West and Central Africa - - - - - - 1,638,283 - -%
East Africa - - - - - - 40,711,711 - -%
3004 - 4/18/2014 4:47:37PM Page 9 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Southern Africa - - - - - - 74,431 - -%
Americas - - - - - - 111,568 - -%
Other Africa - - - - - - 26,407 - -%
Asia and Eastern Europe - - - - - - 4,421,714 - -%
Retreatment IconMaxx 21,519 - 361,420 21,519 3,243 - (94)% 361,420 4,873,846
East Africa - - - - - - 2,297,300 - -%
Asia and Eastern Europe 21,519 - 21,519 - 361,420 361,420 2,576,546 3,243 (94)%
Retreatment KO123 - - 15 - - - (100)% 76 9,124,110
West and Central Africa - - - - - - 4,082 - -%
East Africa - - - - - - 8,813,436 - -%
Southern Africa - - - - - - - - -%
Asia and Eastern Europe - - - - 15 76 306,592 - (100)%
Retreatment KO123 net - - - - - - -% - 10,259,477
East Africa - - - - - - 10,259,477 - -%
Safe Injection Kit - - - - - - -% - 5
Asia and Eastern Europe - - - - - - 5 - -%
Safe Water Solution 1,010,618 828,244 3,515,267 2,524,061 34,560 14,019,414 (28)% 14,818,770 127,656,515
West and Central Africa 110,909 20,903 143,454 466,781 335,080 960,982 11,182,749 2,054 (57)%
East Africa 418,996 351,590 1,192,308 5,923,974 1,391,728 6,100,505 58,003,444 17,068 (14)%
Southern Africa 411,953 330,454 932,507 5,588,259 1,371,423 5,770,773 49,868,419 13,635 (32)%
Americas 63,000 120,000 243,000 1,940,400 376,810 1,861,810 2,554,108 1,778 (36)%
Asia and Eastern Europe 5,760 5,298 12,792 100,000 40,226 124,700 6,047,795 26 (68)%
SD NVP w/o Baby ARV Prophylaxis - - - - - - -% - 271
Asia and Eastern Europe - - - - - - 271 - -%
SD NVP with Baby ARV Prophylaxis - - - - - - -% - 235
Asia and Eastern Europe - - - - - - 235 - -%
SDM (Cycle Beads) 7,027 5,955 16,281 17,930 13,289 80,051 10% 67,711 427,723
West and Central Africa 6,151 5,085 15,456 58,789 9,904 39,752 257,984 11,713 56%
3004 - 4/18/2014 4:47:37PM Page 10 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
East Africa - - - - 262 423 11,624 - (100)%
Southern Africa 870 870 2,468 21,262 6,115 27,536 158,109 1,573 (60)%
Asia and Eastern Europe 6 - 6 - - - 6 3 -%
STI Kit - - - - - - -% - 691,263
West and Central Africa - - - - - - 1,796 - -%
East Africa - - - - - - 438,695 - -%
Asia and Eastern Europe - - - - - - 250,772 - -%
STI Kit (Non-Ulcerative) 41,801 18,954 83,276 80,820 2,877 298,891 (3)% 238,448 3,339,154
West and Central Africa - - - 4,400 1,656 2,900 7,704 - (100)%
East Africa 4,008 6,762 14,264 191,100 68,838 159,142 615,481 773 (79)%
Southern Africa 30,002 2 30,008 1,391 490 1,544 1,845,653 1,359 6,024%
Asia and Eastern Europe 7,791 12,189 36,548 102,000 12,292 74,862 870,316 745 197%
STI Kit (Ulcerative) 1,002 992 9,389 2,652 338 26,563 (72)% 23,751 1,807,048
West and Central Africa - - - 600 199 280 480 - (100)%
East Africa 174 186 441 18,900 7,190 16,733 38,509 80 (94)%
Southern Africa - 1 4 63 6 46 1,720,798 2 (33)%
Asia and Eastern Europe 828 805 2,207 7,000 1,994 6,692 47,261 256 11%
TB DOTS 2,171 1,808 4,332 5,667 33,678 23,860 31% 24,605 195,425
Asia and Eastern Europe 2,171 1,808 5,667 23,860 4,332 24,605 195,425 33,678 31%
Tubal Ligation - 194 1,144 582 2,065 18,619 (49)% 5,964 218,166
Americas - - - 2,619 - 76 76 - -%
Asia and Eastern Europe - 194 582 16,000 1,144 5,888 218,090 2,065 (49)%
Vasectomy - - - - - 220 -% 10 10
Americas - - - 220 - 10 10 - -%
VCT 186,127 161,930 1,093,161 518,072 151,877 1,859,115 (53)% 2,574,044 13,526,183
West and Central Africa 11,589 11,009 38,757 73,772 702,843 833,024 3,167,522 3,417 (94)%
East Africa 65,087 64,999 171,448 690,670 139,284 631,064 2,857,604 20,367 23%
Southern Africa 102,164 80,210 288,916 1,010,807 236,242 1,033,064 6,949,258 126,622 22%
3004 - 4/18/2014 4:47:37PM Page 11 of 12
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION
Americas 3,474 1,959 7,612 32,806 5,309 35,565 179,816 426 43%
Asia and Eastern Europe 3,813 3,754 11,339 51,060 9,483 41,327 371,983 1,044 20%
Water Treatment Tablets 9,834,980 4,788,409 17,308,972 15,790,584 7,638 65,905,007 (9)% 73,394,843 486,216,064
West and Central Africa 1,635,800 1,477,433 4,446,700 23,079,020 1,868,020 20,548,532 105,370,387 2,396 138%
East Africa 8,097,400 2,954,609 11,240,104 42,726,837 11,404,752 37,969,411 272,341,682 5,216 (1)%
Southern Africa 36,000 349,800 36,000 - 3,672,000 13,107,400 100,713,518 9 (99)%
Asia and Eastern Europe 65,780 6,567 67,780 99,150 364,200 1,769,500 7,790,477 17 (81)%
Zinc 157,914 136,010 65,040 559,045 6,212 352,150 760% 305,721 3,309,166
West and Central Africa 790 122,597 368,580 15,000 14,000 20,842 389,422 4,187 2,533%
East Africa 157,124 1,014 160,165 306,050 45,040 235,649 1,436,337 1,710 256%
Southern Africa - - - - - - - - -%
Asia and Eastern Europe - 12,400 30,300 31,100 6,000 49,230 1,483,407 315 405%
3004 - 4/18/2014 4:47:37PM Page 12 of 12
West & Central Africa
POPULATION SERVICES INTERNATIONAL
CYPs, Cases, and Deaths by Country
1/2014 - 3/2014
Cases CYP*
HIV & TB Reproductive Health
Maternal
Deaths
Unintended
Pregnancies
Malaria
Cases
Malaria
Deaths
Diarrhea
Cases
Diarrhea
Deaths
Malaria Control Child Survival
Sum of
All Deaths
Pneumonia
Cases
Pneumonia
Deaths
STI
Deaths
TB
Deaths
Nutrition
Deaths
IDU
Deaths
West and Central Africa 6,643 1,180,947 1,390 373,264 - 71,694 555 - 73,750 - 111 - - - -
Benin 246 68,535 57 22,805 - 6 111 - 174 - - - - - -
C.A.R. - - - - - - - - - - - - - - -
Cameroon 803 73,971 89 21,514 - 79 19 - 298 - 111 - - - -
Congo-Kinshasa 54 46,399 55 16,977 - 35,263 52 - 35,370 - - - - - -
Cote d'Ivoire 25 1,904 2 504 - - 106 - 108 - - - - - -
Cote d'Ivoire (AIMAS) - - - - - - - - - - - - - - -
Guinea 208 46,414 84 15,042 - 212 154 - 450 - - - - - -
Liberia 1 1,308 2 377 - - 1 - 3 - - - - - -
Mali 195 115,326 125 44,381 - 4,320 68 - 4,513 - - - - - -
Nigeria 4,695 767,996 934 234,216 - 31,735 44 - 32,712 - - - - - -
Senegal 181 24,809 17 7,093 - 48 - - 65 - - - - - -
Togo 235 34,287 27 10,355 - 30 - - 57 - - - - - -
3001 - 4/18/2014 4:44:54PM Page 1 of 5
* Using USAID CYP conversion factors
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
West and Central Africa - All 352,036 6,477,337 6,125,301
Basic Care Package - - - - - - 600 -% 600 600 -
Cervical Cancer-VIA and Cryotherapy 13 9 1 38 11 11 - 3,700% 3 41 -
Clean Delivery Kit 800 1,033 81 3,200 384 384 - 3,851% 11,281 205,336 -
Condom 20,901,222 20,551,483 64,139,299 58,252,146 235,425 561,478 311,107,980 (9)% 310,685,161 3,613,373,536 326,053
Diarrhea Treatment Kit 263,904 72,561 393,653 460,034 31,939 31,939 2,073,933 17% 895,712 4,039,306 -
Emergency Contraception 94,680 104,654 203,682 280,427 7,291 7,291 1,580,000 38% 935,598 9,225,271 -
Female Condom 113,158 205,266 991,072 345,093 1,360 3,233 3,260,711 (65)% 3,205,990 17,148,835 1,873
Free Condom 1,935,918 1,133,290 2,071,326 3,653,134 14,244 34,791 6,232,561 76% 19,772,368 100,703,511 20,547
Free Female Condom - 16,667 - 25,000 121 266 136,693 -% 676,424 716,304 144
Implant 5 Distribution (2,804) (4,036) 29,926 (1,301) (1,712) (1,712) 95,251 (104)% 127,071 319,435 -
Implant 5 Insertion 9,041 9,341 16,009 28,646 59,864 59,864 11,000 79% 82,593 111,239 -
Injectable 1 - - 8,400 - - - 30,000 (100)% 44,523 224,928 -
Injectable 2 71,808 88,737 263,961 265,419 22,984 22,984 1,439,000 1% 995,089 11,593,015 -
Injectable 3 4,374 50,172 637,679 494,138 65,921 65,921 2,849,234 (23)% 2,148,499 18,849,462 -
IUD 10 Distribution 5,235 (1,482) 37,268 12,848 30,350 30,350 146,710 (66)% 146,567 1,534,679 -
IUD 10 Insertion 9,072 7,979 21,661 25,396 62,317 62,317 11,658 17% 86,410 111,806 -
LLINs 2,719,390 1,862,092 144,542 5,676,460 4,303,202 4,303,202 7,385,582 3,827% 4,924,948 44,303,699 -
Lubricant A - 167 388 - - - 1,000 (100)% 12,673 12,723 -
Lubricant E 26,845 25,223 66,922 102,515 - - 160,000 53% 187,772 1,323,177 -
Malaria PPT (ACT) 1,621,359 419,966 3,072,573 2,248,125 1,167,952 1,167,952 10,377,742 (27)% 10,770,194 23,969,646 -
Malaria RDK - 60,900 56,497 - - - 2,172,714 (100)% 262,809 262,809 -
3003 - 4/18/2014 4:48:57PM Page 1 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Misoprostol for PAC (Oral) 700 327 351 900 18 18 53,740 156% 77,832 78,732 -
Misoprostol for PPH 2,000 5,067 3,640 11,600 74 74 - 219% 56,210 73,210 -
Multivitamin 3,240 39,580 143,820 100,380 17 17 720,300 (30)% 517,170 15,141,458 -
OCs 1,057,700 721,302 2,431,951 2,657,642 86,976 86,976 12,888,424 9% 12,508,630 81,256,477 -
ORS 7,622 99,050 328,225 230,825 6,361 6,361 496,000 (30)% 516,506 9,454,735 -
Pneumonia PPT - 4,120 151,619 12,360 9,478 9,478 45,030 (92)% 225,124 498,457 -
Pregnancy Test - 167 1,315 500 - - - (62)% 3,526 5,175 -
PUR 222,720 350,400 864,737 1,135,440 373 373 5,166,009 31% 6,293,607 28,715,831 -
Safe Water Solution 110,909 20,903 335,080 143,454 2,054 2,054 466,781 (57)% 960,982 11,160,779 -
SDM (Cycle Beads) 6,151 5,085 9,904 15,456 11,713 11,713 58,789 56% 39,752 257,984 -
STI Kit (Non-Ulcerative) - - 1,656 - - - 4,400 (100)% 2,900 7,304 -
STI Kit (Ulcerative) - - 199 - - - 600 (100)% 280 480 -
VCT 11,589 11,009 702,843 38,757 - 3,417 73,772 (94)% 833,024 2,574,980 3,417
Water Treatment Tablets 1,635,800 1,477,433 1,868,020 4,446,700 2,396 2,396 23,079,020 138% 20,548,532 105,370,387 -
Zinc 790 122,597 14,000 368,580 4,187 4,187 15,000 2,533% 20,842 389,422 -
3003 - 4/18/2014 4:49:12PM Page 2 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
West and Central Africa - All 352,036 6,125,301 6,477,337
Benin 13,288 45,003 58,291
13 9 1 38 11 11 - 3 41 - 3700%Cervical Cancer-VIA and Cryotherapy
2 /13 3,700% 38 11 11 - 41 3 1 - 9 13 Cervical Cancer-VIA and Cryotherapy
747,828 903,264 1,479,486 2,381,752 9,755 22,055 11,200,000 8,017,123 44,686,952 12,300 61%Condom
2 /10 5% 440,956 4,083 1,806 2,277 9,880,894 1,771,531 418,006 2,200,000 149,488 171,720 Koool
1 /08 83% 1,940,796 17,972 7,949 10,023 34,806,058 6,245,592 1,061,480 9,000,000 753,776 576,108 Prudence Plus
155,008 846 148,708 157,254 9,245 9,245 360,000 211,104 1,900,816 - 6%Diarrhea Treatment Kit
4 /08 6% 157,254 9,245 9,245 - 1,900,816 211,104 148,708 360,000 846 155,008 Orasel Zinc DTK
16 275 550 406 2 4 7,650 10,215 64,610 2 (26)%Female Condom
3 /14 -% 16 - - - 16 - - - - 16 Cupid
6 /08 (29)% 390 3 2 2 64,594 10,215 550 7,650 275 - Femidom
1,170 14,027 61,220 43,250 177 400 - 136,252 7,600,126 223 (29)%Free Condom
5 /03 (29)% 43,250 400 177 223 7,600,126 136,252 61,220 - 14,027 1,170 Generic
- - - - - - 850 - 11,230 - 0%Free Female Condom
12/11 -% - - - - 11,230 - - 850 - - Free Femidom
(2,848) 83 136 (3,074) (5,681) (5,681) 20,000 8,362 50,067 - (2360)%Implant 5 Distribution
-%(6,211) (11,478)(11,478) - (22,876)(16,665)(3,585) - (1,330)(2,848) PSI Implant 5 Distributed Inserted (1)
9 /09 (16)% 3,137 5,797 5,797 - 72,943 25,027 3,721 20,000 1,412 - Jadelle
2,848 1,330 3,585 6,211 12,210 12,210 - 16,665 22,876 - 73%Implant 5 Insertion
73% 6,211 12,210 12,210 - 22,876 16,665 3,585 - 1,330 2,848 PSI Implant 5 Inserted
608 3,604 6,361 9,319 787 787 39,000 30,559 86,497 - 47%Injectable 2
1 /12 47% 9,319 787 787 - 86,497 30,559 6,361 39,000 3,604 608 Noristerat
699 468 (1,435) 1,350 3,020 3,020 16,100 7,206 37,161 - 0%IUD 10 Distribution
-%(5,056) (11,310)(11,310) - (16,652)(11,596)(4,118) - (1,108)(2,278) PSI IUD 10 Distributed Inserted (1)
3002 - 4/18/2014 4:45:43PM Page 1 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
9 /09 139% 6,406 14,330 14,330 - 53,813 18,802 2,683 16,100 1,576 2,977 IUD Copper-T TCU 380A
2,278 1,108 4,118 5,056 12,032 12,032 - 11,596 16,652 - 23%IUD 10 Insertion
23% 5,056 12,032 12,032 - 16,652 11,596 4,118 - 1,108 2,278 PSI IUD 10 Inserted
286 395 223 1,052 470 470 7,000 8,450 707,075 - 372%LLINs
5 /06 372% 1,052 470 470 - 707,075 8,450 223 7,000 395 286 Super Moustiquaire Longue Durée
700 199 11 700 12 12 20,000 16,292 16,992 - 6264%Misoprostol for PAC (Oral)
1 /13 6,264% 700 12 12 - 16,992 16,292 11 20,000 199 700 Misoprostol for PAC (oral)
13,368 20,193 51,003 45,627 1,479 1,479 180,000 183,873 313,616 - (11)%OCs
6 /12 (11)% 45,627 1,479 1,479 - 313,616 183,873 51,003 180,000 20,193 13,368 Laafia Pilule
518 497 461 1,560 1,186 1,186 2,000 1,906 24,571 - 238%SDM (Cycle Beads)
12/04 238% 1,560 1,186 1,186 - 24,571 1,906 461 2,000 497 518 CycleBeads
6,726 4,159 13,409 17,070 - 763 - 71,273 282,878 763 27%VCT
1 /10 (98)% 20 - - - 8,444 1,044 814 - 4 8 VCT Concordant Couple (HIV-Negative)
9 /10 -% 2 5 - 5 74 8 2 - 1 - VCT Concordant Couple (HIV-Positive)
1 /10 (100)% - - - - 100 5 5 - - - VCT Discordant Couple (HIV-Negative)
1 /10 (100)% - - - - 100 5 5 - - - VCT Discordant Couple (HIV-Positive)
1 /10 35% 16,846 280 - 280 270,838 69,474 12,448 - 4,099 6,632 VCT Individual (HIV-Negative)
1 /10 50% 202 478 - 478 3,322 737 135 - 55 86 VCT Individual (HIV-Positive)
423,200 421,067 1,065,450 1,042,800 297 297 6,500,000 6,545,950 38,456,160 - (2)%Water Treatment Tablets
1 /08 (2)% 1,042,800 297 297 - 38,456,160 6,545,950 1,065,450 6,500,000 421,067 423,200 Aquatab
C.A.R. - - -
- - 538,560 - - - - 1,892,700 63,900,917 - (100)%Condom
7 /99 (100)% - - - - 63,900,917 1,892,700 538,560 - - - Lovers Plus
- - 3,748 - - - - 14,804 473,257 - (100)%Female Condom
11/08 (100)% - - - - 473,257 14,804 3,748 - - - Condom Feminin
3002 - 4/18/2014 4:46:24PM Page 2 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Cameroon 42,830 50,424 93,254
2,397,094 2,480,087 6,032,947 6,693,116 24,864 64,665 29,500,000 26,757,957 115,264,708 39,801 11%Condom
8 /06 11% 6,693,116 64,665 24,864 39,801 115,264,708 26,757,957 6,032,947 29,500,000 2,480,087 2,397,094 Prudence Plus
900 266 43 1,698 120 120 15,000 43 621,444 - 3849%Diarrhea Treatment Kit
10/09 3,849% 1,698 120 120 - 621,444 43 43 15,000 266 900 Orasel Zinc
77,220 160,594 149,727 180,251 670 1,675 1,645,168 1,555,174 4,845,244 1,005 20%Female Condom
11/13 -% 148,630 1,381 552 829 545,962 397,332 - 145,168 128,134 56,880 Female Condom UNFPA
11/02 (98)% 3,000 28 11 17 4,184,561 1,071,742 149,727 1,300,000 1,000 - Protectiv
11/13 -% 28,621 266 106 160 114,721 86,100 - 200,000 31,460 20,340 Securite Plus Female Condom
642 70 283 1,147 1,923 1,923 14,000 3,130 24,011 - 305%Implant 5 Distribution
-%(613) (1,027)(1,027) - (1,823)(1,210)(337) - (285)(188) PSI Implant 5 Distributed Inserted (1)
7 /09 184% 1,760 2,950 2,950 - 25,834 4,340 620 14,000 355 830 Jadelle
188 285 337 613 1,093 1,093 6,000 1,210 1,823 - 82%Implant 5 Insertion
82% 613 1,093 1,093 - 1,823 1,210 337 6,000 285 188 PSI Implant 5 Inserted
- - - - - - 16,000 50 194,204 - 0%Injectable 3
11/00 -% - - - - 194,204 50 - 16,000 - - Depo-Provera
263 179 2,350 (520) (1,055) (1,055) 18,792 13,404 44,919 - (122)%IUD 10 Distribution
-%(2,695) (5,468)(5,468) - (7,910)(5,215)(1,475) - (1,104)(662) PSI IUD 10 Distributed Inserted (1)
9 /09 (43)% 2,175 4,413 4,413 - 52,829 18,619 3,825 18,792 1,283 925 IUD
662 1,104 1,475 2,695 5,817 5,817 9,840 5,215 7,910 - 83%IUD 10 Insertion
83% 2,695 5,817 5,817 - 7,910 5,215 1,475 9,840 1,104 662 PSI IUD 10 Inserted
5,410 9,975 3,286 10,147 5,916 5,916 41,000 37,230 7,886,702 - 209%LLINs
1 /09 209% 10,147 5,916 5,916 - 7,886,702 37,230 3,286 41,000 9,975 5,410 Super Moustiquaire
99 950 46,336 99 39 39 164,492 56,610 751,252 - (100)%Malaria PPT (ACT)
4 /10 (100)% 99 39 39 - 751,252 56,610 46,336 164,492 950 99 StoPalu
3002 - 4/18/2014 4:46:24PM Page 3 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
- - 56,497 - - - 172,714 80,109 80,109 - (100)%Malaria RDK
12/12 (100)% - - - - 80,109 80,109 56,497 172,714 - - Malaria Ag Pf/Pan_PA
- 128 340 200 6 6 33,740 61,540 61,740 - (41)%Misoprostol for PAC (Oral)
1 /13 (41)% 200 6 6 - 61,740 61,540 340 33,740 128 - Misoprostol for PAC (oral)
- - - - - - 100,000 - 74,936 - 0%OCs
1 /08 -% - - - - 74,936 - - 100,000 - - Novelle Duo
7,622 17,709 18,200 42,510 1,448 1,448 200,000 102,791 3,389,278 - 134%ORS
9 /98 134% 42,510 1,448 1,448 - 3,389,278 102,791 18,200 200,000 17,709 7,622 Orasel
- 4,120 80,760 12,360 9,478 9,478 35,530 80,860 93,220 - (85)%Pneumonia PPT
1 /13 (100)% - - - - 80,860 80,860 80,760 33,398 - - Amoxicillin 500mg x 15's -- Children 1-5 years
1 /13 -% 12,360 9,478 9,478 - 12,360 - - 2,132 4,120 - Amoxicillin 500mg x 7's - Children 2-11 months
2,141 1,116 5,965 2,214 43 43 20,000 19,742 362,425 - (63)%Safe Water Solution
11/06 (63)% 2,214 43 43 - 362,425 19,742 5,965 20,000 1,116 2,141 Sur'Eau Water Guard
- 3,924 - 11,772 - 2,024 8,455 3,920 31,272 2,024 0%VCT
1 /10 -% 10,288 441 - 441 29,072 3,869 - 7,525 3,429 - VCT Individual (HIV-Negative)
1 /10 -% 1,484 1,583 - 1,583 2,200 51 - 930 495 - VCT Individual (HIV-Positive)
790 1,100 14,000 4,090 63 63 15,000 20,842 24,932 - (71)%Zinc
7 /09 (71)% 4,090 63 63 - 24,932 20,842 14,000 15,000 1,100 790 Zinc
Congo-Kinshasa 2,882 2,619,036 2,621,918
- - 81 - - - - 81 180,586 - (100)%Clean Delivery Kit
10/04 (100)% - - - - 180,586 81 81 - - - Delivrans
- 5,070 11,294,119 15,210 74 168 22,000,000 34,284,264 457,671,414 94 (100)%Condom
11/87 (100)% 10,834 119 53 67 457,660,414 34,277,640 11,287,719 22,000,000 3,611 - Prudence
12/12 (32)% 4,376 48 21 27 11,000 6,624 6,400 - 1,459 - Prudence Sensuel
19,326 4,528 27,685 28,109 3,423 3,423 159,100 83,290 232,828 - 2%Diarrhea Treatment Kit
3002 - 4/18/2014 4:46:24PM Page 4 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
7 /10 (9)% 5,089 620 620 - 40,688 16,153 5,595 6,000 - 5,089 DTK1
7 /10 (26)% 16,283 1,983 1,983 - 185,403 67,137 22,090 - 2,392 13,907 DTK2
11/13 -% 6,737 820 820 - 6,737 - - 153,100 2,136 330 ORA-ZINC
- - 601,661 - - - 600,000 1,071,109 6,671,648 - (100)%Female Condom
8 /04 (100)% - - - - 6,671,648 1,071,109 601,661 600,000 - - Prudence Femme
- 233,060 - 429,180 2,085 4,729 1,504,325 6,156,179 22,789,244 2,644 0%Free Condom
3 /09 -% 429,180 4,729 2,085 2,644 18,204,885 1,571,820 - 1,504,325 233,060 - Generic MC
7 /13 -% - - - - 4,584,359 4,584,359 - - - - Prudence Free Distribution
- 16,667 - 25,000 121 266 130,843 675,475 704,075 144 0%Free Female Condom
3 /09 -% 25,000 266 121 144 203,600 175,000 - 130,843 16,667 - Generic FC
7 /13 -% - - - - 500,475 500,475 - - - - Prudence Femme Free Distribution
(485) 757 (826) 1,495 3,276 3,276 21,200 (745) 13,731 - 0%Implant 5 Distribution
-%(9,600) (21,038)(21,038) - (20,373)(10,773)(1,078) - (3,466)(1,921) PSI Implant 5 Distributed Inserted (1)
9 /09 4,303% 11,095 24,315 24,315 - 34,104 10,028 252 21,200 4,223 1,436 Jadelle
1,921 3,486 1,151 9,600 22,381 22,381 - 10,977 20,577 - 734%Implant 5 Insertion
791% 9,600 22,381 22,381 - 20,373 10,773 1,078 - 3,466 1,921 PSI Implant 5 Inserted
(100)% - - - - 204 204 73 - 20 - Non-PSI Implant 5 Inserted
- - 78,909 - - - 195,000 218,591 1,533,312 - (100)%Injectable 3
9 /03 (100)% - - - - 1,340,222 225,671 78,909 195,000 - - Confiance Depo-Provera
4 /11 -% - - - - 193,090 (7,080) - - - - Confiance Petogen
(8) (48) 258 (94) (249) (249) - 1,515 23,064 - (136)%IUD 10 Distribution
-%(165) (438)(438) - (1,106)(941)(319) - (61)(68) PSI IUD 10 Distributed Inserted (1)
9 /03 (88)% 71 188 188 - 24,170 2,456 577 - 14 60 Confiance
68 61 324 165 466 466 - 946 1,111 - (49)%IUD 10 Insertion
(48)% 165 466 466 - 1,106 941 319 - 61 68 PSI IUD 10 Inserted
3002 - 4/18/2014 4:46:24PM Page 5 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
(100)% - - - - 5 5 5 - - - Non-PSI IUD 10 Inserted
72 1,274,844 127,582 2,064,798 2,542,518 2,542,518 5,200,590 2,023,564 20,182,544 - 1518%LLINs
11/13 -% - - - - 136,176 136,176 - - - - MAGNet Large Rectangular
9 /06 1,518% 2,064,798 2,542,518 2,542,518 - 20,046,368 1,887,388 127,582 5,200,590 1,274,844 72 PermaNet
- 167 - - - - - 11,990 11,990 - 0%Lubricant A
7 /13 -% - - - - 11,990 11,990 - - 167 - Personal Lubricant 4.5 g
57,660 166,081 92,432 74,510 44,056 44,056 1,065,000 702,029 1,229,479 - (19)%Malaria PPT (ACT)
4 /11 (30)% 27,998 16,555 16,555 - 271,695 117,119 40,031 24,645 12,442 20,148 ACT 1 (2 to 11 months)
4 /11 (11)% 46,512 27,501 27,501 - 693,417 320,543 52,401 188,805 65,517 37,512 ACT 2 (1 to 5 years)
12/13 -% - - - - 134,092 134,092 - 305,550 44,697 - ACT 3 (6 to 13 years)
12/13 -% - - - - 130,275 130,275 - 546,000 43,425 - ACT 4 (over 13 years)
- 60,900 - - - - 2,000,000 182,700 182,700 - 0%Malaria RDK
12/13 -% - - - - 182,700 182,700 - 2,000,000 60,900 - SD Bioline
- - 222,380 1 - - 918,000 864,489 2,511,764 - (100)%OCs
11/11 (100)% 1 - - - 2,264,551 864,489 222,380 810,000 - - Combination 3
9 /03 -% - - - - 247,213 - - 108,000 - - Confiance Ovrette
- - 70,859 - - - 9,500 144,264 405,237 - (100)%Pneumonia PPT
2 /11 (100)% - - - - 77,805 36,416 14,927 2,000 - - Cotri-pneumo PPT1
2 /11 (100)% - - - - 194,823 68,254 34,825 5,000 - - Cotri-pneumo PPT2
2 /11 (100)% - - - - 132,609 39,594 21,107 2,500 - - Cotri-pneumo PPT3
131,760 254,240 790,577 815,760 301 301 4,666,009 5,318,727 23,703,986 - 3%PUR
3 /14 -% 40,080 15 15 - 40,080 - - - - 40,080 P&G Purifiant Water
11/07 (2)% 775,680 286 286 - 23,663,906 5,318,727 790,577 4,666,009 254,240 91,680 PuR
- - 2,407 - - - 3,600 7,239 69,623 - (100)%SDM (Cycle Beads)
9 /04 (100)% - - - - 69,623 7,239 2,407 3,600 - - CycleBeads
3002 - 4/18/2014 4:46:24PM Page 6 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
344,800 250,133 8,000 792,000 584 584 4,481,648 4,530,382 27,881,516 - 9800%Water Treatment Tablets
7 /08 9,800% 792,000 584 584 - 27,881,516 4,530,382 8,000 4,481,648 250,133 344,800 Aquatab
Cote d'Ivoire 1,427 10,057 11,483
- - - - - - 600 600 600 - 0%Basic Care Package
12/12 -% - - - - 600 600 - 600 - - Life Straw - PLWHIV
106,436 40,677 77,308 228,468 870 2,147 500,000 1,138,398 3,055,517 1,278 196%Free Condom
1 /08 196% 228,468 2,147 870 1,278 3,055,517 1,138,398 77,308 500,000 40,677 106,436 Free Distribution
- - - - - - 5,000 949 999 - 0%Free Female Condom
8 /12 -% - - - - 999 949 - 5,000 - - Female Condom Free
- - 388 - - - 1,000 683 733 - (100)%Lubricant A
9 /12 (100)% - - - - 445 445 150 500 - - Gel Lubricant 4.5 g
8 /12 (100)% - - - - 288 238 238 500 - - Gel Lubricant 5 mL
- 81,340 310,025 188,315 4,913 4,913 296,000 413,715 6,065,457 - (39)%ORS
11/98 (39)% 188,315 4,913 4,913 - 6,065,457 413,715 310,025 296,000 81,340 - Orasel
- - 1,656 - - - 4,400 2,900 7,304 - (100)%STI Kit (Non-Ulcerative)
12/07 (100)% - - - - 1,812 310 199 600 - - LEUCO-P
12/07 (100)% - - - - 1,109 308 199 600 - - LEUCO-S
12/12 (100)% - - - - 561 561 199 500 - - SALPIN-P1
12/12 (100)% - - - - 330 330 199 500 - - SALPIN-P2
12/07 (100)% - - - - 2,580 1,078 661 1,500 - - URET-P
12/07 (100)% - - - - 912 313 199 700 - - URET-S
- - 199 - - - 600 280 480 - (100)%STI Kit (Ulcerative)
12/07 (100)% - - - - 480 280 199 600 - - ULGEN
486 377 4,096 1,208 - 149 20,054 12,915 72,805 149 (71)%VCT
1 /10 (79)% 14 - - - 946 162 66 3,730 5 4 VCT Concordant Couple (HIV-Negative)
3002 - 4/18/2014 4:46:24PM Page 7 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
9 /10 50% 6 9 - 9 64 18 4 80 1 4 VCT Concordant Couple (HIV-Positive)
1 /10 (50)% 3 - - - 45 16 6 100 1 - VCT Discordant Couple (HIV-Negative)
1 /10 (50)% 3 5 - 5 45 16 6 100 1 - VCT Discordant Couple (HIV-Positive)
1 /10 (70)% 1,114 32 - 32 68,195 12,023 3,752 15,402 349 462 VCT Individual (HIV-Negative)
1 /10 (74)% 68 103 - 103 3,510 680 262 642 20 16 VCT Individual (HIV-Positive)
400,000 68,400 8,440 605,200 149 149 2,000,000 25,690 7,987,185 - 7071%Water Treatment Tablets
8 /08 7,071% 605,200 149 149 - 7,987,185 25,690 8,440 2,000,000 68,400 400,000 Aquatab
- 121,497 - 364,490 4,124 4,124 - - 364,490 - 0%Zinc
2 /14 -% 364,490 4,124 4,124 - 364,490 - - - 121,497 - Zincfant 20 mg
Cote d'Ivoire (AIMAS) - - -
- 862,401 5,791,747 - - - 1,734,240 24,098,056 96,983,452 - (100)%Condom
3 /10 (100)% - - - - 78,122,982 20,851,389 4,446,075 1,490,400 800,960 - Prudence
3 /10 (100)% - - - - 18,860,470 3,246,667 1,345,672 243,840 61,441 - UNIDUS Condom
- 20,673 75,900 - - - 30,000 289,319 505,259 - (100)%Emergency Contraception
3 /10 (100)% - - - - 505,259 289,319 75,900 30,000 20,673 - Pregnon
- 17 - - - - - 1,437 113,443 - 0%Female Condom
3 /10 -% - - - - 113,443 1,437 - - 17 - Femidom
- - 1,015,704 - - - - 1,301,016 1,301,016 - (100)%Free Condom
11/12 (100)% - - - - 1,301,016 1,301,016 1,015,704 - - - Free Male Condoms
- 2,771 41,316 - - - 5,000 138,244 163,644 - (100)%Injectable 3
9 /11 (100)% - - - - 163,644 138,244 41,316 5,000 2,771 - Harmonia
- 75,285 79,834 - - - 150,000 2,562,275 8,599,722 - (100)%OCs
3 /10 (100)% - - - - 8,599,722 2,562,275 79,834 150,000 75,285 - Confiance OC
Guinea 10,925 54,367 65,293
610,080 506,600 1,595,220 2,121,480 9,553 20,478 6,864,751 8,347,940 33,975,338 10,925 33%Condom
3002 - 4/18/2014 4:46:24PM Page 8 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
1 /08 33% 2,121,480 20,478 9,553 10,925 33,975,338 8,347,940 1,595,220 6,864,751 506,600 610,080 Prudence Plus
59,800 37,510 192,720 172,210 11,102 11,102 612,175 446,790 949,996 - (11)%Diarrhea Treatment Kit
9 /12 (11)% 172,210 11,102 11,102 - 949,996 446,790 192,720 612,175 37,510 59,800 Orasel Zinc DTK
39,000 10,740 18,600 71,020 9,897 9,897 255,066 130,208 1,109,754 - 282%Injectable 3
9 /07 282% 71,020 9,897 9,897 - 1,109,754 130,208 18,600 255,066 10,740 39,000 Equilibre
15,819 279 - 15,819 16,014 16,014 - 1,045,074 1,060,893 - 0%LLINs
3 /13 -% 12,170 12,320 12,320 - 418,000 405,830 - - 247 12,170 Moustiquaires Coniques
3 /13 -% 3,649 3,694 3,694 - 642,893 639,244 - - 33 3,649 Moustiquaires Rectangulaires
90,000 31,200 33,876 164,700 5,871 5,871 374,430 273,969 5,626,333 - 386%OCs
12/95 386% 164,700 5,871 5,871 - 5,626,333 273,969 33,876 374,430 31,200 90,000 Planyl
106,488 13,771 127,755 133,848 1,930 1,930 386,781 357,839 2,438,012 - 5%Safe Water Solution
7 /06 5% 133,848 1,930 1,930 - 2,438,012 357,839 127,755 386,781 13,771 106,488 Sur Eau
- - 25,399 - - - - 64,665 326,262 - (100)%VCT
2 /11 (100)% - - - - 1,100 322 322 - - - VCT Concordant Couple (HIV-Negative)
12/09 (100)% - - - - 310,017 62,148 24,153 - - - VCT Individual (HIV-Negative)
12/09 (100)% - - - - 15,145 2,195 924 - - - VCT Individual (HIV-Positive)
Liberia 75 729 804
- 416 92,640 - - - 600,000 530,908 1,957,202 - (100)%Condom
7 /09 (100)% - - - - 1,957,202 530,908 92,640 600,000 416 - STAR
4,632 7,176 - 13,512 56 131 12,000 28,332 41,844 75 0%Free Condom
11/13 -% 13,512 131 56 75 41,844 28,332 - 12,000 7,176 4,632 Free Condom
118 121 - 287 539 539 900 580 867 - 0%Implant 5 Distribution
11/13 -% 287 539 539 - 867 580 - 900 121 118 Jadelle
95 138 - 246 32 32 1,000 785 1,031 - 0%Injectable 3
11/13 -% 246 32 32 - 1,031 785 - 1,000 138 95 Depo-Provera
3002 - 4/18/2014 4:46:24PM Page 9 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
80 308 - 644 21 21 2,000 934 1,578 - 0%OCs
11/13 -% 644 21 21 - 1,578 934 - 2,000 308 80 Oral Contraceptive Pill
2,280 6,016 4,344 7,392 82 82 60,000 26,697 387,847 - 70%Safe Water Solution
7 /09 70% 7,392 82 82 - 387,847 26,697 4,344 60,000 6,016 2,280 WaterGuard
Mali 10,586 399,310 409,896
560 374,569 4,462,080 1,966,480 9,432 19,512 22,103,357 19,220,910 112,926,297 10,080 (56)%Condom
7 /01 (56)% 1,966,480 19,512 9,432 10,080 112,926,297 19,220,910 4,462,080 22,103,357 374,569 560 Protector Plus
10,370 19,078 24,497 51,263 4,354 4,354 177,658 154,485 284,722 - 109%Diarrhea Treatment Kit
11/12 109% 51,263 4,354 4,354 - 284,722 154,485 24,497 177,658 19,078 10,370 Orasel Zinc
1,034 1,608 - 5,194 25 50 4,053 3,524 232,154 25 0%Female Condom
8 /02 -% 5,194 50 25 25 232,154 3,524 - 4,053 1,608 1,034 Protectiv
395 (7,478) (2,864)(1,292) (2,796) (2,796) 21,651 10,917 68,269 - 0%Implant 5 Distribution
-%(5,172) (11,193)(11,193) - (25,425)(20,253)(6,044) - (1,535)(1,945) PSI Implant 5 Distributed Inserted (1)
7 /09 22% 3,880 8,397 8,397 - 93,694 31,170 3,180 21,651 (5,943) 2,340 Jadelle
1,945 1,535 6,044 5,172 11,907 11,907 - 20,253 25,425 - (14)%Implant 5 Insertion
(14)% 5,172 11,907 11,907 - 25,425 20,253 6,044 - 1,535 1,945 PSI Implant 5 Inserted
48,186 (123,032) 147,754 112,110 16,641 16,641 576,168 501,016 3,704,324 - (24)%Injectable 3
5 /03 (24)% 112,110 16,641 16,641 - 3,704,324 501,016 147,754 576,168 (123,032) 48,186 Confiance Injectable
1,934 (6,596) (733) 2,231 5,845 5,845 - (420) 41,818 - 0%IUD 10 Distribution
-%(4,314) (11,302)(11,302) - (22,265)(17,951)(5,458) - (1,427)(1,666) PSI IUD 10 Distributed Inserted (1)
10/09 (100)% - - - - 49,403 9,892 4,725 - (6,700) - IUD
12/09 -% 6,545 17,146 17,146 - 14,680 7,639 - - 1,532 3,600 IUD (insertion)
1,666 1,427 5,458 4,314 12,023 12,023 - 17,951 22,265 - (21)%IUD 10 Insertion
(21)% 4,314 12,023 12,023 - 22,265 17,951 5,458 - 1,427 1,666 PSI IUD 10 Inserted
643,460 262,413 - 648,076 325,690 325,690 2,014,967 1,595,111 8,697,598 - 0%LLINs
3002 - 4/18/2014 4:46:24PM Page 10 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
8 /04 -% - - - - 5,544,858 812,489 - - - - Famille Protégé
11/13 -% 1,340 673 673 - 1,350 10 - - 450 - Olyset 2.0
4 /08 -% - - - - 1,722,042 - - 2,014,967 - - Olyset Net Moustiquaire Impregnee GP
11/13 -% 1,243 625 625 - 1,253 10 - - 418 - Olyset+
11/13 -% 644,664 323,975 323,975 - 1,427,256 782,592 - - 261,265 643,460 Permanet 2.0
11/13 -% 829 417 417 - 839 10 - - 280 - Permanet 3.0
- - 34,605 - - - 1,140,447 34,605 1,290,854 - (100)%Malaria PPT (ACT)
5 /10 (100)% - - - - 541,387 70 70 485,786 - - Coartem 12 tabs
5 /10 (100)% - - - - 749,467 34,535 34,535 654,661 - - Coartem 6 tabs
386,736 (98,523) 355,550 386,736 14,683 14,683 1,624,740 1,482,567 11,767,489 - 9%OCs
5 /03 9% 386,736 14,683 14,683 - 11,767,489 1,482,567 355,550 1,624,740 (98,523) 386,736 Pilplan
- 52 154 156 139 139 639 663 26,911 - 1%SDM (Cycle Beads)
9 /07 1% 156 139 139 - 26,911 663 154 639 52 - Cycle Beads
4,377 2,549 3,151 8,707 - 482 25,263 23,463 88,285 482 176%VCT
1 /10 200% 36 1 - 1 504 86 12 - 10 20 VCT Concordant Couple (HIV-Negative)
1 /11 -% - - - - 22 2 - - - - VCT Concordant Couple (HIV-Positive)
1 /10 -% 1 - - - 19 3 1 - - 1 VCT Discordant Couple (HIV-Negative)
1 /10 -% 1 2 - 2 19 3 1 - - 1 VCT Discordant Couple (HIV-Positive)
1 /10 173% 8,500 133 - 133 85,870 22,944 3,109 24,770 2,497 4,272 VCT Individual (HIV-Negative)
1 /10 504% 169 346 - 346 1,851 425 28 493 42 83 VCT Individual (HIV-Positive)
467,800 733,833 779,500 2,000,700 1,365 1,365 8,111,410 7,053,400 28,590,170 - 157%Water Treatment Tablets
2 /09 157% 2,000,700 1,365 1,365 - 28,590,170 7,053,400 779,500 8,111,410 733,833 467,800 Aquatab
Nigeria 248,400 2,925,242 3,173,642
800 1,033 - 3,200 384 384 - 11,200 24,750 - 0%Clean Delivery Kit
3002 - 4/18/2014 4:46:24PM Page 11 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
9 /10 -% 3,200 384 384 - 24,750 11,200 - - 1,033 800 Clean Delivery Kit
15,584,040 14,646,529 30,499,560 42,181,488 177,199 414,923 201,000,000 178,105,703 2,627,380,501 237,724 38%Condom
3 /90 39% 42,027,264 413,406 176,551 236,855 2,622,191,704 177,265,184 30,252,672 200,000,000 14,601,600 15,539,328 Gold Circle
10/06 (95)% 3,240 32 14 18 1,217,235 157,464 66,096 1,000,000 1,080 1,296 Lifestyle - Flavours
10/06 (70)% 17,496 172 73 99 1,190,226 176,256 57,672 - 4,752 4,536 Lifestyle - Original Small Cartons
10/06 11% 66,744 657 280 376 1,414,227 275,433 60,264 - 19,657 18,144 Lifestyle - Ribbed
10/06 6% 66,744 657 280 376 1,367,109 231,366 62,856 - 19,440 20,736 Lifestyle - Ultra Thin
18,500 10,333 - 49,500 3,695 3,695 750,000 - 49,500 - 0%Diarrhea Treatment Kit
2 /14 -% 49,500 3,695 3,695 - 49,500 - - 750,000 10,333 18,500 Pediatric Zinc Sulphate Tabs/ORS Co-PAC
94,680 83,981 127,782 280,427 7,291 7,291 1,550,000 646,279 8,720,012 - 119%Emergency Contraception
4 /99 93% 246,227 6,402 6,402 - 8,289,663 645,919 127,782 1,500,000 74,501 88,560 Postinor II
11/07 -% 34,200 889 889 - 430,349 360 - 50,000 9,480 6,120 Pregnon
31,240 41,000 234,836 154,240 648 1,463 1,000,000 526,534 4,171,298 815 (34)%Female Condom
7 /09 (34)% 154,240 1,463 648 815 4,171,298 526,534 234,836 1,000,000 41,000 31,240 Female Condom
871,200 674,400 885,600 1,749,600 7,350 17,210 - 9,597,456 60,190,489 9,860 98%Free Condom
12/05 98% 1,749,600 17,210 7,350 9,860 60,190,489 9,597,456 885,600 - 674,400 871,200 Condom Sample
510 507 10,825 1,710 3,241 3,241 12,500 29,264 59,717 - (84)%Implant 5 Distribution
-% - - - - (5,496)(5,496)(1,665) - - - PSI Implant 5 Distributed Inserted (1)
9 /07 (86)% 1,710 3,241 3,241 - 65,213 34,760 12,490 12,500 507 510 Jadelle
1,003 1,080 1,665 3,314 6,682 6,682 - 10,203 13,517 - 99%Implant 5 Insertion
(100)% - - - - 5,496 5,496 1,665 - - - PSI Implant 5 Inserted
-% 3,314 6,682 6,682 - 8,021 4,707 - - 1,080 1,003 Non-PSI Implant 5 Inserted
- - 8,400 - - - 30,000 44,523 224,928 - (100)%Injectable 1
6 /07 (100)% - - - - 224,928 44,523 8,400 30,000 - - Norigynon
71,200 85,133 257,600 256,100 22,196 22,196 1,400,000 964,530 11,506,518 - (1)%Injectable 2
3002 - 4/18/2014 4:46:24PM Page 12 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
12/95 (1)% 256,100 22,196 22,196 - 11,506,518 964,530 257,600 1,400,000 85,133 71,200 Noristerat
(84,800) 153,067 341,300 293,100 38,105 38,105 1,700,000 1,093,003 11,711,261 - (14)%Injectable 3
12/95 (14)% 293,100 38,105 38,105 - 11,711,261 1,093,003 341,300 1,700,000 153,067 (84,800)Depo-Provera
2,460 2,088 15,406 10,080 23,128 23,128 110,000 65,317 1,324,155 - (35)%IUD 10 Distribution
-% - - - - (22,173)(22,173)(9,614) - (1,272) - PSI IUD 10 Distributed Inserted (1)
9 /12 105% 2,460 5,644 5,644 - 17,820 8,400 1,200 - 760 360 Copper T 380
5 /93 (68)% 7,620 17,484 17,484 - 1,328,508 79,090 23,820 110,000 2,600 2,100 IUD
4,285 4,149 9,614 12,915 31,525 31,525 - 46,905 59,820 - 34%IUD 10 Insertion
(100)% - - - - 22,173 22,173 9,614 - 1,272 - PSI IUD 10 Inserted
-% 12,915 31,525 31,525 - 37,647 24,732 - - 2,877 4,285 Non-PSI IUD 10 Inserted
2,043,832 309,884 13,420 2,917,527 1,406,699 1,406,699 - 175,045 5,458,777 - 21640%LLINs
11/13 -% 2,910,320 1,403,224 1,403,224 - 3,067,840 157,520 - - 306,280 2,042,000 GF Rectangular Net
11/04 (39)% 6,982 3,366 3,366 - 2,139,479 11,200 11,445 - 3,388 1,782 PermaNet
9 /06 (89)% 225 108 108 - 251,458 6,325 1,975 - 217 50 PermaNet Student
26,845 25,223 66,922 102,515 - - 160,000 187,772 1,323,177 - 53%Lubricant E
12/03 53% 102,515 - - - 1,323,177 187,772 66,922 160,000 25,223 26,845 Lubrica
1,563,600 252,935 2,899,200 2,173,516 1,123,857 1,123,857 8,007,803 9,976,950 20,698,061 - (25)%Malaria PPT (ACT)
9 /12 (22)% 669,364 346,107 346,107 - 5,062,857 3,262,370 856,800 2,171,011 116,311 406,320 ACT 1 (Yellow)
9 /12 (22)% 603,520 312,061 312,061 - 5,686,394 3,476,840 769,280 1,519,714 131,973 270,600 ACT 2 (Blue)
9 /12 (63)% 219,520 113,507 113,507 - 4,834,328 2,106,540 586,080 1,060,572 33 219,420 ACT 3 (Orange)
9 /12 (1)% 681,112 352,182 352,182 - 5,114,482 1,131,200 687,040 3,256,506 4,617 667,260 ACT 4 (Green)
2,000 5,067 3,640 11,600 74 74 - 56,210 73,210 - 219%Misoprostol for PPH
7 /11 2,800% 11,600 74 74 - 49,830 32,830 400 - 5,067 2,000 Misoprostol
12/12 (100)% - - - - 23,380 23,380 3,240 - - - Vanprazol
528,300 632,700 1,569,150 1,914,300 63,657 63,657 9,000,000 6,525,858 50,978,912 - 22%OCs
3002 - 4/18/2014 4:46:24PM Page 13 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
10/11 22% 1,914,300 63,657 63,657 - 14,016,402 6,525,480 1,569,150 9,000,000 632,700 528,300 Combination 3
7 /97 -% - - - - 36,962,510 378 - - - - Duofem
90,960 96,160 74,160 319,680 72 72 500,000 974,880 5,011,845 - 331%PUR
1 /08 331% 319,680 72 72 - 5,011,845 974,880 74,160 500,000 96,160 90,960 PuR
- - 197,016 - - - - 556,704 7,972,495 - (100)%Safe Water Solution
11/04 (100)% - - - - 7,972,495 556,704 197,016 - - - WaterGuard
4,400 4,367 6,528 12,100 9,438 9,438 50,000 27,660 124,221 - 85%SDM (Cycle Beads)
7 /06 85% 12,100 9,438 9,438 - 124,221 27,660 6,528 50,000 4,367 4,400 CycleBeads
- - 656,788 - - - - 656,788 1,743,681 - (100)%VCT
12/09 (100)% - - - - 1,611,623 620,573 620,573 - - - VCT Individual (HIV-Negative)
12/09 (100)% - - - - 132,058 36,215 36,215 - - - VCT Individual (HIV-Positive)
Senegal 9,356 5,640 14,996
710,220 634,480 1,770,640 1,831,020 1,239 10,594 8,155,632 7,046,800 10,848,733 9,356 3%Condom
11/12 27% 745,920 4,316 505 3,811 3,946,800 2,390,400 589,440 3,262,279 186,880 313,920 Fagaru
11/12 -% - - - - 1,160,433 - - 4,893,353 - - Protec
1 /13 (27)% 176,700 1,022 120 903 1,229,100 1,052,400 243,600 - 87,200 21,900 Protec Fraise
1 /13 (3)% 908,400 5,256 614 4,642 4,512,400 3,604,000 937,600 - 360,400 374,400 Protec Naturel
1,893 1,954 - 6,060 127 127 50,000 13,196 33,733 - 0%Injectable 3
11/12 -% 6,060 127 127 - 33,733 13,196 - 50,000 1,954 1,893 Depo-Provera
9,599 3,348 - 15,271 3,629 3,629 115,000 34,087 49,358 - 0%LLINs
8 /13 -% 15,271 3,629 3,629 - 49,358 34,087 - 115,000 3,348 9,599 MILDA
38,016 49,104 96,336 120,528 645 645 428,254 500,256 1,086,480 - 25%OCs
11/12 25% 120,528 645 645 - 1,086,480 500,256 96,336 428,254 49,104 38,016 Securil
- 4,000 6,630 6,000 1 1 1,985,962 2,393,110 2,455,356 - (10)%Water Treatment Tablets
11/12 (10)% 6,000 1 1 - 2,455,356 2,393,110 6,630 1,985,962 4,000 - Aquatabs 67 mg (20 L)
3002 - 4/18/2014 4:46:24PM Page 14 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Togo 12,267 15,494 27,760
851,400 138,067 582,300 1,061,600 3,309 9,083 7,950,000 2,382,800 47,778,022 5,774 82%Condom
12/07 82% 1,061,600 9,083 3,309 5,774 47,778,022 2,382,800 582,300 7,950,000 138,067 851,400 Protector Plus Banane
3,648 1,771 550 5,002 16 41 3,840 23,193 577,181 26 809%Female Condom
6 /01 809% 5,002 41 16 26 577,181 23,193 550 3,840 1,771 3,648 Protectiv
952,480 163,950 31,494 1,189,124 3,706 10,174 4,216,236 1,414,735 5,725,275 6,467 3676%Free Condom
2 /11 3,676% 1,189,124 10,174 3,706 6,467 5,725,275 1,414,735 31,494 4,216,236 163,950 952,480 Condom No Logo
(1,136) (517) 7,451 (1,574) (2,214) (2,214) 5,000 2,806 30,016 - (121)%Implant 5 Distribution
-%(3,736) (5,254)(5,254) - (22,096)(18,360)(2,212) - (1,571)(1,136) PSI Implant 5 Distributed Inserted (1)
10/09 (78)% 2,162 3,040 3,040 - 52,112 21,166 9,663 5,000 1,054 - Jadelle
1,136 1,626 3,227 3,736 5,589 5,589 5,000 23,285 27,021 - 16%Implant 5 Insertion
69% 3,736 5,589 5,589 - 22,096 18,360 2,212 5,000 1,571 1,136 PSI Implant 5 Inserted
(100)% - - - - 4,925 4,925 1,015 - 55 - Non-PSI Implant 5 Inserted
- 4,534 9,800 11,602 1,119 1,119 51,000 46,326 591,289 - 18%Injectable 3
5 /00 18% 11,602 1,119 1,119 - 591,289 46,326 9,800 51,000 4,534 - Depo-Provera
(113) (105) 181 (199) (339) (339) 1,818 16 4,033 - (210)%IUD 10 Distribution
-%(251) (427)(427) - (1,904)(1,653)(257) - (122)(113) PSI IUD 10 Distributed Inserted (1)
7 /11 (100)% - - - - 4,522 306 198 - - - IUD
9 /12 (78)% 52 89 89 - 1,415 1,363 240 1,818 17 - IUD Copper-T TCU 380A
113 129 672 251 455 455 1,818 3,797 4,048 - (63)%IUD 10 Insertion
(2)% 251 455 455 - 1,904 1,653 257 1,818 122 113 PSI IUD 10 Inserted
(100)% - - - - 2,144 2,144 415 - 7 - Non-PSI IUD 10 Inserted
912 953 31 3,770 2,267 2,267 7,025 6,387 260,752 - 12061%LLINs
4 /02 12,061% 3,770 2,267 2,267 - 260,752 6,387 31 7,025 953 912 Serena
3,240 39,580 143,820 100,380 17 17 720,300 517,170 15,141,458 - (30)%Multivitamin
3002 - 4/18/2014 4:46:24PM Page 15 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
2 /02 (30)% 100,380 17 17 - 15,141,458 517,170 143,820 720,300 39,580 3,240 Vitalite
1,200 11,035 23,822 25,106 619 619 111,000 114,409 295,647 - 5%OCs
12/10 5% 25,106 619 619 - 295,647 114,409 23,822 111,000 11,035 1,200 Combo 3
- 167 1,315 500 - - - 3,526 5,175 - (62)%Pregnancy Test
4 /11 (62)% 500 - - - 5,175 3,526 1,315 - 167 - Pregnancy Test
1,233 169 354 1,640 949 949 2,550 2,284 12,658 - 363%SDM (Cycle Beads)
10/09 363% 1,640 949 949 - 12,658 2,284 354 2,550 169 1,233 Cycle Beads
- - - - - - 20,000 - 29,797 - 0%VCT
12/09 -% - - - - 758 - - 324 - - VCT Concordant Couple (HIV-Negative)
12/09 -% - - - - 30 - - 33 - - VCT Concordant Couple (HIV-Positive)
12/09 -% - - - - 53 - - 16 - - VCT Discordant Couple (HIV-Negative)
12/09 -% - - - - 53 - - 16 - - VCT Discordant Couple (HIV-Positive)
12/09 -% - - - - 27,473 - - 19,027 - - VCT Individual (HIV-Negative)
12/09 -% - - - - 1,430 - - 584 - - VCT Individual (HIV-Positive)
3002 - 4/18/2014 4:46:24PM Page 16 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
WeWest and Central Africa
Benin $135,741 $114,388 $68,667 1.67
Other RevenuesNAAmour et Vie 03/2014 0 $0 NA0 0 $0 2,643 NANA $0 00
NAAmour et Vie + 03/2014 46,900 $4,812 0%2,350 0 $1,995 19,120 0.945% $0 20,38749,250
Condom0.07Koool 03/2014 170,856 $9,676 6%864 0 $8,152 385,421 2.621% $551 146,985171,720
0.00Prudence Plus 03/2014 563,520 $12,680 0%12,588 0 $10,660 14,441,286 22.322% $49 646,932576,108
Female CondomNACupid 03/2014 0 $0 NA16 0 NA 9,984 NA100% $0 NA16
NAFemidom 03/2014 0 $0 NA0 0 $14 3,830 29.46NA $0 1300
Free CondomNAGeneric 03/2014 0 $0 NA1,170 0 $0 6,212 0.43100% $0 14,4171,170
Free Female CondomNAFree Femidom 03/2014 0 $0 NA0 0 $0 5,000 NANA $0 00
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 8 $0 NA0 0 $0 0 NA0% $0 78
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 6,632 $0 NA0 0 $0 0 NA0% $0 5,6156,632
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 86 $0 NA0 0 $0 0 NA0% $0 6786
LLINNAMoustiquaires Peace Corps 03/2014 0 $0 NA0 0 $0 25,000 NANA $0 00
0.86Super Moustiquaire Longue Durée 03/2014 210 $1,589 61%76 -25 $2,443 4,090 11.6627% $2,099 351261
RetreatmentNAAlafia 03/2014 0 $0 NA0 0 $0 0 NANA $2,828 00
Diarrhea Treatment Kit3.02Orasel Zinc DTK 03/2014 154,924 $94,931 100%84 0 $32,088 12,386 0.240% $97,025 52,418155,008
Misoprostol for PAC (Oral)NAMisoprostol for PAC (oral) 03/2014 700 $583 0%0 0 $194 20,630 88.410% $0 233700
ORSNAOrasel 03/2014 0 $0 NA0 0 $0 0 NANA $1,557 00
Water Treatment Tablets0.37Aquatab 03/2014 421,200 $7,381 30%2,000 460 $6,022 3,427,020 9.860% $2,237 347,600423,660
Page 1 of 47 4/15/2014 11:13:25 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Benin $135,741 $114,388 $68,667 1.67
Implant 5NAJadelle 03/2014 0 $0 NA0 0 $132 63 0.06NA $0 1,0460
Injectable 2NANoristerat 03/2014 450 $422 0%158 0 $2,638 2,474 0.8026% $0 3,106608
Injectable 3NAEquilibre 03/2014 0 $0 NA0 0 $0 0 NANA $2,485 00
IUD 10NAIUD Copper-T TCU 380A 03/2014 700 $73 0%2,277 0 $83 13,958 6.5476% $0 2,1352,977
OCsNAHarmonie 03/2014 0 $0 NA0 0 $0 0 NANA $1,892 00
0.79Laafia Pilule 03/2014 12,720 $3,318 84%648 0 $3,911 56,211 3.705% $3,105 15,20913,368
SDM (Cycle Beads)1.68CycleBeads 03/2014 410 $273 77%108 10 $333 5,993 11.5321% $560 520528
Cervical Cancer-VIA and CryotherapyNACervical Cancer-VIA and Cryother 03/2014 13 $0 NA0 0 $0 0 NA0% $0 1313
Burkina Faso $0 $90,883 $18,343 4.95
Condom0.24Prudence 03/2014 0 $0 NA0 0 $11,513 6,283,288 4.93NA $2,740 1,273,7120
Female CondomNAFemale Condom 03/2014 0 $0 NA0 0 $0 118,344 56.90NA $751 2,0800
OCs12.79Planif 03/2014 0 $0 NA0 0 $6,830 352,800 14.08NA $87,392 25,0560
C.A.R. $0 $422 $0 NA
Other RevenuesNA100% Jeune 03/2014 0 $0 NA0 0 $0 822 NANA $0 00
CondomNALovers Plus 03/2014 0 $0 NA0 0 $0 19,021,716 NANA $327 00
Female CondomNACondom Feminin 03/2014 0 $0 NA0 0 $0 72,402 NANA $95 00
Cameroon $129,106 $43,995 $103,132 0.43
Other Revenues28.82100% Jeune 03/2014 2,214 $389 -103%2,900 0 $334 28,273 7.9957% $9,626 3,5405,114
Condom0.06Prudence Plus 03/2014 2,334,946 $71,699 20%62,148 44,092 $65,510 51,435,367 23.053% $4,201 2,231,0392,441,186
Page 2 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Cameroon $129,106 $43,995 $103,132 0.43
Female Condom1.11Female Condom UNFPA 03/2014 56,880 $2,638 0%0 15,000 $2,303 262,558 5.300% $2,557 49,54371,880
-3.39Protectiv 03/2014 0 $0 NA0 0 -$498 825,428 825.43NA $1,688 1,0000
2.52Securite Plus Female Condom 03/2014 19,380 $967 -19%960 0 $515 221,139 23.185% $1,298 9,54020,340
LLIN0.22Super Moustiquaire 03/2014 5,406 $45,246 84%4 0 $28,317 22,921 6.780% $6,229 3,3825,410
Malaria PPT (ACT)NAStoPalu 03/2014 0 $0 NA99 0 $0 15,128 458.42100% $0 3399
Malaria RDKNAMalaria Ag Pf/Pan_PA 03/2014 0 $0 NA0 0 $0 2,816 NANA $0 00
Retreatment KO123NAKO Tab 123 03/2014 0 $0 NA0 0 NA 0 NANA $1 NA0
Diarrhea Treatment Kit-0.16Orasel Zinc 03/2014 900 $698 -6%0 0 $395 -297,654 -525.890% -$64 566900
Misoprostol for PAC (Oral)417.38Misoprostol for PAC (oral) 03/2014 0 $0 NA0 0 $21 -400 -6.00NA $8,721 670
ORS-3.09Orasel 03/2014 7,522 $1,567 12%100 7,647 $2,729 71,585 5.051% -$8,442 14,17015,269
Safe Water Solution44.69Sur'Eau Water Guard 03/2014 2,116 $1,832 41%25 2,068 $580 -27,857 -37.751% $25,931 7384,209
ZincNAZinc 03/2014 790 $226 -1%0 0 $187 206,934 151.790% $0 1,363790
Implant 50.32Jadelle 03/2014 830 $3,458 1%0 0 $2,445 1,752 2.990% $782 587830
Injectable 3NADepo-Provera 03/2014 0 $0 NA0 0 $0 13,775 NANA -$8,676 00
IUD 100.49IUD 03/2014 925 $385 3%0 0 $295 51,122 70.510% $143 725925
Pneumonia PPTNAAmoxicillin 500mg x 15's -- Childre 03/2014 0 $0 NA0 0 $0 295,640 NANA $0 00
NAAmoxicillin 500mg x 7's - Children 03/2014 0 $0 NA0 0 $0 262,140 63.63NA $0 4,1200
Congo-Kinshasa $13,317 $0 $21,727 NA
Other RevenuesNA100% Jeune 03/2014 0 $0 NA0 0 $0 574 NANA $0 00
Page 3 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Congo-Kinshasa $13,317 $0 $21,727 NA
CondomNAPrudence 03/2014 0 $0 NA0 0 $33 16,627,514 4,604.26NA $0 3,6110
NAPrudence Sensuel 03/2014 0 $0 NA0 0 $1,316 14,526,500 9,958.75NA $0 1,4590
Female CondomNAPrudence Femme 03/2014 0 $0 NA0 0 $0 37,400 NANA $0 00
Lubricant ANAPersonal Lubricant 4.5 g 03/2014 0 $0 NA0 0 $0 7,510 NANA $0 00
LLINNAPermaNet-Large Rectangular 03/2014 0 $0 NA72 0 $0 1,022,817 1.66100% $0 617,31772
NAPermaNet-Rectangular 03/2014 0 $0 NA0 0 $0 2,867,047 40.41NA $0 70,9490
NASerena-Conical 03/2014 0 $0 NA0 0 $0 1 NANA $0 00
NASerena-Rectangular 03/2014 0 $0 NA0 0 $0 1 NANA $0 00
Malaria PPT (ACT)NAACT 1 (2 to 11 months) 03/2014 0 $0 NA20,148 0 $0 85,896 9.20100% $0 9,33320,148
NAACT 2 (1 to 5 years) 03/2014 0 $0 NA37,512 0 $0 271,747 17.53100% $0 15,50437,512
NAACT 3 (6 to 13 years) 03/2014 0 $0 NA0 0 $0 97,400 NANA $0 00
NAACT 4 (over 13 years) 03/2014 0 $0 NA0 0 $0 56,722 NANA $0 00
Malaria RDKNASD Bioline 03/2014 0 $0 NA0 0 $0 250 NANA $0 00
Diarrhea Treatment KitNADTK1 03/2014 0 $0 NA5,089 0 $0 396 0.23100% $0 1,6965,089
NADTK2 03/2014 0 $0 NA13,907 0 $0 249 0.05100% $0 5,42813,907
NAORA-ZINC 03/2014 320 $208 0%10 0 $69 79,691 35.493% $0 2,246330
PURNAP&G Purifiant 03/2014 0 $0 NA0 227,040 $0 907,680 NANA $0 0227,040
NAP&G Purifiant Water 03/2014 27,360 $1,490 0%12,720 0 NA 1,321,824 NA32% $0 NA40,080
NAPuR 03/2014 91,680 $1,635 0%0 60,000 $12,032 984,842 3.810% $0 258,560151,680
Water Treatment TabletsNAAquatab 03/2014 341,920 $8,894 0%2,880 3,840 $6,925 19,732,706 74.751% $0 264,000348,640
Implant 5NAJadelle 03/2014 526 $1,044 0%910 357 $841 861 0.2363% $0 3,6981,793
Injectable 3NAConfiance Depo-Provera 03/2014 0 $0 NA0 0 $0 33,686 NANA $0 00
Page 4 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Congo-Kinshasa $13,317 $0 $21,727 NA
IUD 10NAConfiance 03/2014 60 $46 0%0 60 $15 120 5.070% $0 24120
OCsNACombination 3 03/2014 0 $0 NA0 0 $0 840,801 ,522,403.00NA $0 00
SDM (Cycle Beads)NACycleBeads 03/2014 0 $0 NA0 0 $0 74,465 NANA $0 00
Cote d'Ivoire $6,771 $30,398 $13,831 2.20
Basic Care PackageNALife Straw - PLWHIV 03/2014 0 $0 NA0 0 $0 50 NANA $0 00
Free CondomNAFree Distribution 03/2014 0 $0 NA106,436 -3,696 $0 1,154,236 15.16100% $0 76,156102,740
Free Female CondomNAFemale Condom Free 03/2014 0 $0 NA0 0 $0 1 NANA $0 00
Lubricant ANAGel Lubricant 4.5 g 03/2014 0 $0 NA0 0 $0 4 NANA $0 00
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 4 $0 NA0 0 $0 0 NA0% $0 54
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 4 $0 NA0 0 $0 0 NA0% $0 24
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 462 $0 NA0 0 $0 0 NA0% $0 371462
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 16 $0 NA0 0 $0 0 NA0% $0 2316
OlysetNAOlyset Free Distribution 03/2014 0 $0 NA0 0 $0 139 NANA $0 00
ORS1.83Orasel 03/2014 0 $0 NA0 0 $10,450 279,594 4.45NA $19,167 62,7720
Water Treatment Tablets3.32Aquatab 03/2014 400,000 $6,771 100%0 0 $3,381 1,975,455 9.790% $11,231 201,733400,000
ZincNAZincfant 20 mg 03/2014 0 $0 NA0 0 NA 547,490 NANA $0 NA0
Cote d'Ivoire (AIMAS) $0 $307,702 $0 NA
CondomNAPrudence 03/2014 0 $0 NA0 0 $0 14,235,400 NANA $136,912 00
NAUNIDUS Condom 03/2014 0 $0 NA0 0 $0 2,069,677 NANA $0 00
Page 5 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Cote d'Ivoire (AIMAS) $0 $307,702 $0 NA
Female CondomNAFemidom 03/2014 0 $0 NA0 0 $0 -8,453 NANA $0 00
Emergency ContraceptionNAPregnon 03/2014 0 $0 NA0 0 $0 177,631 NANA $63,365 00
Injectable 3NAHarmonia 03/2014 0 $0 NA0 0 $0 235,680 NANA $34,205 00
OCsNAConfiance OC 03/2014 0 $0 NA0 0 $0 449,047 NANA $73,220 00
Guinea $91,289 $40,606 $58,911 0.69
Condom0.19Prudence Plus 03/2014 609,600 $9,658 20%480 0 $10,340 474,700 0.670% $1,971 707,160610,080
LLINNAMoustiquaires Coniques-Conical 03/2014 0 $0 NA12,170 0 $0 0 NA100% $0 4,05712,170
NAMoustiquaires Rectangulaires 03/2014 0 $0 NA3,649 0 $0 0 NA100% $0 1,2163,649
Diarrhea Treatment Kit0.52Orasel Zinc DTK 03/2014 59,520 $18,794 30%280 0 $17,496 228,044 3.970% $9,153 57,40359,800
Safe Water Solution0.13Sur Eau 03/2014 104,688 $37,665 5%1,800 0 $15,749 11,978 0.272% $1,982 44,616106,488
Injectable 31.83Equilibre 03/2014 39,000 $9,914 100%0 0 $6,019 88,280 3.730% $11,033 23,67339,000
OCs1.77Planyl 03/2014 90,000 $15,257 100%0 0 $9,306 453,096 8.250% $16,466 54,90090,000
Liberia $596 $918 $461 1.99
CondomNASTAR 03/2014 0 $0 NA0 0 $0 0 NANA $843 00
Free CondomNAFree Condom 03/2014 0 $0 NA4,632 0 $0 0 NA100% $0 4,5044,632
Safe Water Solution0.16WaterGuard 03/2014 2,160 $596 0%120 0 $461 15,807 6.425% $75 2,4642,280
Implant 5NAJadelle 03/2014 0 $0 NA118 0 $0 3,848 40.22100% $0 96118
Injectable 3NADepo-Provera 03/2014 0 $0 NA95 0 $0 0 NA100% $0 8295
OCsNAOral Contraceptive Pill 03/2014 0 $0 NA80 0 $0 0 NA100% $0 21580
Page 6 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Mali $53,606 $109,159 $52,999 2.06
Other RevenuesNAVCT Fees 03/2014 31 $32 0%4,324 0 $44 -49,142 -17.0199% $0 2,8904,355
Condom0.54Protector Plus 03/2014 0 $0 NA560 0 $19,557 15,326 0.02100% $10,486 655,493560
Female Condom0.38Protectiv 03/2014 25 $1 0%1,009 3,000 $16 37,998 21.9598% $6 1,7314,034
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 20 $0 NA0 0 $0 0 NA0% $0 1220
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 1 $0 NA0 0 $0 0 NA0% $0 01
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 1 $0 NA0 0 $0 0 NA0% $0 01
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 4,272 $0 NA0 0 $0 0 NA0% $0 2,8334,272
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 83 $0 NA0 0 $0 0 NA0% $0 5683
LLINNAFamille Protégé 03/2014 0 $0 NA0 0 $0 12,229 NANA $0 00
NAOlyset 2.0 03/2014 0 $0 NA0 0 $0 152 0.34NA $0 4470
NAOlyset+ 03/2014 0 $0 NA0 0 $0 283 0.68NA $0 4140
NAPermanet 2.0 03/2014 0 $0 NA643,460 0 $0 1,045,049 4.86100% $0 214,888643,460
NAPermanet 3.0 03/2014 0 $0 NA0 0 $0 705 2.55NA $0 2760
Malaria PPT (ACT)NACoartem 12 tabs 03/2014 0 $0 NA0 0 $0 18 NANA $0 00
NACoartem 6 tabs 03/2014 0 $0 NA0 0 $0 13 NANA $0 00
OlysetNAOlyset Net Moustiquaire Impregne 03/2014 0 $0 NA0 0 $0 11,956 NANA $0 00
Diarrhea Treatment Kit0.77Orasel Zinc 03/2014 9,370 $2,928 13%1,000 0 $4,639 147,279 8.6210% $3,553 17,08810,370
Water Treatment Tablets3.73Aquatab 03/2014 455,000 $5,688 86%12,800 0 $8,100 5,980,500 8.973% $30,225 666,900467,800
Implant 50.16Jadelle 03/2014 140 $146 14%2,200 0 $132 18,510 14.3194% $21 1,2932,340
Page 7 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Mali $53,606 $109,159 $52,999 2.06
Injectable 31.24Confiance Injectable 03/2014 48,036 $12,510 33%150 0 $9,716 396,756 10.620% $12,086 37,37048,186
IUD 10NAIUD 03/2014 0 $0 NA0 0 $0 99 NANA $329 00
13.15IUD (insertion) 03/2014 1,150 $120 100%2,450 0 $54 5,516 2.5368% $708 2,1823,600
OCs4.82Pilplan 03/2014 386,176 $32,182 100%560 0 $10,727 1,900 0.010% $51,689 128,912386,736
SDM (Cycle Beads)4.28Cycle Beads 03/2014 0 $0 NA0 0 $13 39,944 768.15NA $56 520
Nigeria $723,485 $0 $714,318 NA
Reading GlassesNAGoGo 03/2014 0 $0 NA0 0 $0 4,573 NANA $0 00
CondomNAGold Circle 03/2014 15,539,328 $345,516 0%0 0 $316,738 218,153,288 15.570% $0 14,009,08815,539,328
NALifestyle - Flavours 03/2014 1,296 $263 0%0 -1,296 $223 116,946 108.280% $0 1,0800
NALifestyle - Original Small Cartons 03/2014 4,536 $922 0%0 1,152 $1,209 121,266 20.790% $0 5,8325,688
NALifestyle - Ribbed 03/2014 18,144 $3,689 0%0 811 $4,609 193,370 8.690% $0 22,24818,955
NALifestyle - Ultra Thin 03/2014 20,736 $4,215 0%0 2,088 $4,603 204,345 9.180% $0 22,24822,824
Female CondomNAFemale Condom 03/2014 26,000 $1,586 0%5,240 0 $529 3,780,409 73.5317% $0 51,41331,240
Free CondomNACondom Sample 03/2014 0 $0 NA871,200 0 $0 4,016,800 6.89100% $0 583,200871,200
Lubricant ENALubrica 03/2014 26,845 $9,987 0%0 0 $12,957 47,890 1.400% $0 34,17226,845
LLINNAGF Rectangular Net 03/2014 175,880 $53,632 0%1,866,120 0 $32,827 1,062,120 1.0991% $0 970,1072,042,000
NAPermaNet-King Conical 03/2014 0 $0 NA0 0 $0 2 NANA $0 00
NAPermaNet-King Rectangular 03/2014 0 $0 NA0 0 $0 55 NANA $0 00
NAPermaNet-Rectangular 03/2014 1,780 $13,536 0%2 0 $18,037 52,641 22.620% $0 2,3271,782
NAPermaNet Student 03/2014 50 $250 0%0 0 $384 2,750 36.670% $0 7550
Malaria PPT (ACT)NAACT 1 (Yellow) 03/2014 358,000 $10,917 0%48,320 0 $5,339 272,970 1.2212% $0 223,121406,320
NAACT 2 (Blue) 03/2014 252,300 $15,387 0%18,300 0 $10,451 211,460 1.057% $0 201,173270,600
Page 8 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Nigeria $723,485 $0 $714,318 NA
Malaria PPT (ACT)NAACT 3 (Orange) 03/2014 219,420 $20,073 0%0 0 $6,691 119,040 1.630% $0 73,173219,420
NAACT 4 (Green) 03/2014 667,260 $81,389 0%0 0 $27,682 371,843 1.640% $0 227,037667,260
Clean Delivery KitNAClean Delivery Kit 03/2014 800 $732 0%0 0 $996 5,600 5.250% $0 1,067800
Diarrhea Treatment KitNAPediatric Zinc Sulphate Tabs/ORS 03/2014 18,500 $12,411 0%0 0 NA 10,500 NA0% $0 NA18,500
Misoprostol for PPHNAMisoprostol 03/2014 2,000 $1,342 0%0 0 $2,655 6,770 1.750% $0 3,8672,000
NAVanprazol 03/2014 0 $0 NA0 0 $0 1,620 NANA $0 00
PURNAPuR 03/2014 90,960 $3,889 0%0 0 $4,638 977,520 9.170% $0 106,56090,960
Safe Water SolutionNAWaterGuard 03/2014 0 $0 NA0 0 $0 20 NANA $0 00
Emergency ContraceptionNAPostinor II 03/2014 88,560 $83,716 0%0 0 $78,856 308,093 3.750% $0 82,07688,560
NAPregnon 03/2014 6,120 $1,680 0%0 0 $3,194 66,118 5.800% $0 11,4006,120
Implant 5NAJadelle 03/2014 510 $1,555 0%0 0 $1,770 33,263 58.360% $0 570510
Injectable 2NANoristerat 03/2014 71,100 $30,353 0%100 0 $37,149 3,274,654 38.360% $0 85,36771,200
Injectable 3NADepo-Provera 03/2014 -84,800 -$41,374 0%0 0 $49,242 1,586,787 16.240% $0 97,700-84,800
IUD 10NACopper T 380 03/2014 360 $220 0%0 0 $510 14,286 17.420% $0 820360
NAIUD 03/2014 2,100 $1,281 0%0 0 $1,579 134,813 53.080% $0 2,5402,100
OCsNACombination 3 03/2014 528,300 $64,439 0%0 0 $79,009 7,036,895 11.030% $0 638,100528,300
SDM (Cycle Beads)NACycleBeads 03/2014 4,400 $1,878 0%0 0 $1,210 36,052 8.940% $0 4,0334,400
Senegal $0 $0 $14,968 NA
CondomNAFagaru 03/2014 313,920 $0 NA0 0 $6,331 1,953,168 7.860% $0 248,640313,920
NAProtec Fraise 03/2014 21,900 $0 NA0 0 $2,358 186,668 3.170% $0 58,90021,900
Page 9 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Senegal $0 $0 $14,968 NA
CondomNAProtec Naturel 03/2014 374,400 $0 NA0 0 $6,279 1,520,416 5.020% $0 302,800374,400
NAProtec Vanille 03/2014 0 $0 NA0 0 $0 1,151,700 NANA $0 00
LLINNAMILDA 03/2014 9,599 $0 NA0 0 $0 93,714 18.410% $0 5,0909,599
Water Treatment TabletsNAAquatabs 67 mg (20 L) 03/2014 0 $0 NA0 0 $0 1,957,700 978.85NA $0 2,0000
Injectable 3NADepo-Provera 03/2014 1,893 $0 NA0 0 $0 0 NA0% $0 2,0201,893
OCsNASecuril 03/2014 38,016 $0 NA0 0 $0 531,936 13.240% $0 40,17638,016
Togo $29,127 $26,351 $24,500 1.08
Condom0.44Protector Plus Banane 03/2014 851,400 $21,733 18%0 0 $9,050 19,098,746 53.970% $3,981 353,867851,400
Female CondomNAProtectiv 03/2014 0 $0 NA3,648 0 $7 64,309 38.57100% $0 1,6673,648
Free CondomNACondom No Logo 03/2014 0 $0 NA952,480 0 $0 285,525 0.72100% $0 396,375952,480
LLIN1.99Serena 03/2014 912 $6,270 100%0 0 $9,008 4,866 3.870% $17,937 1,257912
Multivitamin0.83Vitalite 03/2014 3,240 $203 100%0 0 $2,089 619,920 18.530% $1,733 33,4603,240
Pregnancy TestNAPregnancy Test 03/2014 0 $0 NA0 0 $0 2,824 16.94NA $0 1670
Implant 5NAJadelle 03/2014 0 $0 NA0 0 $0 1,628 2.26NA $0 7210
Injectable 30.47Depo-Provera 03/2014 0 $0 NA0 0 $2,175 22,204 5.74NA $1,013 3,8670
IUD 10NAIUD Copper-T TCU 380A 03/2014 0 $0 NA0 0 $0 2,185 126.06NA $0 170
OCs0.89Combo 3 03/2014 1,200 $150 0%0 0 $1,899 40,408 4.830% $1,688 8,3691,200
SDM (Cycle Beads)NACycle Beads 03/2014 1,233 $771 0%0 0 $273 3,341 6.110% $0 5471,233
Page 10 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
East Africa
POPULATION SERVICES INTERNATIONAL
CYPs, Cases, and Deaths by Country
1/2014 - 3/2014
Cases CYP*
HIV & TB Reproductive Health
Maternal
Deaths
Unintended
Pregnancies
Malaria
Cases
Malaria
Deaths
Diarrhea
Cases
Diarrhea
Deaths
Malaria Control Child Survival
Sum of
All Deaths
Pneumonia
Cases
Pneumonia
Deaths
STI
Deaths
TB
Deaths
Nutrition
Deaths
IDU
Deaths
East Africa 12,408 1,111,748 818 355,376 - 15,567 658 - 17,404 - 348 14 - - -
Angola 92 7,505 22 2,793 - 668 42 - 733 - - - - - -
Burundi 210 7,728 16 2,513 - 13 - - 29 - - - - - -
Ethiopia 201 14,317 18 4,440 - - 52 - 84 - - 14 - - -
Kenya 2,665 346,659 274 98,353 - 816 97 - 1,187 - - - - - -
Malawi 1,337 32,166 39 10,516 - 1,691 51 - 1,782 - - - - - -
Mozambique 2,392 48,668 35 15,173 - 5,356 71 - 5,462 - - - - - -
Rwanda 8 - - - - - - - - - - - - - -
SFH Rwanda 642 28,761 34 8,626 - 157 17 - 208 - - - - - -
Somaliland - 489 3 166 - - 24 - 26 - - - - - -
South Sudan 11 1,817 1 468 - 6,385 276 - 7,010 - 348 - - - -
Tanzania 4,397 434,512 173 137,659 - - 20 - 193 - - - - - -
Uganda 453 189,125 203 74,670 - 479 8 - 690 - - - - - -
3001 - 4/18/2014 4:45:11PM Page 2 of 5
* Using USAID CYP conversion factors
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
East Africa - All 728,342 2,548,000 1,819,658
Basic Care Package 1,781,706 725,276 1,135,334 3,440,122 - 176,230 22,599,000 203% 17,923,739 50,195,302 176,230
Cervical Cancer-VIA and Cryotherapy 88 98 - 143 47 47 1,456 -% 326 469 -
Clean Delivery Kit 5,334 3,382 12,909 8,578 504 504 64,000 (34)% 51,214 311,378 -
Condom 25,882,286 11,467,616 41,649,189 50,581,134 201,947 613,565 200,814,705 21% 188,113,573 1,745,182,402 411,618
Diarrhea Treatment Kit - 6,059 27,130 8,356 1,224 1,224 133,553 (69)% 115,546 223,234 -
Emergency Contraception 7,840 5,850 3,600 21,710 542 542 42,320 503% 37,920 61,310 -
Female Condom 293,908 121,855 337,788 508,038 2,051 6,052 1,441,005 50% 1,843,651 7,287,171 4,001
Free Condom 5,652,765 6,739,339 15,513,409 14,356,318 56,055 154,570 70,840,680 (7)% 80,275,339 375,728,786 98,516
Free Female Condom 69,300 13,000 142,313 92,300 467 1,404 306,000 (35)% 777,529 2,669,687 937
Implant 3 Distribution 28,609 1,801 3,521 30,770 35,696 35,696 22,550 774% 26,041 77,045 -
Implant 3 Insertion 1,744 1,565 3,973 4,742 7,667 7,667 27,000 19% 17,755 22,497 -
Implant 4 Insertion - 174 - 523 906 906 - -% 188 711 -
Implant 5 Distribution 5,946 2,590 15,418 9,467 20,181 20,181 70,807 (39)% 66,454 161,241 -
Implant 5 Insertion 6,656 5,278 15,371 17,645 33,204 33,204 50,200 15% 64,006 81,651 -
Injectable 3 31,686 55,813 329,710 106,184 12,801 12,801 796,098 (68)% 980,711 4,678,663 -
IUD 10 Distribution 17,258 6,032 23,603 21,496 55,226 55,226 106,691 (9)% 120,863 356,827 -
IUD 10 Insertion 9,359 6,548 48,685 24,588 60,692 60,692 132,824 (49)% 124,394 148,982 -
IUD 5 Distribution 1,121 186 10 1,427 2,876 2,876 2,000 14,173% 380 17,151 -
IUD 5 Insertion 431 348 1,229 1,257 2,695 2,695 6,700 2% 6,461 7,718 -
LLINs 545,738 524,857 1,340,786 1,602,810 586,369 586,369 7,469,167 20% 8,892,806 51,597,353 -
Lubricant A - 33,333 - 100,000 - - 120,000 -% 363,003 463,003 -
3003 - 4/18/2014 4:49:12PM Page 3 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Malaria PPT (ACT) 433,390 119,241 248,229 789,327 602,784 602,784 2,197,650 218% 1,363,985 10,869,442 -
Malaria RDK 14,150 83 - 14,400 - - 500,000 -% 425 14,825 -
Male Circumcision 2,110 3,045 1,601 8,002 - 15,819 30,313 400% 25,096 58,597 15,819
Micronutrient Powder 312,200 45,767 - 449,460 - - 1,500,000 -% 960 450,420 -
Misoprostol for PAC (Oral) 56 - 166,320 56 1 1 1,129,724 (100)% 1,075,928 1,386,392 -
Misoprostol for PPH 168,486 19,200 62,860 184,536 679 679 267,600 194% 328,124 1,423,789 -
OCs 545,105 612,546 1,697,428 1,854,691 55,889 55,889 6,185,098 9% 6,528,861 33,649,248 -
ORS 493,979 29,595 169,202 558,245 24,016 24,016 563,050 230% 893,844 16,780,236 -
Pneumonia PPT 26,338 3,792 42,802 37,715 29,765 29,765 190,613 (12)% 634,661 1,069,056 -
PUR 7,123,387 1,747,798 22,702,831 9,770,464 1,382 1,382 32,251,310 (57)% 47,701,985 211,645,192 -
Safe Water Solution 418,996 351,590 1,391,728 1,192,308 17,068 17,068 5,923,974 (14)% 6,100,587 51,812,859 -
SDM (Cycle Beads) - - 262 - - - - (100)% 423 8,577 -
STI Kit (Non-Ulcerative) 4,008 6,762 68,838 14,264 - 773 191,100 (79)% 159,142 584,775 773
STI Kit (Ulcerative) 174 186 7,190 441 - 80 18,900 (94)% 16,733 38,509 80
VCT 65,087 64,999 139,284 171,448 - 20,367 690,670 23% 631,064 1,639,539 20,367
Water Treatment Tablets 8,097,400 2,954,609 11,404,752 11,240,104 5,216 5,216 42,726,837 (1)% 37,969,411 194,774,233 -
Water Vessel - 7 11 - - - - (100)% 243 198,399 -
Zinc 157,124 1,014 45,040 160,165 1,710 1,710 306,050 256% 235,649 670,014 -
3003 - 4/18/2014 4:49:12PM Page 4 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
East Africa - All 728,342 1,819,658 2,548,000
Angola 4,857 62,031 66,889
309,204 209,040 499,284 766,440 4,491 8,625 4,035,000 3,180,567 81,797,568 4,134 54%Condom
6 /01 -% 297,216 3,345 1,742 1,603 79,064,997 1,298,892 - 1,500,000 71,712 124,848 Legal
12/12 (46)% 84,240 948 494 454 774,000 562,104 157,140 590,000 32,412 23,436 Sensual Chocolate
12/12 (54)% 75,816 853 444 409 761,220 560,988 163,944 550,000 28,200 25,380 Sensual Menta
12/12 31% 233,640 2,629 1,369 1,260 981,747 618,507 178,200 660,000 50,568 120,960 Sensual Morango
11/13 -% 30,492 343 179 164 147,780 117,288 - 440,000 11,244 11,016 Sensual Saliências
11/13 -% 45,036 507 264 243 67,824 22,788 - 295,000 14,904 3,564 Sensual Sensitive
22,200 39,000 180,000 133,200 781 1,499 300,000 750,000 3,408,200 718 (26)%Free Condom
7 /08 (26)% 133,200 1,499 781 718 3,408,200 750,000 180,000 300,000 39,000 22,200 Generic Condom
1,000 - - 1,000 6 11 - - 1,000 5 0%Free Female Condom
3 /14 -% 1,000 11 6 5 1,000 - - - - 1,000 Generic Female Condom
58,100 9,709 5,552 58,100 20,942 20,942 750,000 555,478 1,863,820 - 946%LLINs
4 /11 -% 58,100 20,942 20,942 - 1,219,075 535,524 - 700,000 9,709 58,100 Generic LLINs
11/04 (100)% - - - - 222,543 19,952 5,552 50,000 - - Joia
10/12 -% - - - - 422,202 2 - - - - PermaNet
8,000 17,120 - 59,360 32,902 32,902 100,500 43,020 102,380 - 0%Malaria PPT (ACT)
7 /13 -% 27,200 15,076 15,076 - 45,920 18,720 - 31,500 8,400 2,000 Coartem B12 (15-25 kg)
7 /13 -% 2,480 1,375 1,375 - 2,480 - - 28,000 160 2,000 Coartem B18 (25-35 kg)
7 /13 -% 2,480 1,375 1,375 - 2,480 - - 24,500 160 2,000 Coartem B24 (> 35 kg)
7 /13 -% 27,200 15,076 15,076 - 51,500 24,300 - 16,500 8,400 2,000 Coartem B6 (5-15kg)
11,350 - - 11,350 - - - - 11,350 - 0%Malaria RDK
2 /14 -% 11,350 - - - 11,350 - - - - 11,350 Bioline (RDT)
898,560 1,095,850 4,248,720 3,112,560 2,909 2,909 10,000,000 9,481,710 18,005,790 - (27)%Water Treatment Tablets
3002 - 4/18/2014 4:46:24PM Page 17 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
4 /11 (27)% 3,112,560 2,909 2,909 - 18,005,790 9,481,710 4,248,720 10,000,000 1,095,850 898,560 Certeza Water Tabs
Burundi 10,950 5,900 16,851
- 254,640 711,630 612,000 3,287 10,394 3,600,000 3,273,228 31,282,010 7,107 (14)%Condom
7 /90 -% - - - - 21,267,164 (8,352) - - - - Prudence
12/09 (14)% 612,000 10,394 3,287 7,107 10,014,846 3,281,580 711,630 3,600,000 254,640 - Prudence Class
315,360 22,000 480,608 315,360 1,694 5,356 800,000 1,596,608 3,236,760 3,662 (34)%Free Condom
5 /11 (34)% 315,360 5,356 1,694 3,662 3,236,760 1,596,608 480,608 800,000 22,000 315,360 Free Male Condoms
- - - - - - - 11,000 55,930 - 0%Free Female Condom
5 /11 -% - - - - 55,930 11,000 - - - - Free Female Condoms
4,170 7,595 54,500 7,730 920 920 755,000 484,740 4,495,939 - (86)%LLINs
4 /06 -% - - - - 202,123 - - 55,000 - - Mama Supanet
4 /10 (95)% 2,950 351 351 - 4,268,858 464,562 54,500 600,000 5,850 2,950 MII Permanet Free
9 /13 -% 4,780 569 569 - 24,958 20,178 - 100,000 1,745 1,220 Supanet (LLIN)
- - - - - - - 98,000 98,000 - 0%Lubricant A
9 /13 -% - - - - 98,000 98,000 - - - - Lubricant gel 4.5 g
- - - - - - - (82) 114,069 - 0%Safe Water Solution
4 /06 -% - - - - 114,069 (82) - - - - Sur Eau
915 785 4,381 2,418 - 181 11,450 15,003 38,505 181 (45)%VCT
12/09 167% 80 5 - 5 1,218 402 30 250 31 28 VCT Concordant Couple (HIV-Negative)
2 /12 (100)% - - - - 3 2 1 - - - VCT Discordant Couple (HIV-Negative)
2 /12 (100)% - - - - 3 2 1 - - - VCT Discordant Couple (HIV-Positive)
12/09 (46)% 2,311 145 - 145 36,873 14,471 4,305 11,000 745 878 VCT Individual (HIV-Negative)
12/09 (39)% 27 31 - 31 408 126 44 200 8 9 VCT Individual (HIV-Positive)
Ethiopia 12,030 11,935 23,964
346,161 2,297,346 8,220,260 1,717,961 8,441 17,931 35,000,000 33,856,905 133,313,256 9,490 (79)%Free Condom
3002 - 4/18/2014 4:46:24PM Page 18 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
1 /08 (100)% - - - - 76,779,820 1,262,594 834,994 - - - Blue Denim
10/09 -% 176 2 1 1 18,682,770 - - - - 176 Condom for PCP Kit
12/12 (77)% 1,717,785 17,930 8,440 9,489 37,850,666 32,594,311 7,385,266 35,000,000 2,297,346 345,985 Protector Plus
100 - - 100 - 1 6,000 - 100 1 0%Free Female Condom
10/13 -% 100 1 - 1 100 - - 6,000 - 100 Free Female Condoms
- - 40 - - - - 340 305,333 - (100)%LLINs
9 /04 (100)% - - - - 305,333 340 40 - - - PermaNet NGO Bag
2,166,624 153,470 5,165,412 2,436,729 351 351 11,300,000 11,311,740 68,870,508 - (53)%PUR
7 /06 (53)% 2,436,729 351 351 - 68,870,508 11,311,740 5,165,412 11,300,000 153,470 2,166,624 PuR
84,336 72,747 1,424 217,942 3,142 3,142 1,800,000 1,273,154 16,855,965 - 15205%Safe Water Solution
2 /06 15,205% 217,942 3,142 3,142 - 16,855,965 1,273,154 1,424 1,800,000 72,747 84,336 Wuha Agar
4,008 6,762 68,838 14,264 - 773 191,100 159,142 584,775 773 (79)%STI Kit (Non-Ulcerative)
11/10 (75)% 7,828 353 - 353 339,433 76,954 31,882 86,100 3,916 1,968 STI kit for Urethral Discharge
11/10 (83)% 6,436 420 - 420 245,342 82,188 36,956 105,000 2,846 2,040 STI Kit for Vaginal Discharge
174 186 7,190 441 - 80 18,900 16,733 38,509 80 (94)%STI Kit (Ulcerative)
11/10 (94)% 441 80 - 80 38,509 16,733 7,190 18,900 186 174 STI Kit for Genital Ulcer
25,153 31,381 44,343 43,738 - 1,686 186,712 151,301 195,039 1,686 (1)%VCT
4 /13 -% 40 1 - 1 308 268 - - 5 24 VCT Concordant Couple (HIV-Negative)
4 /13 -% - - - - 14 14 - - - - VCT Concordant Couple (HIV-Positive)
5 /13 -% 2 - - - 3 1 - - 1 - VCT Discordant Couple (HIV-Negative)
5 /13 -% 2 3 - 3 3 1 - - 1 - VCT Discordant Couple (HIV-Positive)
3 /13 (1)% 43,155 813 - 813 189,786 146,631 43,610 183,382 30,415 24,795 VCT Individual (HIV-Negative)
3 /13 (26)% 539 869 - 869 4,925 4,386 733 3,330 960 334 VCT Individual (HIV-Positive)
- 7 11 - - - - 243 198,399 - (100)%Water Vessel
10/09 (100)% - - - - 198,399 243 11 - 7 - Water Vessel for PCP Kit
3002 - 4/18/2014 4:46:24PM Page 19 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Kenya 133,392 212,339 345,731
40 56 - 40 9 9 877 205 245 - 0%Cervical Cancer-VIA and Cryotherapy
7 /13 -% 40 9 9 - 245 205 - 877 56 40 Cervical Cancer-VIA and Cryotherapy
2,796,912 3,037,176 7,255,404 8,912,592 31,794 90,223 38,041,742 35,522,352 436,758,953 58,428 23%Condom
11/08 (7)% 255,096 2,582 910 1,672 5,501,160 1,396,656 275,400 1,536,322 101,448 55,584 Femiplan [MC]
10/93 38% 7,006,824 70,930 24,996 45,935 400,749,305 26,531,208 5,065,236 26,531,208 2,331,360 2,254,104 Trust
1 /08 (14)% 1,650,672 16,710 5,888 10,821 30,508,488 7,594,488 1,914,768 9,974,212 604,368 487,224 Trust Studded
4,021,669 2,982,141 4,620,700 10,658,069 38,021 107,892 20,000,000 21,464,696 121,424,910 69,871 131%Free Condom
2 /14 -% 8,237,200 83,385 29,385 54,001 8,237,200 - - - 1,871,333 2,623,200 Free Male Condom - GOK
5 /11 -% - - - - 42,955,117 - - 20,000,000 - - Free Male Condom - NASCOP
5 /11 (48)% 2,420,869 24,507 8,636 15,871 70,092,097 21,426,200 4,620,700 - 1,109,200 1,398,469 Free Male Condom - UNFPA
7 /08 -% - - - - 140,496 38,496 - - 1,608 - Trust Regular Samplers
20,000 - - 20,000 21,179 21,179 - - 20,000 - 0%Implant 3 Distribution
3 /14 -% 20,000 21,179 21,179 - 20,000 - - - - 20,000 Implanon
530 (9) 4,907 (215) (346) (346) 28,000 3,912 38,417 - (104)%Implant 5 Distribution
-%(4,605) (7,412)(7,412) - (23,823)(19,218)(1,193) - (1,485)(1,450) PSI Implant 5 Distributed Inserted (1)
1 /09 (28)% 4,390 7,066 7,066 - 62,240 23,130 6,100 28,000 1,477 1,980 Jadelle
3,443 3,415 2,603 10,539 18,046 18,046 31,944 36,887 47,426 - 305%Implant 5 Insertion
286% 4,605 7,885 7,885 - 23,823 19,218 1,193 14,497 1,485 1,450 PSI Implant 5 Inserted
321% 5,934 10,161 10,161 - 23,603 17,669 1,410 17,447 1,929 1,993 Non-PSI Implant 5 Inserted
20,880 38,400 148,740 66,600 7,353 7,353 548,008 498,189 3,488,335 - (55)%Injectable 3
3 /00 (55)% 66,600 7,353 7,353 - 3,488,335 498,189 148,740 548,008 38,400 20,880 Femiplan Injectable
84 (331) 2,306 (1,026) (1,999) (1,999) 16,000 3,305 41,722 - (144)%IUD 10 Distribution
-%(3,046) (5,935)(5,935) - (13,001)(9,955)(490) - (924)(1,136) PSI IUD 10 Distributed Inserted (1)
3 /09 (28)% 2,020 3,936 3,936 - 54,723 13,260 2,796 16,000 593 1,220 CU 380A (Copper T)
3002 - 4/18/2014 4:46:24PM Page 20 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
3,145 2,760 1,340 8,807 18,255 18,255 31,944 24,964 33,771 - 557%IUD 10 Insertion
522% 3,046 6,314 6,314 - 13,001 9,955 490 11,050 924 1,136 PSI IUD 10 Inserted
578% 5,761 11,941 11,941 - 20,770 15,009 850 20,894 1,836 2,009 Non-PSI IUD 10 Inserted
261,658 200,022 552,642 740,352 55,709 55,709 3,000,000 2,245,897 16,519,636 - 34%LLINs
7 /08 40% 539,986 40,632 40,632 - 12,901,016 1,527,354 386,417 2,200,000 144,523 192,974 ANC LLIN
8 /08 21% 200,366 15,077 15,077 - 3,618,620 718,543 166,225 800,000 55,500 68,684 Social Marketed LLIN
- - - - - - 100,000 - - - 0%Malaria PPT (ACT)
1 /08 -% - - - - - - - 100,000 - - Malaria PPT (ACT)
2,725 - - 2,725 - - 500,000 425 3,150 - 0%Malaria RDK
11/13 -% 2,725 - - - 3,150 425 - 500,000 - 2,725 Malaria Rapid Diagnostic Kit
14 5 33 30 - 14 300 149 412 14 (9)%Male Circumcision
3 /12 -% 30 14 - 14 379 142 30 285 5 14 Male Circumcision (HIV-Negative)
4 /12 (100)% - - - - 33 7 3 15 - - Male Circumcision (HIV-Unknown)
221,280 245,080 706,800 628,440 17,746 17,746 3,186,744 2,897,040 21,148,287 - (11)%OCs
3 /00 (11)% 628,440 17,746 17,746 - 21,148,287 2,897,040 706,800 3,186,744 245,080 221,280 Femiplan Pill
3,388,160 682,720 3,087,550 3,717,920 522 522 8,501,310 8,501,310 49,482,402 - 20%PUR
2 /06 20% 3,717,920 522 522 - 49,482,402 8,501,310 3,087,550 8,501,310 682,720 3,388,160 PuR
146,832 120,944 708,047 428,256 6,017 6,017 1,916,474 2,866,499 15,542,036 - (40)%Safe Water Solution
5 /03 (40)% 428,256 6,017 6,017 - 15,542,036 2,866,499 708,047 1,916,474 120,944 146,832 WaterGuard
16,285 11,377 33,394 50,416 - 5,079 185,672 171,970 425,885 5,079 51%VCT
9 /11 54% 6,484 366 - 366 52,428 25,004 4,198 25,311 1,439 2,168 VCT Concordant Couple (HIV-Negative)
9 /11 36% 114 162 - 162 2,878 502 84 539 23 44 VCT Concordant Couple (HIV-Positive)
9 /11 72% 100 14 - 14 867 322 58 355 22 34 VCT Discordant Couple (HIV-Negative)
9 /11 72% 100 148 - 148 867 322 58 355 22 34 VCT Discordant Couple (HIV-Positive)
9 /11 51% 42,209 2,383 - 2,383 354,833 141,245 27,864 154,177 9,564 13,517 VCT Individual (HIV-Negative)
3002 - 4/18/2014 4:46:24PM Page 21 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
9 /11 24% 1,409 2,006 - 2,006 14,012 4,575 1,132 4,935 307 488 VCT Individual (HIV-Positive)
71,280 37,620 36,720 121,500 34 34 596,772 542,520 2,441,700 - 231%Water Treatment Tablets
3 /09 231% 121,500 34 34 - 2,441,700 542,520 36,720 596,772 37,620 71,280 Aquatab
Malawi 43,864 137,190 181,055
1,050,160 822,907 3,154,012 3,055,776 13,958 51,180 12,000,000 10,552,000 138,980,298 37,222 (3)%Condom
10/94 (3)% 3,055,776 51,180 13,958 37,222 138,980,298 10,552,000 3,154,012 12,000,000 822,907 1,050,160 Chishango
2,640 570 - 4,350 123 123 - - 4,350 - 0%Emergency Contraception
2 /14 -% 4,350 123 123 - 4,350 - - - 570 2,640 NORLEVO (Norlevo 1.5mg)
2,650 2,522 62,464 5,444 25 87 82,530 99,707 491,568 62 (91)%Female Condom
1 /08 (91)% 5,444 87 25 62 491,568 99,707 62,464 82,530 2,522 2,650 Care
2,000 2,721 1,321,165 10,162 46 170 - 5,001,479 5,011,794 124 (99)%Free Condom
2 /14 -% 10,162 170 46 124 10,162 - - - 2,721 2,000 Free Male Condoms
11/11 (100)% - - - - 5,001,632 5,001,479 1,321,165 - - - NAC Condoms
- - 119,313 - - - - 506,330 506,330 - (100)%Free Female Condom
12/12 (100)% - - - - 506,330 506,330 119,313 - - - Silvertouch Female Condom
(15) (273) 218 43 58 58 2,550 (147) 502 - (80)%Implant 3 Distribution
-%(191) (259)(259) - (1,221)(1,030) - - (375)(96) PSI Implant 3 Distributed Inserted (1)
10/12 7% 234 317 317 - 1,723 883 218 2,550 102 81 Implanon
96 375 - 191 276 276 - 1,030 1,221 - 0%Implant 3 Insertion
-% 191 276 276 - 1,221 1,030 - - 375 96 PSI Implant 3 Inserted
117 (297) 328 162 334 334 2,550 5,258 6,071 - (51)%Implant 5 Distribution
-%(178) (367)(367) - (1,304)(1,126) - - (408)(79) PSI Implant 5 Distributed Inserted (1)
10/12 4% 340 701 701 - 7,375 6,384 328 2,550 112 196 Jadelle
79 408 - 178 390 390 - 1,126 1,304 - 0%Implant 5 Insertion
-% 178 390 390 - 1,304 1,126 - - 408 79 PSI Implant 5 Inserted
3002 - 4/18/2014 4:46:24PM Page 22 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
3,448 2,961 3,518 11,292 1,596 1,596 35,000 22,929 358,090 - 221%Injectable 3
1 /08 221% 11,292 1,596 1,596 - 358,090 22,929 3,518 35,000 2,961 3,448 SafePlan Inj3
35 (34) 74 121 302 302 1,256 177 404 - 64%IUD 10 Distribution
-%(41) (102)(102) - (239)(198) - - (72)(24) PSI IUD 10 Distributed Inserted (1)
10/12 119% 162 404 404 - 643 375 74 1,256 38 59 IUD Copper T 380A
24 72 - 41 109 109 - 198 239 - 0%IUD 10 Insertion
-% 41 109 109 - 239 198 - - 72 24 PSI IUD 10 Inserted
68,760 84,661 252,724 241,641 109,503 109,503 1,262,000 1,069,477 6,776,879 - (4)%LLINs
4 /07 (6)% 230,591 104,496 104,496 - 6,576,332 1,028,253 244,397 1,200,000 78,864 68,420 PMI Permanets
2 /11 33% 11,050 5,007 5,007 - 200,547 41,224 8,327 62,000 5,797 340 Super Chitetezo Net
- 33,333 - 100,000 - - 120,000 265,003 365,003 - 0%Lubricant A
12/12 -% 100,000 - - - 365,003 265,003 - 120,000 33,333 - Personal Lubricant Water 4.5 g
9,410 3,724 69,681 18,796 6,173 6,173 40,718 158,985 5,273,744 - (73)%Malaria PPT (ACT)
6 /10 (100)% - - - - 1,902,545 97,147 59,885 - 260 - Coartem 6x1
6 /10 17% 8,003 2,628 2,628 - 3,307,793 28,867 6,814 14,192 1,150 4,687 Coartem 6x2
9 /12 475% 3,567 1,171 1,171 - 22,685 12,564 620 9,687 740 1,764 Coartem 6x3
9 /12 206% 7,226 2,373 2,373 - 40,721 20,407 2,362 16,839 1,574 2,959 Coartem 6x4
635 958 34 2,320 - 6,456 18,513 8,650 10,970 6,456 6724%Male Circumcision
3 /13 23,100% 2,320 6,456 - 6,456 10,946 8,626 10 18,327 958 635 Male Circumcision (HIV-Negative)
3 /13 (100)% - - - - 24 24 24 186 - - Male Circumcision (HIV-Unknown)
1,655 4,897 10,305 13,629 493 493 50,000 47,228 166,478 - 32%OCs
11/11 32% 13,629 493 493 - 106,563 47,228 10,305 - 4,897 1,655 Microgynon
1 /08 -% - - - - 59,915 - - 50,000 - - Safeplan [Ocs]
- 22,037 115,248 41,592 1,617 1,617 257,000 689,514 15,873,317 - (64)%ORS
5 /99 (64)% 41,592 1,617 1,617 - 15,873,317 689,514 115,248 257,000 22,037 - Thanzi
3002 - 4/18/2014 4:46:24PM Page 23 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
- - 32,280 - - - - 503,300 883,003 - (100)%Pneumonia PPT
10/10 (100)% - - - - 883,003 503,300 32,280 - - - Cotrimoxazole
1,550,400 625,841 4,038,480 3,427,920 480 480 5,600,000 8,632,024 36,278,596 - (15)%PUR
3 /06 (15)% 3,427,920 480 480 - 36,278,596 8,632,024 4,038,480 5,600,000 625,841 1,550,400 PuR WaterGuard Waufa
58,860 27,604 158,779 121,786 1,707 1,707 360,000 372,501 7,672,760 - (23)%Safe Water Solution
12/02 (23)% 121,786 1,707 1,707 - 7,672,760 372,501 158,779 360,000 27,604 58,860 WaterGuard
- - 25,438 - - - - 176,638 401,250 - (100)%Zinc
6 /10 (100)% - - - - 401,250 176,638 25,438 - - - Zinc 20 mg
Mozambique 76,964 396,380 473,343
3,860 2,207 24,005 8,480 - 4,161 - 41,105 227,525 4,161 (65)%Basic Care Package
1 /13 (76)% 5,300 246 - 246 38,250 32,950 21,850 - 1,540 680 BCP Kit COV ISM
1 /13 51% 3,180 3,915 - 3,915 9,280 6,100 2,100 - - 3,180 BCP Kit PVHS ISM
5 /10 (100)% - - - - 91,073 55 55 - - - BCP Kits OVC
5 /10 -% - - - - 88,922 2,000 - - 667 - BCP Kits PLWHIV
1,844,632 1,674,241 4,358,072 5,249,744 22,497 72,887 23,400,000 19,470,308 107,098,859 50,390 20%Condom
4 /08 -% - - - - 7,410,328 (1,152)(1,152) - - - Confiança Condom
10/12 (4)% 2,320,992 32,224 9,946 22,278 14,617,800 10,249,560 2,428,416 11,000,000 750,408 781,704 J1
10/12 -% 929,448 12,904 3,983 8,921 5,423,184 3,599,640 932,256 4,600,000 308,160 345,528 J2
10/12 17% 1,033,488 14,349 4,429 9,920 5,783,472 3,885,480 883,440 5,000,000 366,312 309,096 J3
11/13 -% 185,040 2,569 793 1,776 486,216 301,176 - 450,000 63,144 75,816 Jeito 4
1 /14 -% 191,664 2,661 821 1,840 191,664 - - 850,000 49,692 42,588 Jeito 5
3 /07 -% - - - - 14,141,408 (27,360)(27,360) - - - Jeito Aromatizado
3 /09 -% - - - - 40,885,968 (58,272)(58,272) - - - Jeito Classico
4 /09 (100)% - - - - 6,321,172 21,056 21,056 - - - Jeito de Manobra
3002 - 4/18/2014 4:46:24PM Page 24 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
4 /09 -% - - - - 5,764,784 (60,216)(60,216) - - - Jeito Saliente
6 /13 -% 81,800 1,136 351 785 191,180 109,380 - 1,500,000 19,213 45,100 Jzero
8 /10 (100)% - - - - 79,272 23,904 23,904 - - - Sedutor Fogo
8 /10 (100)% - - - - 1,158,771 1,112,040 214,992 - - - Sedutor Puro
8 /10 -% 507,312 7,043 2,174 4,869 867,600 314,064 - - 117,312 244,800 Sedutor XXL
10/05 (100)% - - - - 3,776,040 1,008 1,008 - - - Trust Studded
139,338 11,873 (436) 174,094 746 2,311 300,000 26,384 314,297 1,565 0%Female Condom
12/08 -% - - - - 94,751 510 - - - - Female Condom
5 /12 -% 174,094 2,311 746 1,565 219,546 25,874 (436) 300,000 11,873 139,338 Jeitosa Female Condom
28,095 58,950 25,716 158,866 681 2,206 1,000,000 1,139,875 27,419,719 1,525 518%Free Condom
1 /03 (100)% 82 1 - 1 26,268,997 180,775 25,656 - 6 63 Generic
6 /13 -% 158,784 2,205 680 1,524 1,117,824 959,040 - 1,000,000 58,944 28,032 PAWA Miltar
1 /11 (100)% - - - - 32,898 60 60 - - - Protector Plus Free
9,200 333 3,000 10,200 44 135 - 6,199 640,698 92 240%Free Female Condom
8 /09 240% 10,200 135 44 92 640,698 6,199 3,000 - 333 9,200 Female Condom Free
- 174 - 523 906 906 - 188 711 - 0%Implant 4 Insertion
-% 523 906 906 - 711 188 - - 174 - Non-PSI Implant 4 Inserted
74 33 - 174 23 23 12,360 - 174 - 0%Injectable 3
6 /13 -% 174 23 23 - 174 - - 12,360 33 74 Enaf Injectable
- 20 - 61 152 152 - 189 250 - 0%IUD 10 Insertion
-% 61 152 152 - 250 189 - - 20 - Non-PSI IUD 10 Inserted
151,150 183,785 475,290 436,855 366,496 366,496 1,000,000 1,752,585 5,125,104 - (8)%LLINs
12/07 -% 20,000 16,779 16,779 - 3,017,664 62,000 - - 6,667 - Olyset
1 /13 (12)% 416,855 349,717 349,717 - 2,107,440 1,690,585 475,290 1,000,000 177,118 151,150 Permanet ISM
1,082 1,997 1,534 5,220 - 8,572 10,000 15,546 46,032 8,572 240%Male Circumcision
3002 - 4/18/2014 4:46:24PM Page 25 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
5 /10 240% 5,220 8,572 - 8,572 46,005 15,545 1,534 10,000 1,997 1,082 Male Circumcision (HIV-Negative)
5 /10 -% - - - - 27 1 - - - - Male Circumcision (HIV-Unknown)
312,200 45,767 - 449,460 - - 1,500,000 960 450,420 - 0%Micronutrient Powder
9 /13 -% 449,460 - - - 450,420 960 - 1,500,000 45,767 312,200 Super Bebe
429 169 - 935 32 32 63,180 - 935 - 0%OCs
6 /13 -% 772 26 26 - 772 - - 63,180 151 318 Microlenyn 30 Combined OC
6 /13 -% 163 6 6 - 163 - - - 17 111 Progestyn OC
111,388 84,203 468,527 306,739 4,746 4,746 1,100,000 955,337 5,566,701 - (35)%Safe Water Solution
10/04 (100)% - - - - 3,931,349 93,688 93,688 600,000 - - Certeza
9 /12 31% 197,793 3,060 3,060 - 631,569 433,776 150,848 - 51,383 77,281 Certeza Commercial ISM
9 /12 (51)% 108,946 1,686 1,686 - 608,753 424,463 220,581 - 32,820 34,107 Certeza Free ISM
5 /10 (100)% - - - - 395,030 3,410 3,410 500,000 - - Certeza Green
14,684 15,767 43,792 52,177 - 10,659 242,000 195,964 690,314 10,659 19%VCT
12/09 2% 5,434 763 - 763 68,974 19,192 5,308 - 1,707 1,506 VCT Concordant Couple (HIV-Negative)
12/09 (100)% - - - - 4,850 2,884 536 - - - VCT Concordant Couple (HIV-Positive)
12/09 (87)% 56 19 - 19 1,726 754 442 - 10 28 VCT Discordant Couple (HIV-Negative)
12/09 (87)% 56 104 - 104 1,726 754 442 - 10 28 VCT Discordant Couple (HIV-Positive)
12/09 26% 44,608 6,265 - 6,265 574,690 163,255 35,316 217,800 13,451 12,355 VCT Individual (HIV-Negative)
12/09 16% 2,023 3,508 - 3,508 38,348 9,125 1,748 24,200 588 767 VCT Individual (HIV-Positive)
227,500 - - 227,500 57 57 1,400,000 - 227,500 - 0%Water Treatment Tablets
2 /14 -% 159,840 49 49 - 159,840 - - 600,000 - 159,840 Certeza Comprimido 20L
2 /14 -% 57,660 4 4 - 57,660 - - 300,000 - 57,660 Certeza Comprimido 5L
2 /14 -% 10,000 3 3 - 10,000 - - 500,000 - 10,000 Certeza Free Comprimido 20L
Rwanda 615 - 615
3002 - 4/18/2014 4:46:24PM Page 26 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
- - 645,397 - - - - 645,397 126,538,486 - (100)%Condom
1 /08 (100)% - - - - 6,078,066 266,099 266,099 - - - Plaisir
3 /93 (100)% - - - - 120,460,420 379,298 379,298 - - - Prudence Plus
- - - - - - - 1,308,000 1,308,000 - 0%Free Condom
11/13 -% - - - - 1,308,000 1,308,000 - - - - Military Condom
- - 3 - - - - 3 91,618 - (100)%Injectable 3
1 /06 (100)% - - - - 91,618 3 3 - - - Depo-Provera (3 Month)
- - 4,453 - - - - 4,453 232,931 - (100)%OCs
1 /08 (100)% - - - - 232,931 4,453 4,453 - - - Confiance Duofem
- - 3,088,620 - - - - 3,088,620 6,571,452 - (100)%PUR
1 /11 (100)% - - - - 6,571,452 3,088,620 3,088,620 - - - PuR
- - 1,903 - - - - 1,903 2,954,573 - (100)%Safe Water Solution
8 /02 (100)% - - - - 2,954,573 1,903 1,903 - - - Sur Eau
- - 19 - - - - 19 8,173 - (100)%SDM (Cycle Beads)
1 /08 (100)% - - - - 8,173 19 19 - - - Collier
2,546 1,483 13,374 6,995 - 615 16,976 51,176 228,442 615 (48)%VCT
1 /10 -% 1,314 70 - 70 20,972 5,844 1,318 1,198 298 420 VCT Concordant Couple (HIV-Negative)
1 /10 (75)% 2 2 - 2 104 10 8 2 1 - VCT Concordant Couple (HIV-Positive)
1 /10 (40)% 9 1 - 1 270 62 15 13 2 4 VCT Discordant Couple (HIV-Negative)
1 /10 (40)% 9 11 - 11 270 62 15 13 2 4 VCT Discordant Couple (HIV-Positive)
1 /10 (53)% 5,458 292 - 292 195,405 43,241 11,522 15,068 1,149 2,012 VCT Individual (HIV-Negative)
1 /10 (59)% 203 239 - 239 11,421 1,957 496 682 32 106 VCT Individual (HIV-Positive)
SFH Rwanda 29,221 28,996 58,218
919,920 1,115,685 2,032,460 2,935,280 12,141 41,362 11,500,000 11,662,744 14,598,024 29,221 44%Condom
2 /13 126% 831,640 11,719 3,440 8,279 3,593,724 2,762,084 367,640 3,500,000 345,253 305,080 Plaisir
3002 - 4/18/2014 4:46:24PM Page 27 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
2 /13 26% 2,103,640 29,643 8,701 20,942 11,004,300 8,900,660 1,664,820 8,000,000 770,432 614,840 Prudence Plus
- 33 - 100 187 187 1,600 320 420 - 0%Implant 5 Distribution
2 /13 -% 100 187 187 - 420 320 - 1,600 33 - Jadelle
2,400 2,400 2,897 8,641 1,106 1,106 18,750 20,697 29,338 - 198%Injectable 3
2 /13 -% - - - - - - - 18,750 - - Confiance Depo-Provera
2 /13 198% 8,641 1,106 1,106 - 29,338 20,697 2,897 - 2,400 2,400 Depo-Provera (3 Month)
- - - - - - - 2 2 - 0%LLINs
2 /13 -% - - - - 2 2 - - - - Tuzanet
- 32,290 - 96,870 13,544 13,544 60,000 15,000 111,870 - 0%Malaria PPT (ACT)
2 /13 -% 96,870 13,544 13,544 - 111,870 15,000 - 60,000 32,290 - PRIMO
10,080 5,441 11,507 26,403 864 864 60,000 52,169 78,572 - 129%OCs
2 /13 129% 26,403 864 864 - 78,572 52,169 11,507 60,000 5,441 10,080 Confiance Duofem
12,642 7,322 69,353 31,479 4 4 1,250,000 517,520 548,999 - (55)%PUR
2 /13 (55)% 31,479 4 4 - 548,999 517,520 69,353 1,250,000 7,322 12,642 PuR
11,580 24,748 20,876 85,773 1,150 1,150 187,500 198,845 284,618 - 311%Safe Water Solution
2 /13 311% 85,773 1,150 1,150 - 284,618 198,845 20,876 187,500 24,748 11,580 Sur Eau
- - 243 - - - - 404 404 - (100)%SDM (Cycle Beads)
2 /13 (100)% - - - - 404 404 243 - - - Collier
Somaliland - 2,311 2,311
- 6,059 27,130 8,356 1,224 1,224 133,553 115,546 223,234 - (69)%Diarrhea Treatment Kit
9 /11 (45)% 8,356 1,224 1,224 - 183,182 99,729 15,329 15,800 5,725 - SD OFLV-DTK
6 /11 (100)% - - - - 40,052 15,817 11,801 117,753 333 - Shuban Daweeye_DTK
199 338 402 582 108 108 3,080 3,533 7,623 - 45%Injectable 3
6 /11 45% 582 108 108 - 7,623 3,533 402 3,080 338 199 Nasiye - Inj 3
500 2,333 9,560 7,450 73 73 27,600 28,710 76,258 - (22)%Misoprostol for PPH
3002 - 4/18/2014 4:46:24PM Page 28 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
3 /10 (22)% 7,450 73 73 - 76,258 28,710 9,560 27,600 2,333 500 Ummul-gargaar
1,830 2,019 3,481 5,156 244 244 25,594 26,005 73,624 - 48%OCs
3 /10 (100)% - - - - 42,854 391 1 - 130 - Kala-Koriye
3 /12 48% 5,156 244 244 - 30,770 25,614 3,480 25,594 1,889 1,830 Nasiye - OC
314,300 231,372 1,057,462 692,384 662 662 5,430,065 5,041,076 53,878,472 - (35)%Water Treatment Tablets
9 /10 (100)% - - - - 34,074,790 1,720,998 354,498 1,720,998 10,000 - Aquatab
7 /08 (2)% 692,384 662 662 - 19,803,682 3,320,078 702,964 3,709,067 221,372 314,300 Biyosifeeye
South Sudan 574 604,820 605,394
- 46,672 139,968 140,016 489 857 - 1,256,596 6,280,648 369 0%Condom
4 /06 -% 140,016 857 489 369 6,280,648 1,256,596 139,968 - 46,672 - Number One
- 26,025 478,000 78,076 272 478 - 1,506,900 13,777,000 206 (84)%Free Condom
11/07 (84)% 78,076 478 272 206 13,777,000 1,506,900 478,000 - 26,025 - Generic
- - 37 - - - 261,000 2,783,263 8,033,439 - (100)%LLINs
1 /08 -% - - - - 187,446 - - 261,000 - - Free LLIN
4 /08 (100)% - - - - 7,845,993 2,783,263 37 - - - Free Permanet Mesh
415,980 66,107 178,548 614,301 550,165 550,165 1,896,432 1,146,980 5,381,448 - 244%Malaria PPT (ACT)
1 /08 -% - - - - 871,995 7,600 - - - - ACT
2 /13 5,045% 135,050 120,950 120,950 - 315,180 180,130 2,625 - 3,217 125,400 ACTs for Adult (14+ years)
2 /13 4,551% 90,700 81,231 81,231 - 241,170 150,470 1,950 - 2,733 82,500 ACTs for Child (6-14 years)
2 /13 484% 265,200 237,512 237,512 - 655,292 390,092 45,409 - 28,540 179,580 ACTs for Infant (2-12 months)
2 /13 (1)% 123,351 110,473 110,473 - 538,539 415,188 125,064 - 31,617 28,500 ACTs for Toddler (1-5 years)
1 /08 (100)% - - - - 2,759,272 3,500 3,500 1,896,432 - - Malaria PPT (ACT)
493,979 7,558 53,954 516,653 22,400 22,400 306,050 204,330 906,919 - 858%ORS
9 /08 858% 516,653 22,400 22,400 - 906,919 204,330 53,954 306,050 7,558 493,979 ORS
26,338 3,792 10,522 37,715 29,765 29,765 190,613 131,361 186,053 - 258%Pneumonia PPT
3002 - 4/18/2014 4:46:24PM Page 29 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
10/12 391% 31,960 25,223 25,223 - 153,282 114,124 6,508 142,960 2,457 24,588 Amoxicillin for Children (1-5 years)
10/12 43% 5,755 4,542 4,542 - 32,771 17,237 4,014 47,653 1,335 1,750 Amoxicillin for Infant (2-12 months)
- 22,618 72,960 67,855 10 10 1,500,000 1,504,503 6,455,135 - (7)%PUR
1 /09 (7)% 67,855 10 10 - 6,455,135 1,504,503 72,960 1,500,000 22,618 - PuR
- 11,200 1,373,050 33,600 10 10 4,000,000 4,162,420 56,543,010 - (98)%Water Treatment Tablets
3 /09 -% - - - - 1,076,220 - - 2,000,000 - - WaterGuard - Emergency Response
6 /06 (98)% 33,600 10 10 - 55,466,790 4,162,420 1,373,050 2,000,000 11,200 - WaterGuard Tablets
157,124 1,014 19,602 160,165 1,710 1,710 306,050 59,011 268,764 - 717%Zinc
1 /08 717% 160,165 1,710 1,710 - 268,764 59,011 19,602 306,050 1,014 157,124 Zinc
Tanzania 224,381 205,012 429,394
- 11 - - - - 399 34 34 - 0%Cervical Cancer-VIA and Cryotherapy
12/13 -% - - - - 34 34 - 399 11 - Cervical Cancer-VIA and Cryotherapy
15 462 - 1,231 75 75 21,000 1,748 2,979 - 0%Clean Delivery Kit
9 /13 -% 1,231 75 75 - 2,979 1,748 - 21,000 462 15 Clean Delivery Pack-CDP
18,584,208 4,186,155 22,054,608 28,389,536 110,617 329,602 104,737,963 99,897,115 849,102,856 218,985 29%Condom
8 /11 (15)% 3,321,216 38,559 12,941 25,618 45,440,784 12,131,856 3,916,080 16,308,864 470,448 2,156,112 Dume Condom
10/07 (100)% 720 8 3 6 40,194,688 668,880 668,880 - 240 - Familia
12/93 -% 4,328,640 50,255 16,866 33,389 448,294,688 6,833,627 - - - 4,328,640 Salama
2 /11 4% 18,135,792 210,556 70,664 139,892 141,861,456 63,472,464 17,469,648 59,580,000 3,142,944 10,905,840 Salama Halisi
8 /06 -% 731,312 8,491 2,849 5,641 86,679,256 9,017,744 - 15,759,099 267 730,512 Salama Scented
6 /04 -% 1,871,856 21,732 7,294 14,439 86,631,984 7,772,544 - 13,090,000 572,256 463,104 Salama Studded
5,200 5,280 3,600 17,360 419 419 42,320 37,920 56,960 - 382%Emergency Contraception
7 /12 382% 17,360 419 419 - 56,960 37,920 3,600 42,320 5,280 5,200 Emergency Contraception
151,920 107,460 275,760 328,500 1,280 3,654 1,058,475 1,717,560 6,481,306 2,374 19%Female Condom
11/98 (100)% - - - - 3,940,606 578,160 86,040 391,755 - - Care
3002 - 4/18/2014 4:46:24PM Page 30 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
11/11 73% 328,500 3,654 1,280 2,374 2,540,700 1,139,400 189,720 666,720 107,460 151,920 Lady Pepeta
391,680 840,755 - 391,824 1,527 4,549 9,540,680 9,540,680 19,933,304 3,022 0%Free Condom
7 /10 -% 391,824 4,549 1,527 3,022 19,933,304 9,540,680 - 9,540,680 840,755 391,680 Free Familia
4,480 277 (755) 5,184 5,996 5,996 - 2,061 7,245 - 0%Implant 3 Distribution
-% - - - - (755)(755)(755) - - - PSI Implant 3 Distributed Inserted (1)
1 /09 -% 5,184 5,996 5,996 - 8,000 2,816 - - 277 4,480 Implanon
- - 3,973 - - - 10,000 3,973 3,973 - (100)%Implant 3 Insertion
(100)% - - - - 755 755 755 - - - PSI Implant 3 Inserted
(100)% - - - - 3,218 3,218 3,218 10,000 - - Non-PSI Implant 3 Inserted
223 1,041 34 3,296 5,795 5,795 22,657 10,342 41,468 - 9594%Implant 5 Distribution
-%(1,534) (2,697)(2,697) - (8,372)(6,838)(6,066) - (252)(777) PSI Implant 5 Distributed Inserted (1)
11/09 (21)% 4,830 8,491 8,491 - 49,840 17,180 6,100 22,657 1,293 1,000 Jadelle
1,956 649 6,066 3,904 7,302 7,302 10,256 7,819 11,723 - (36)%Implant 5 Insertion
(75)% 1,534 2,869 2,869 - 8,372 6,838 6,066 10,256 252 777 PSI Implant 5 Inserted
-% 2,370 4,433 4,433 - 3,351 981 - - 397 1,179 Non-PSI Implant 5 Inserted
- 9,413 170,840 10,160 1,225 1,225 153,900 412,770 648,150 - (94)%Injectable 3
1 /10 (94)% 10,160 1,225 1,225 - 648,150 412,770 170,840 153,900 9,413 - Familia Injectable 3 Kit
5,680 1,139 (13,400) 8,817 18,764 18,764 52,635 5,472 67,497 - 0%IUD 10 Distribution
-%(3,483) (7,412)(7,412) - (35,053)(31,570)(23,542) - (621)(1,620) PSI IUD 10 Distributed Inserted (1)
11/09 21% 12,300 26,177 26,177 - 102,550 37,042 10,142 52,635 1,760 7,300 Familia IUD Kit
3,030 1,144 38,334 6,461 14,628 14,628 33,168 51,665 58,126 - (83)%IUD 10 Insertion
(85)% 3,483 7,886 7,886 - 35,053 31,570 23,542 33,168 621 1,620 PSI IUD 10 Inserted
(80)% 2,978 6,742 6,742 - 23,073 20,095 14,792 - 523 1,410 Non-PSI IUD 10 Inserted
75 83 - 325 - - - - 325 - 0%Malaria RDK
2 /14 -% 325 - - - 325 - - - 83 75 Malaria Rapid Diagnostic Kit
3002 - 4/18/2014 4:46:24PM Page 31 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
56 - 166,320 56 1 1 1,129,724 1,075,928 1,386,392 - (100)%Misoprostol for PAC (Oral)
9 /12 (100)% 56 1 1 - 1,386,392 1,075,928 166,320 1,129,724 - 56 Misoprostol for PAC (oral)
304,704 351,408 953,424 1,168,848 36,051 36,051 2,769,580 3,469,392 11,872,236 - 23%OCs
2 /08 32% 458,064 14,128 14,128 - 5,213,964 1,381,680 345,744 1,548,000 118,320 143,424 Familia [OC]
11/11 17% 710,784 21,923 21,923 - 6,658,272 2,087,712 607,680 1,221,580 233,088 161,280 Flexi P
- - 2,514,480 - - - 2,100,000 5,128,800 19,606,800 - (100)%PUR
6 /11 (100)% - - - - 19,606,800 5,128,800 2,514,480 2,100,000 - - PuR
6,000 21,344 32,172 31,812 306 306 560,000 432,348 2,936,206 - (1)%Safe Water Solution
7 /02 (100)% - - - - 2,492,446 20,400 20,400 - - - WaterGuard
3 /13 170% 31,812 306 306 - 443,760 411,948 11,772 560,000 21,344 6,000 WaterGuard Liquid (150mL) DNR PLWHA
4,987,200 143,200 3,948,000 5,344,800 1,028 1,028 16,800,000 12,040,800 18,300,000 - 35%Water Treatment Tablets
3 /13 (100)% - - - - 9,590,400 9,590,400 3,304,800 16,800,000 - - WaterGuard Tablet DNR PLWHA
7 /12 731% 5,344,800 1,028 1,028 - 8,709,600 2,450,400 643,200 - 143,200 4,987,200 WaterGuard Tablet ENF
Uganda 191,492 152,744 344,235
1,777,846 723,069 1,111,329 3,431,642 - 172,069 22,599,000 17,882,634 49,967,777 172,069 209%Basic Care Package
10/11 201% 3,103,200 116,784 - 116,784 31,695,343 12,387,440 1,031,840 12,400,000 504,000 1,720,800 PLP Condom Resupply
2 /12 304% 193,973 7,300 - 7,300 809,125 583,152 48,000 - 52,000 46,973 PLP Female Condom
11/11 830% 2,790 92 - 92 24,959 9,080 300 11,000 1,050 1,290 PLP Kit - FB (with WaterGuard Tab)
6 /13 -% - - - - 5,863 5,863 - - - - PLP Kit - FB (with WaterGuard Tab, no LLIN)
5 /12 -% - - - - 1,465 - - 8,000 - - PLP Kit - NFB (with Female Condom)
11/11 1,240% 20,615 47,764 - 47,764 219,816 67,203 1,539 180,000 11,530 7,891 PLP Kit - NFB (with WaterGuard Tab)
3 /13 (100)% - - - - 43,783 43,783 5,650 - 19 - PLP Kit - NFB (with WaterGuard Tab, no LLIN)
10/11 -% 11,064 99 - 99 35,823 9,393 - - 5,083 892 PLP LLIN Resupply
10/11 317% 100,000 30 - 30 17,131,600 4,776,720 24,000 10,000,000 149,387 - PLP Waterguard Tablet (67mg) Resupply
3002 - 4/18/2014 4:46:24PM Page 32 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
48 30 - 103 38 38 180 87 190 - 0%Cervical Cancer-VIA and Cryotherapy
11/13 -% 103 38 38 - 190 87 - 180 30 48 Cervical Cancer-VIA and Cryotherapy
5,319 2,920 12,909 7,347 428 428 43,000 49,466 308,399 - (43)%Clean Delivery Kit
11/01 (39)% 2,374 138 138 - 218,788 12,580 3,915 5,000 694 1,661 Maama Kit
8 /10 (45)% 4,973 290 290 - 89,611 36,886 8,994 38,000 2,226 3,658 Maama Kit Extra Clean Delivery
377,250 121,100 651,354 519,750 2,673 8,435 3,500,000 2,497,914 42,214,352 5,762 (20)%Condom
6 /06 (20)% 519,750 8,435 2,673 5,762 42,214,352 2,497,914 651,354 3,500,000 121,100 377,250 Trust
525,600 470,400 186,960 892,800 4,592 14,489 4,200,000 4,110,196 46,895,843 9,897 378%Free Condom
1 /99 378% 892,800 14,489 4,592 9,897 46,895,843 4,110,196 186,960 4,200,000 470,400 525,600 Generic
59,000 12,667 20,000 81,000 417 1,256 300,000 254,000 1,465,629 840 305%Free Female Condom
11/09 305% 81,000 1,256 417 840 1,465,629 254,000 20,000 300,000 12,667 59,000 Female Condom Free
4,144 1,302 3,303 5,543 8,463 8,463 20,000 14,487 39,658 - 68%Implant 3 Distribution
-%(2,384) (3,640)(3,640) - (10,239)(7,855) - - (670)(829) PSI Implant 3 Distributed Inserted (1)
12/08 140% 7,927 12,103 12,103 - 49,897 22,342 3,303 20,000 1,972 4,973 Implanon
1,648 1,190 - 4,551 7,392 7,392 17,000 12,752 17,303 - 0%Implant 3 Insertion
-% 2,384 3,872 3,872 - 10,239 7,855 - 5,000 670 829 PSI Implant 3 Inserted
-% 2,167 3,520 3,520 - 7,064 4,897 - 12,000 520 819 Non-PSI Implant 3 Inserted
5,076 912 (2,739) 6,124 14,212 14,212 16,000 7,363 35,606 - 0%Implant 5 Distribution
-%(1,586) (3,681)(3,681) - (13,663)(12,077)(5,629) - (430)(594) PSI Implant 5 Distributed Inserted (1)
12/08 167% 7,710 17,892 17,892 - 49,269 19,440 2,890 16,000 1,342 5,670 Jadelle
1,178 805 6,702 3,024 7,466 7,466 8,000 18,174 21,198 - (55)%Implant 5 Insertion
(72)% 1,586 3,915 3,915 - 13,663 12,077 5,629 4,000 430 594 PSI Implant 5 Inserted
34% 1,438 3,550 3,550 - 7,535 6,097 1,073 4,000 375 584 Non-PSI Implant 5 Inserted
4,685 2,267 3,310 8,735 1,390 1,390 25,000 22,590 55,335 - 164%Injectable 3
11/11 164% 8,735 1,390 1,390 - 55,335 22,590 3,310 25,000 2,267 4,685 Depo-Provera
3002 - 4/18/2014 4:46:24PM Page 33 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
11,459 4,616 3,229 13,584 38,160 38,160 36,800 43,455 178,750 - 321%IUD 10 Distribution
-%(4,786) (13,446)(13,446) - (31,517)(26,731)(7,362) - (1,324)(1,681) PSI IUD 10 Distributed Inserted (1)
12/08 (77)% 850 2,388 2,388 - 59,697 13,525 3,750 - 50 700 Copper T 380
4 /11 (34)% 4,403 12,369 12,369 - 105,795 34,361 6,691 36,800 2,357 3,373 IUD PACK CU T380A
11/11 8,645% 13,117 36,849 36,849 - 44,775 22,300 150 - 3,533 9,067 Optima Copper T 380
3,160 2,552 9,011 9,218 27,548 27,548 67,712 47,378 56,596 - 2%IUD 10 Insertion
(35)% 4,786 14,304 14,304 - 31,517 26,731 7,362 27,712 1,324 1,681 PSI IUD 10 Inserted
169% 4,432 13,244 13,244 - 25,079 20,647 1,649 40,000 1,228 1,479 Non-PSI IUD 10 Inserted
1,121 146 (994) 1,427 2,876 2,876 2,000 (3,265) 13,506 - 0%IUD 5 Distribution
-%(653) (1,315)(1,315) - (4,298)(3,645)(1,004) - (181)(229) PSI IUD 5 Distributed Inserted (1)
5 /11 20,700% 2,080 4,192 4,192 - 17,804 380 10 2,000 327 1,350 IUD Pack CU 375
431 348 1,229 1,257 2,695 2,695 6,700 6,461 7,718 - 2%IUD 5 Insertion
(35)% 653 1,399 1,399 - 4,298 3,645 1,004 3,700 181 229 PSI IUD 5 Inserted
169% 604 1,296 1,296 - 3,420 2,816 225 3,000 167 202 Non-PSI IUD 5 Inserted
1,900 39,085 1 118,132 32,800 32,800 441,167 1,024 8,477,201 - 11813100%LLINs
12/10 -% 109,982 30,537 30,537 - 7,392,563 - - 441,167 36,661 - LLIN - Global Fund (SI)
12/00 814,900% 8,150 2,263 2,263 - 1,084,638 1,024 1 - 2,424 1,900 SmartNet
379 84 - 432 - 777 1,500 751 1,183 777 0%Male Circumcision
8 /13 -% 432 777 - 777 1,183 751 - 1,500 84 379 Male Circumcision (HIV-Negative)
167,986 16,867 53,300 177,086 606 606 240,000 299,414 1,347,531 - 232%Misoprostol for PPH
7 /09 232% 177,086 606 606 - 1,347,531 299,414 53,300 240,000 16,867 167,986 Misoprostol Tablet
5,127 3,533 7,458 11,280 459 459 30,000 32,574 76,185 - 51%OCs
11/11 51% 11,280 459 459 - 76,185 32,574 7,458 30,000 3,533 5,127 Family Planning Pills
5,561 255,827 4,665,976 88,561 13 13 2,000,000 9,017,468 23,831,300 - (98)%PUR
10/04 (98)% 88,561 13 13 - 23,831,300 9,017,468 4,665,976 2,000,000 255,827 5,561 PuR
3002 - 4/18/2014 4:46:24PM Page 34 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
5,504 4,206 - 15,704 - 2,147 47,860 45,650 61,354 2,147 0%VCT
8 /13 -% 1,042 103 - 103 5,390 4,348 - 5,560 360 (38)VCT Concordant Couple (HIV-Negative)
8 /13 -% 74 120 - 120 164 90 - 100 5 60 VCT Concordant Couple (HIV-Positive)
8 /13 -% 1 - - - 42 41 - 100 - 1 VCT Discordant Couple (HIV-Negative)
8 /13 -% 1 2 - 2 42 41 - 100 - 1 VCT Discordant Couple (HIV-Positive)
8 /13 -% 14,275 1,417 - 1,417 53,656 39,381 - 40,000 3,744 5,339 VCT Individual (HIV-Negative)
8 /13 -% 311 504 - 504 2,060 1,749 - 2,000 97 141 VCT Individual (HIV-Positive)
1,598,560 1,435,367 740,800 1,707,760 515 515 4,500,000 6,700,885 45,377,761 - 131%Water Treatment Tablets
12/06 131% 1,707,760 515 515 - 45,377,761 6,700,885 740,800 4,500,000 1,435,367 1,598,560 WaterGuard Tablets
3002 - 4/18/2014 4:46:24PM Page 35 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
EasEast Africa
Angola $90,234 $4,626 $77,271 0.06
CondomNALegal 03/2014 118,800 $12,547 0%6,048 68,800 $10,092 6,345,526 64.055% $0 99,072193,648
NASensual Chocolate 03/2014 23,436 $7,277 0%0 0 $8,848 229,104 8.160% $0 28,08023,436
NASensual Menta 03/2014 25,380 $7,919 0%0 0 $8,029 241,956 9.570% $0 25,27225,380
NASensual Morango 03/2014 120,960 $37,251 0%0 0 $24,115 21,384 0.270% $0 77,880120,960
NASensual Saliências 03/2014 10,692 $2,191 0%324 180 $1,307 745,992 73.403% $0 10,16411,196
NASensual Sensitive 03/2014 3,564 $763 0%0 12 $3,124 1,893,876 126.160% $0 15,0123,576
Free CondomNAGeneric Condom 03/2014 0 $0 NA22,200 0 $0 178,500 4.02100% $0 44,40022,200
Free Female CondomNAGeneric Female Condom 03/2014 0 $0 NA1,000 0 NA 59,000 NA100% $0 NA1,000
LLINNAGeneric LLINs 03/2014 0 $0 NA58,100 0 $0 227,650 11.75100% $0 19,36758,100
NAJoia 03/2014 0 $0 NA0 0 $0 48 NANA $0 00
NAPermaNet-Rectangular 03/2014 0 $0 NA0 0 $0 903 NANA $0 00
Malaria PPT (ACT)3.00Coartem B12 (15-25 kg) 03/2014 1,400 $645 100%600 0 $215 80,080 8.8330% $645 9,0672,000
3.00Coartem B18 (25-35 kg) 03/2014 1,400 $861 100%600 0 $287 35,920 43.4530% $861 8272,000
3.00Coartem B24 (> 35 kg) 03/2014 1,400 $861 100%600 0 $287 29,920 36.1930% $861 8272,000
3.00Coartem B6 (5-15kg) 03/2014 1,400 $645 100%600 0 $215 91,750 10.1230% $645 9,0672,000
Malaria RDKNABioline (RDT) 03/2014 7,875 $1,614 100%3,475 0 NA 229,000 NA31% $1,614 NA11,350
Water Treatment TabletsNACerteza Water Tabs 03/2014 855,360 $17,659 0%43,200 0 $20,215 3,559,710 3.435% $0 1,037,520898,560
Burundi $2,471 $1,255 $4,704 0.27
Condom0.15Prudence Class 03/2014 0 $0 NA0 0 $1,460 2,952 0.01NA $225 204,0000
Free CondomNAFree Male Condoms 03/2014 0 $0 NA315,360 0 $0 772,320 7.35100% $0 105,120315,360
Lubricant ANALubricant gel 4.5 g 03/2014 0 $0 NA0 0 $0 46,000 NANA $0 00
Page 12 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Burundi $2,471 $1,255 $4,704 0.27
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 28 $0 NA0 0 $0 0 NA0% $0 2728
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 878 $0 NA0 0 $0 0 NA0% $0 770878
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 9 $0 NA0 0 $0 0 NA0% $0 99
LLINNAMII Permanet Free 03/2014 0 $0 NA2,950 0 $0 0 NA100% $0 9832,950
0.32Supanet (LLIN) 03/2014 1,200 $2,471 0%20 0 $3,244 25,042 15.722% $1,030 1,5931,220
OlysetNASupanet (Olyset) 03/2014 0 $0 NA0 0 $0 29 NANA $0 00
IUD 10NACopper-T 380-A IUD 03/2014 0 $0 NA0 0 NA 6,860 NANA $0 NA0
Ethiopia $70,335 $81,313 $38,673 2.10
HIV Test KitNACapillary Tubes (Microhematocrit), 03/2014 0 $0 NA63,300 0 $0 229,000 9.81100% $0 23,33363,300
NADiagnostic kit for HIV(1+2) Antibod 03/2014 0 $0 NA31,750 0 $0 113,000 9.60100% $0 11,76731,750
Medicines & SuppliesNAAcyclovir 400mg Tablet 03/2014 0 $0 NA0 0 $0 2,974 NANA $0 00
NACiprofloxacin 500mg Tablet 03/2014 0 $0 NA0 37,500 $0 102,015 NANA $0 037,500
NADisposable syringe -5mL with 21G 03/2014 0 $0 NA0 0 $0 19,810 NANA $0 00
NADoxycycline 100mg Tablet 03/2014 0 $0 NA0 525,000 $0 247,950 NANA $0 0525,000
NAMetronidazol 250mg Tablet 03/2014 0 $0 NA0 225,000 $0 951,240 NANA $0 0225,000
NAPennicillin G Benzathine 2.4 MIU I 03/2014 0 $0 NA0 0 $0 15 NANA $0 00
NAWater for injection 10 mL 03/2014 0 $0 NA0 0 $0 131 NANA $0 00
Reading GlassesNAGoGo 03/2014 0 $0 NA0 0 $0 10,082 NANA $0 00
Free CondomNABlue Denim 03/2014 0 $0 NA0 0 $0 443 NANA $0 00
NACondom for PCP Kit 03/2014 0 $0 NA176 0 $0 0 NA100% $0 59176
NAProtector Plus 03/2014 0 $0 NA345,985 225,000 $0 23,067,700 40.29100% $0 572,595570,985
Free Female CondomNAFree Female Condoms 03/2014 0 $0 NA100 0 $0 29,900 897.00100% $0 33100
Page 13 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Ethiopia $70,335 $81,313 $38,673 2.10
STI Kit (Non-Ulcerative)0.99STI kit for Urethral Discharge 03/2014 1,616 $401 56%352 0 $611 30,631 11.7418% $604 2,6091,968
0.96STI Kit for Vaginal Discharge 03/2014 1,660 $865 69%380 0 $1,050 15,493 7.2219% $1,013 2,1452,040
STI Kit (Ulcerative)NASTI Kit for Genital Ulcer 03/2014 24 $62 0%150 0 $153 11,721 79.7386% $0 147174
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 24 $0 NA0 0 $0 0 NA0% $0 1324
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 24,795 $0 NA0 0 $0 0 NA0% $0 14,38524,795
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 334 $0 NA0 0 $0 0 NA0% $0 180334
LLINNAPermaNet NGO Bag-Light Blue 03/2014 0 $0 NA0 0 $0 15 NANA $0 00
PUR2.16PuR 03/2014 944,448 $50,900 87%1,222,176 0 $21,438 18,182,507 22.3956% $46,335 812,2432,166,624
Safe Water Solution2.16Wuha Agar 03/2014 84,336 $18,107 79%0 0 $15,421 64,693 0.890% $33,361 72,64784,336
Water VesselNAWater Vessel for PCP Kit 03/2014 0 $0 NA0 0 $0 2,564 NANA $0 00
Kenya $0 $0 $0 NA
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 14 $0 NA0 0 $0 0 NA0% $0 1014
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 2,168 $0 NA0 0 $0 0 NA0% $0 2,1612,168
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 44 $0 NA0 0 $0 0 NA0% $0 3844
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 34 $0 NA0 0 $0 0 NA0% $0 3334
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 34 $0 NA0 0 $0 0 NA0% $0 3334
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 13,517 $0 NA0 0 $0 0 NA0% $0 14,07013,517
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 488 $0 NA0 0 $0 0 NA0% $0 470488
Page 14 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Kenya $0 $0 $0 NA
Cervical Cancer-VIA and CryotherapyNACervical Cancer-VIA and Cryother 03/2014 40 $0 NA0 0 $0 0 NA0% $0 1340
Malawi $101,503 $67,396 $110,344 0.61
Condom0.76Chishango 03/2014 1,049,640 $15,528 32%520 0 $14,997 8,464,760 8.310% $11,370 1,018,5921,050,160
Female Condom1.37Care 03/2014 2,600 $122 66%50 0 $79 18,514 10.202% $108 1,8152,650
Free CondomNAFree Male Condoms 03/2014 0 $0 NA2,000 0 NA 787,162 NA100% $0 NA2,000
Free Female CondomNAFree Female Condoms 03/2014 0 $0 NA0 0 NA 3,000 NANA $0 NA0
Lubricant ANAPersonal Lubricant Water 4.5 g 03/2014 0 $0 NA0 0 $0 124,994 3.75NA $0 33,3330
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 635 $0 NA0 0 $0 0 NA0% $0 773635
LLINNAPMI Permanets 03/2014 0 $0 NA68,420 0 $0 1,305 0.02100% $0 76,86468,420
0.94Super Chitetezo Net 03/2014 340 $2,809 91%0 0 $29,991 1 0.000% $28,321 3,683340
Malaria PPT (ACT)NACoartem 6x1 03/2014 0 $0 NA0 0 $0 0 NANA $57 00
1.59Coartem 6x2 03/2014 4,687 $3,961 74%0 0 $2,415 6,229 2.330% $3,835 2,6684,687
1.32Coartem 6x3 03/2014 1,764 $1,924 80%0 0 $1,471 6,120 5.150% $1,944 1,1891,764
1.50Coartem 6x4 03/2014 2,959 $4,381 66%0 0 $3,991 9,613 3.990% $5,980 2,4092,959
ORS0.34Thanzi 03/2014 0 $0 NA0 0 $3,783 128 0.01NA $1,270 13,8640
PURNAPuR WaterGuard Waufa 03/2014 1,550,400 $55,996 0%0 2,663,277 $40,669 1,112,877 0.970% $0 1,142,6404,213,677
Safe Water Solution1.15WaterGuard 03/2014 58,860 $13,200 65%0 0 $9,088 145,097 3.570% $10,433 40,59558,860
Emergency ContraceptionNANORLEVO (Norlevo 1.5mg) 03/2014 2,640 $965 1%0 0 NA 16,429 NA0% $12 NA2,640
Implant 30.76Implanon 03/2014 70 $123 77%11 0 $124 6,149 78.8314% $94 7881
Page 15 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Malawi $101,503 $67,396 $110,344 0.61
Implant 52.11Jadelle 03/2014 180 $382 93%16 0 $168 16,225 143.168% $354 113196
Injectable 30.97SafePlan Inj3 03/2014 3,410 $1,670 60%38 0 $1,850 1,302,308 345.991% $1,787 3,7643,448
IUD 10NAIUD Copper T 380A 03/2014 55 $13 0%4 0 $47 2,292 42.447% $0 5459
OCs1.60Microgynon 03/2014 1,642 $428 18%13 0 $1,141 247,998 54.591% $1,831 4,5431,655
Mozambique $72,826 $202,689 $66,754 3.04
Other RevenuesNASabonetes BCP 03/2014 0 $0 NA0 4,180 $0 6,532 NANA $0 04,180
Basic Care PackageNABCP Kit COV ISM 03/2014 0 $0 NA680 7 $0 7 0.00100% $0 1,767687
NABCP Kit PVHS ISM 03/2014 0 $0 NA3,180 -3,309 $0 388 0.37100% $0 1,060-129
NABCP Kits OVC 03/2014 0 $0 NA0 0 $0 513 NANA $0 00
NABCP Kits PLWHIV 03/2014 0 $0 NA0 0 $0 185 NANA $0 00
CondomNAConfiança Condom 03/2014 0 $0 NA0 0 $0 7,704 NANA $6,229 00
1.16J1 03/2014 781,632 $13,177 20%72 0 $13,181 4,416,912 5.710% $15,312 773,664781,704
2.69J2 03/2014 345,456 $12,789 29%72 0 $11,265 5,687,485 18.360% $30,294 309,816345,528
2.21J3 03/2014 309,024 $11,619 16%72 0 $12,933 2,383,056 6.920% $28,560 344,496309,096
1.09Jeito 4 03/2014 75,744 $3,849 25%72 0 $3,239 374,832 6.080% $3,531 61,68075,816
1.01Jeito 5 03/2014 41,616 $4,396 36%972 0 $6,147 672,120 10.522% $6,217 63,88842,588
NAJeito Aromatizado 03/2014 0 $0 NA0 0 $0 0 NANA $17,057 00
NAJeito Classico 03/2014 0 $0 NA0 0 $0 0 NANA $44,922 00
NAJeito de Manobra 03/2014 0 $0 NA0 0 $0 466,560 NANA $3,255 00
NAJeito Saliente 03/2014 0 $0 NA0 0 $0 0 NANA $24,204 00
NAJzero 03/2014 45,100 $713 0%0 0 $441 4,310,420 158.080% $0 27,26745,100
NASedutor Fogo 03/2014 0 $0 NA0 21,960 $0 14,256 NANA $2,733 021,960
NASedutor Puro 03/2014 0 $0 NA0 0 $0 276,693 NANA $2,374 00
NASedutor XXL 03/2014 0 $0 NA244,800 0 $0 562,032 3.32100% $2,447 169,104244,800
Page 16 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Mozambique $72,826 $202,689 $66,754 3.04
CondomNATrust Studded 03/2014 0 $0 NA0 0 $0 101,324 NANA $5,820 00
Female Condom2.98Jeitosa Female Condom 03/2014 144 $11 0%139,194 7,314 $141 258,120 4.45100% $420 58,031146,652
Free CondomNAGeneric 03/2014 0 $0 NA63 0 $0 3,663 134.01100% $0 2763
NAPAWA Miltar 03/2014 0 $0 NA28,032 0 $0 569,568 10.76100% $0 52,92828,032
NAProtector Plus Free 03/2014 0 $0 NA0 0 $0 865 NANA $0 00
Free Female CondomNAFemale Condom Free 03/2014 0 $0 NA9,200 0 $0 21,164 6.22100% $0 3,4009,200
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 1,082 $0 NA0 0 $0 0 NA0% $0 1,7401,082
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 1,506 $0 NA0 0 $0 0 NA0% $0 1,8111,506
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 28 $0 NA0 0 $0 0 NA0% $0 1928
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 28 $0 NA0 0 $0 0 NA0% $0 1928
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 12,355 $0 NA0 0 $0 0 NA0% $0 14,86912,355
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 767 $0 NA0 0 $0 0 NA0% $0 674767
LLINNAPermanet ISM 03/2014 0 $0 NA151,150 0 $0 292,510 2.11100% $0 138,952151,150
NAPermanet Npl Campanha-Rectang 03/2014 0 $0 NA0 0 $0 386 NANA $0 00
OlysetNAOlyset 03/2014 0 $0 NA0 0 $0 70,614 10.59NA $0 6,6670
RetreatmentNAForca da Rede 03/2014 0 $0 NA0 0 $0 25 NANA $0 00
Micronutrient Powder0.31Super Bebe 03/2014 302,740 $10,017 14%9,460 0 $4,935 1,546,380 10.323% $1,534 149,820312,200
Safe Water SolutionNACerteza 03/2014 0 $0 NA0 0 $0 3,027 NANA $11,525 00
0.27Certeza Commercial ISM 03/2014 77,281 $12,675 11%0 0 $10,949 153,951 2.340% $2,929 65,93177,281
Page 17 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Mozambique $72,826 $202,689 $66,754 3.04
Safe Water Solution-7.41Certeza Free ISM 03/2014 1,344 $425 100%32,763 0 $2,472 122,598 3.3896% -$18,317 36,31534,107
Water Treatment TabletsNACerteza Comprimido 20L 03/2014 151,200 $1,527 58%8,640 0 NA 440,160 NA5% $888 NA159,840
NACerteza Comprimido 5L 03/2014 52,740 $1,627 87%4,920 0 NA 244,740 NA9% $1,415 NA57,660
NACerteza Free Comprimido 20L 03/2014 0 $0 NA10,000 0 NA 472,170 NA100% $0 NA10,000
Injectable 3NAEnaf Injectable 03/2014 0 $0 NA74 0 $0 326 5.62100% $0 5874
OCsNAConfiança Pills 03/2014 0 $0 NA0 0 $0 9,654 NANA $9,341 00
NAMicrolenyn 30 Combined OC 03/2014 0 $0 NA318 0 $0 562 2.18100% $0 257318
NAProgestyn OC 03/2014 0 $0 NA111 0 $0 1,171 21.55100% $0 54111
Rwanda $0 $2,931 $0 NA
CondomNAPlaisir 03/2014 0 $0 NA0 0 $0 0 NANA $285 00
NAPrudence Plus 03/2014 0 $0 NA0 0 $0 0 NANA $662 00
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 420 $0 NA0 0 $0 0 NA0% $0 438420
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 4 $0 NA0 0 $0 0 NA0% $0 34
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 4 $0 NA0 0 $0 0 NA0% $0 34
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 2,012 $0 NA0 0 $0 0 NA0% $0 1,8192,012
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 106 $0 NA0 0 $0 0 NA0% $0 68106
Safe Water SolutionNASur Eau 03/2014 0 $0 NA0 0 $0 0 NANA $1,500 00
OCsNAConfiance Duofem 03/2014 0 $0 NA0 0 $0 0 NANA $466 00
SDM (Cycle Beads)NACollier 03/2014 0 $0 NA0 0 $0 0 NANA $18 00
Page 18 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
SFH Rwanda $20,116 $0 $25,217 NA
CondomNAPlaisir 03/2014 287,040 $7,914 0%18,040 0 $7,323 2,262,194 8.166% $0 277,213305,080
NAPrudence Plus 03/2014 557,760 $7,689 0%57,080 0 $9,001 19,912,416 28.409% $0 701,213614,840
LLINNATuzanet 03/2014 0 $0 NA0 0 $0 626 NANA $0 00
PURNAPuR 03/2014 9,600 $353 0%3,042 0 $221 2,335,309 222.5624% $0 10,49312,642
Safe Water SolutionNASur Eau 03/2014 11,232 $2,890 0%348 0 $7,347 14,367 0.503% $0 28,59111,580
Implant 5NAJadelle 03/2014 0 $0 NA0 0 $37 1,588 47.64NA $0 330
Injectable 3NADepo-Provera (3 Month) 03/2014 2,400 $529 0%0 0 $638 21,741 7.550% $0 2,8802,400
OCsNAConfiance Duofem 03/2014 10,080 $741 0%0 0 $650 34,585 3.930% $0 8,80110,080
SDM (Cycle Beads)NACollier 03/2014 0 $0 NA0 0 $0 20 NANA $0 00
Somaliland $1,622 $0 $1,692 NA
Diarrhea Treatment KitNASD OFLV-DTK 03/2014 0 $0 NA0 0 $198 181 0.06NA $0 2,7850
NAShuban Daweeye_DTK 03/2014 0 $0 NA0 0 $0 249 NANA $0 00
Misoprostol for PPHNAUmmul-gargaar 03/2014 500 $34 0%0 0 $218 6,180 2.490% $0 2,483500
ORSNASD OFLV-ORS 03/2014 0 $0 NA0 0 $0 1 NANA $0 00
Water Treatment TabletsNAAquatab 03/2014 0 $0 NA0 0 $0 722,602 NANA $0 00
NABiyosifeeye 03/2014 314,300 $1,074 0%0 0 $792 2,867,268 12.420% $0 230,795314,300
ZincNAShuban Daweeye_Zinc 03/2014 0 $0 NA0 0 $0 4,600 NANA $0 00
Injectable 3NA3-month Injectables 03/2014 0 $0 NA0 400 $0 6,975 NANA $0 0400
NANasiye - Inj 3 03/2014 199 $99 0%0 0 $95 401 2.070% $0 194199
Page 19 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Somaliland $1,622 $0 $1,692 NA
OCsNAKala-Koriye 03/2014 0 $0 NA0 0 $0 446 NANA $0 00
NANasiye - OC 03/2014 1,830 $414 0%0 0 $389 19,876 11.560% $0 1,7191,830
NAOC 03/2014 0 $0 NA0 0 $0 9,591 NANA $0 00
South Sudan $0 $0 $2,095 NA
CondomNANumber One 03/2014 0 $0 NA0 0 $1,409 301,536 6.46NA $0 46,6720
Free CondomNAGeneric 03/2014 0 $0 NA0 0 $0 764,776 29.39NA $0 26,0250
LLINNAFree Permanet Mesh 03/2014 0 $0 NA0 0 $0 5,645 NANA $0 00
Malaria PPT (ACT)NAACTs for Adult (14+ years) 03/2014 0 $0 NA125,400 100 $0 608,825 13.52100% $0 45,017125,500
NAACTs for Child (6-14 years) 03/2014 0 $0 NA82,500 75 $0 220,661 7.30100% $0 30,23382,575
NAACTs for Infant (2-12 months) 03/2014 0 $0 NA179,580 50 $0 298,065 3.37100% $0 88,400179,630
NAACTs for Toddler (1-5 years) 03/2014 0 $0 NA28,500 50 $0 156,950 3.82100% $0 41,11728,550
ORSNAORS 03/2014 0 $0 NA493,979 260 $0 1,428,831 8.30100% $0 172,218494,239
PURNAPuR 03/2014 0 $0 NA0 0 $649 2,811,570 124.30NA $0 22,6180
Water Treatment TabletsNAWaterGuard Tablets 03/2014 0 $0 NA0 0 $37 505,200 45.11NA $0 11,2000
ZincNAZinc 03/2014 0 $0 NA157,124 130 $0 479,707 8.99100% $0 53,388157,254
Pneumonia PPTNAAmoxicillin for Children (1-5 years) 03/2014 0 $0 NA24,588 0 $0 34,718 3.26100% $0 10,65324,588
NAAmoxicillin for Infant (2-12 months) 03/2014 0 $0 NA1,750 0 $0 3,036 1.58100% $0 1,9181,750
Uganda $0 $0 $0 NA
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 379 $0 NA0 0 $0 0 NA0% $0 144379
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 -38 $0 NA0 0 $0 0 NA0% $0 347-38
Page 20 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Uganda $0 $0 $0 NA
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 60 $0 NA0 0 $0 0 NA0% $0 2560
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 1 $0 NA0 0 $0 0 NA0% $0 01
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 1 $0 NA0 0 $0 0 NA0% $0 01
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 5,339 $0 NA0 0 $0 0 NA0% $0 4,7585,339
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 141 $0 NA0 0 $0 0 NA0% $0 104141
Cervical Cancer-VIA and CryotherapyNACervical Cancer-VIA and Cryother 03/2014 48 $0 NA0 0 $0 0 NA0% $0 3448
Page 21 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Southern Africa
POPULATION SERVICES INTERNATIONAL
CYPs, Cases, and Deaths by Country
1/2014 - 3/2014
Cases CYP*
HIV & TB Reproductive Health
Maternal
Deaths
Unintended
Pregnancies
Malaria
Cases
Malaria
Deaths
Diarrhea
Cases
Diarrhea
Deaths
Malaria Control Child Survival
Sum of
All Deaths
Pneumonia
Cases
Pneumonia
Deaths
STI
Deaths
TB
Deaths
Nutrition
Deaths
IDU
Deaths
Southern Africa 34,146 711,361 458 160,368 - 20,195 223 - 21,125 - 225 23 - - -
Botswana 619 16,932 7 3,023 - - - - 7 - - - - - -
Lesotho 1,422 40,002 49 8,871 - - - - 49 - - - - - -
Madagascar 236 211,804 168 56,713 - 1,284 97 - 1,797 - 225 23 - - -
Namibia - - - - - - - - - - - - - - -
South Africa 8,773 241,514 40 29,375 - - - - 40 - - - - - -
Swaziland 1,613 24,006 11 5,053 - - - - 11 - - - - - -
Zambia 9,454 108,567 133 40,818 - 1,307 123 - 1,563 - - - - - -
Zimbabwe 12,028 68,536 51 16,516 - 17,604 3 - 17,658 - - - - - -
3001 - 4/18/2014 4:45:11PM Page 3 of 5
* Using USAID CYP conversion factors
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Southern Africa - All 1,071,816 2,418,310 1,346,494
Cervical Cancer-VIA and Cryotherapy 180 77 - 330 101 101 1,800 -% 604 934 -
Condom 15,064,654 11,594,460 35,162,030 34,083,224 83,578 517,355 149,365,174 (3)% 148,066,830 985,606,685 433,777
Diarrhea Treatment Kit 20,595 10,797 25,036 44,931 1,823 1,823 194,970 79% 108,671 760,260 -
Early Infant MC (HIV-Negative) 39 52 151 134 - 1,007 1,200 (11)% 788 1,776 1,007
Early Infant MC (HIV-Unknown) 19 25 553 64 - 453 800 (88)% 957 1,817 453
Emergency Contraception 8,728 7,915 14,864 14,354 267 267 118,272 (3)% 123,332 517,908 -
Female Condom 492,346 271,944 599,932 990,068 3,579 15,710 3,092,019 65% 3,393,608 27,729,009 12,131
Free Condom 6,176,356 7,651,173 25,451,842 17,867,628 36,624 271,756 101,051,600 (30)% 114,403,021 850,515,656 235,132
Free Female Condom 58,000 61,667 470,524 209,500 403 2,995 1,190,250 (55)% 1,198,545 2,250,934 2,592
Implant 3 Distribution (128) 188 560 (554) (564) (564) 3,050 (199)% 3,917 12,075 -
Implant 3 Insertion 462 398 640 1,257 1,362 1,362 - 96% 3,699 4,956 -
Implant 4 Distribution 138 172 1,416 154 201 201 600 (89)% 2,466 21,254 -
Implant 4 Insertion 21 8 41 43 60 60 - 5% 166 209 -
Implant 5 Distribution (2,894) 413 6,390 (7,086) (16,622) (16,622) 72,698 (211)% 38,980 168,954 -
Implant 5 Insertion 5,604 4,449 10,828 15,836 36,514 36,514 37,200 46% 44,340 60,176 -
Injectable 3 130,849 156,916 402,119 443,649 47,028 47,028 1,901,111 10% 1,818,024 11,077,575 -
IUD 10 Distribution 62 774 9,424 (2,314) (5,722) (5,722) 47,900 (125)% 44,707 184,911 -
IUD 10 Insertion 3,961 3,203 10,280 10,783 24,854 24,854 24,800 5% 42,688 53,471 -
LLINs 11,586 2,358,992 78,326 861,870 952,428 952,428 4,258,090 1,000% 8,287,907 21,212,050 -
Lubricant A 128,400 (33,325,650) 100,244,620 (99,858,750) - - - (200)% 100,524,109 1,137,264 -
Lubricant E 6,240 6,064 6,672 18,732 - - 72,000 181% 64,764 83,496 -
3003 - 4/18/2014 4:49:12PM Page 5 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Malaria PPT (ACT) 98,675 51,484 214,934 206,956 110,255 110,255 750,000 (4)% 941,369 2,255,613 -
Malaria RDK 115,669 72,084 157,547 278,968 - - 1,064,908 77% 1,196,873 3,075,327 -
Male Circumcision 27,045 27,537 42,606 69,084 - 258,740 327,317 62% 317,405 755,307 258,740
Micronutrient Powder 31,080 37,310 444,150 100,110 - - 2,400,000 (77)% 1,161,600 1,261,710 -
Misoprostol for PPH - - - - - - - -% 119,988 119,988 -
OCs 397,928 473,075 1,066,753 1,177,700 35,860 35,860 5,994,952 10% 5,668,634 47,759,364 -
Pneumonia PPT 19,105 7,656 22,816 39,979 19,247 19,247 96,000 75% 49,924 189,954 -
PUR - - 9,557 - - - - (100)% 10,037 2,109,240 -
Safe Water Solution 411,953 330,454 1,371,423 932,507 13,635 13,635 5,588,259 (32)% 5,770,773 47,828,389 -
SDM (Cycle Beads) 870 870 6,115 2,468 1,573 1,573 21,262 (60)% 27,536 70,896 -
STI Kit (Non-Ulcerative) 30,002 2 490 30,008 - 1,359 1,391 6,024% 1,544 32,776 1,359
STI Kit (Ulcerative) - 1 6 4 - 2 63 (33)% 46 289 2
VCT 102,164 80,210 236,242 288,916 - 126,622 1,010,807 22% 1,033,064 3,907,344 126,622
Water Treatment Tablets 36,000 349,800 3,672,000 36,000 9 9 - (99)% 13,107,400 99,214,900 -
3003 - 4/18/2014 4:49:12PM Page 6 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Southern Africa - All 1,071,816 1,346,494 2,418,310
Botswana 28,805 4,364 33,170
1,207,360 259,826 623,304 1,986,838 4,268 32,435 2,138,400 3,393,176 57,314,742 28,168 219%Condom
6 /93 459% 1,440,283 23,513 3,094 20,419 47,649,067 1,337,576 257,472 648,000 141,001 1,017,280 Lovers Plus
8 /06 412% 103,680 1,693 223 1,470 7,306,582 378,576 20,232 388,800 17,280 51,840 Lovers Plus C&F
-% 51,840 846 111 735 69,120 17,280 - - 5,760 34,560 Lovers Plus Extra Play
10/13 -% 51,840 846 111 735 264,672 212,832 - 250,560 11,520 17,280 Lovers Plus R&S
6 /07 (18)% 200,955 3,281 432 2,849 1,444,693 1,008,144 245,376 475,200 61,225 17,280 Trust
11/12 38% 138,240 2,257 297 1,960 580,608 438,768 100,224 375,840 23,040 69,120 Trust Studded
- 15,000 1,060,608 45,000 97 735 1,000,000 1,339,708 15,035,800 638 (96)%Free Condom
1 /10 -% 45,000 735 97 638 1,125,000 90,000 - - 15,000 - Carex
1 /10 (100)% - - - - 7,520,800 201,100 12,000 - - - Lorato
6 /11 (100)% - - - - 6,390,000 1,048,608 1,048,608 1,000,000 - - Sekwata
- - - - - - - 4,800 4,800 - 0%Lubricant E
-% - - - - 2,400 2,400 - - - - Lovers Plus Lube Natural (100mL)
-% - - - - 2,400 2,400 - - - - Lovers Plus Lube Natural (50mL)
Lesotho 76,727 16,890 93,617
3,744 391,488 803,088 1,178,208 4,146 18,732 3,731,400 3,270,060 26,741,218 14,586 47%Condom
3 /99 -% 329,976 5,246 1,161 4,085 2,558,353 14,364 - 103,680 109,968 72 Lovers Plus
1 /05 11% 16,704 266 59 207 535,408 76,968 15,048 91,800 5,544 72 Lovers Plus C&F
11/12 (15)% 6,696 106 24 83 40,968 32,976 7,920 36,720 2,184 144 Lovers Plus R&S
5 /01 21% 432,000 6,868 1,520 5,348 12,156,194 1,334,808 358,488 1,422,000 143,424 1,728 Trust
1 /05 (7)% 392,832 6,245 1,382 4,863 11,450,295 1,810,944 421,632 2,077,200 130,368 1,728 Trust Studded
88,000 71,667 151,680 211,000 742 3,188 794,031 1,140,660 3,214,236 2,445 39%Female Condom
3002 - 4/18/2014 4:46:24PM Page 36 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
7 /06 39% 211,000 3,188 742 2,445 3,214,236 1,140,660 151,680 794,031 71,667 88,000 Female Condom
1,239,000 1,242,000 938,400 3,411,000 12,002 54,230 7,804,500 13,818,600 44,866,816 42,228 263%Free Condom
1 /08 1,136% 3,411,000 54,230 12,002 42,228 25,188,000 13,149,000 276,000 5,190,900 1,242,000 1,239,000 Blue & Gold Workplace
4 /05 (100)% - - - - 19,678,816 669,600 662,400 2,613,600 - - Generic
68 85 412 194 - 738 - 2,814 3,800 738 (53)%Male Circumcision
9 /12 (53)% 194 738 - 738 3,789 2,811 411 - 85 68 Male Circumcision (HIV-Negative)
10/12 (100)% - - - - 11 3 1 - - - Male Circumcision (HIV-Unknown)
10,199 8,357 11,278 28,695 - 16,729 93,447 92,998 236,413 16,729 154%VCT
12/09 (28)% 550 193 - 193 5,466 2,038 760 495 171 200 VCT Concordant Couple (HIV-Negative)
12/09 (41)% 66 145 - 145 890 258 112 46 19 20 VCT Concordant Couple (HIV-Positive)
12/09 (23)% 43 35 - 35 406 178 56 21 16 13 VCT Discordant Couple (HIV-Negative)
12/09 (23)% 43 107 - 107 406 178 56 21 16 13 VCT Discordant Couple (HIV-Positive)
12/09 166% 24,508 8,614 - 8,614 202,913 79,913 9,207 80,148 7,146 8,804 VCT Individual (HIV-Negative)
12/09 221% 3,485 7,635 - 7,635 26,332 10,433 1,087 12,716 990 1,149 VCT Individual (HIV-Positive)
Madagascar 13,957 225,963 239,920
969,264 820,864 2,147,812 2,272,944 7,802 19,584 10,008,168 10,668,052 37,775,882 11,782 6%Condom
1 /08 6% 2,272,944 19,584 7,802 11,782 37,775,882 10,668,052 2,147,812 10,008,168 820,864 969,264 Protector Plus
20,595 10,797 25,036 44,931 1,823 1,823 194,970 108,671 760,260 - 79%Diarrhea Treatment Kit
1 /10 -% - - - - 274,865 50,790 - 85,507 - - Hydrazinc
1 /10 79% 44,931 1,823 1,823 - 485,395 57,881 25,036 109,463 10,797 20,595 Viasur
420 513 - 1,960 42 42 - - 1,960 - 0%Emergency Contraception
1 /14 -% 1,960 42 42 - 1,960 - - - 513 420 Norlevo
23,106 1,201 24,864 25,056 86 208 51,000 42,144 278,321 122 1%Female Condom
10/07 1% 25,056 208 86 122 278,321 42,144 24,864 51,000 1,201 23,106 Feeling
116,556 649,493 214,800 129,256 444 1,114 2,000,000 2,928,652 43,074,906 670 (40)%Free Condom
3002 - 4/18/2014 4:46:24PM Page 37 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
1 /02 (40)% 129,256 1,114 444 670 43,074,906 2,928,652 214,800 2,000,000 649,493 116,556 Generic
(128) 55 (80)(554) (564) (564) 3,050 218 8,376 - 0%Implant 3 Distribution
-%(1,257) (1,281)(1,281) - (4,956)(3,699)(640) - (398)(462) PSI Implant 3 Distributed Inserted (1)
7 /06 26% 703 716 716 - 13,332 3,917 560 3,050 453 334 Implanon
462 398 640 1,257 1,362 1,362 - 3,699 4,956 - 96%Implant 3 Insertion
96% 1,257 1,362 1,362 - 4,956 3,699 640 - 398 462 PSI Implant 3 Inserted
138 172 1,045 154 201 201 600 1,970 9,088 - (85)%Implant 4 Distribution
-%(43) (56)(56) - (209)(166)(41) - (8)(21) PSI Implant 4 Distributed Inserted (1)
7 /11 (82)% 197 257 257 - 5,571 1,714 1,086 - 179 159 Implant Zarin
11/10 -% - - - - 3,726 422 - 600 - - Zarin
21 8 41 43 60 60 - 166 209 - 5%Implant 4 Insertion
5% 43 60 60 - 209 166 41 - 8 21 PSI Implant 4 Inserted
127,250 154,359 396,821 436,104 46,325 46,325 1,880,567 1,791,016 10,957,568 - 10%Injectable 3
10/98 10% 436,104 46,325 46,325 - 10,957,568 1,791,016 396,821 1,880,567 154,359 127,250 Confiance Injectable
(59) (108) (596)(1,352) (2,535) (2,535) 21,500 213 83,500 - 0%IUD 10 Distribution
-%(6,496) (12,178)(12,178) - (34,580)(28,084)(6,814) - (1,990)(2,465) PSI IUD 10 Distributed Inserted (1)
5 /06 (13)% 5,124 9,606 9,606 - 116,495 27,552 5,908 20,500 1,851 2,396 Copper T
8 /11 (94)% 20 37 37 - 1,585 745 310 1,000 32 10 IUD 1 x 5
2,492 2,012 6,814 6,581 13,125 13,125 - 28,182 34,763 - (3)%IUD 10 Insertion
(5)% 6,496 12,956 12,956 - 34,580 28,084 6,814 - 1,990 2,465 PSI IUD 10 Inserted
-% 85 170 170 - 183 98 - - 22 27 Non-PSI IUD 10 Inserted
- 2,005,711 65,784 2,294 269 269 950,000 6,470,277 12,569,411 - (97)%LLINs
5 /09 (100)% - - - - 550,783 758 758 - - - Interceptor Blue
12/13 -% 4 - - - 2,498,304 2,498,300 - - 832,768 - Net Protect
5 /12 -% 1,400 164 164 - 650,273 2,760 - - 500 - Olyset Net Blue
3002 - 4/18/2014 4:46:24PM Page 38 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
5 /12 44,400% 890 105 105 - 1,262,419 140,077 2 750,000 361 - Olyset Net White
3 /07 (100)% - - - - 1,817,177 407 317 - - - PermaNet
7 /13 -% - - - - 1,171,262 1,171,262 - - 390,421 - Royal Sentry Blue (Generic Net)
9 /01 (100)% - - - - 2,274,641 312,161 64,707 200,000 144 - Super Moustiquaire
9 /13 -% - - - - 2,344,552 2,344,552 - - 781,517 - Yorkool White (Generic Net)
4,400 3,683 9,000 9,250 - - - 53,928 171,988 - 3%Lubricant A
8 /11 3% 9,250 - - - 171,988 53,928 9,000 - 3,683 4,400 Lubricant
98,675 51,484 214,934 206,956 110,255 110,255 750,000 941,369 2,255,613 - (4)%Malaria PPT (ACT)
10/10 (32)% 53,651 28,582 28,582 - 820,886 361,004 78,570 250,000 15,760 31,869 Artesunate Amodiaquine 25 mg
10/10 12% 153,305 81,672 81,672 - 1,434,727 580,365 136,364 500,000 35,723 66,806 Artesunate Amodiaquine combo 50 mg
115,669 72,084 157,547 278,968 - - 1,064,908 1,196,873 3,075,327 - 77%Malaria RDK
8 /11 77% 278,968 - - - 3,075,327 1,196,873 157,547 1,064,908 72,084 115,669 RDT Malaria
31,080 37,310 444,150 100,110 - - 2,400,000 1,161,600 1,261,710 - (77)%Micronutrient Powder
2 /13 (77)% 100,110 - - - 1,261,710 1,161,600 444,150 2,400,000 37,310 31,080 ZAZATOMADY (ZZT)
222,176 279,436 573,385 784,643 21,319 21,319 3,277,499 3,121,428 26,118,726 - 37%OCs
10/98 37% 784,643 21,319 21,319 - 26,118,726 3,121,428 573,385 3,277,499 279,436 222,176 Pilplan
19,105 7,656 22,816 39,979 19,247 19,247 96,000 49,924 189,954 - 75%Pneumonia PPT
12/11 75% 39,979 19,247 19,247 - 189,954 49,924 22,816 96,000 7,656 19,105 Pneumostop
197,105 148,325 634,925 399,203 5,129 5,129 2,588,259 2,566,980 15,305,277 - (37)%Safe Water Solution
12/11 (45)% 73,683 303 303 - 1,143,464 406,849 134,914 646,165 25,205 24,305 Sur Eau 40 mL
9 /04 (35)% 325,520 4,825 4,825 - 14,161,813 2,160,131 500,011 1,942,094 123,120 172,800 Sur Eau Vaovao
870 870 6,115 2,468 1,573 1,573 21,262 27,536 70,896 - (60)%SDM (Cycle Beads)
3 /12 (60)% 2,468 1,573 1,573 - 70,896 27,536 6,115 21,262 870 870 Rojo
30,000 - - 30,000 - 1,358 - 100 30,100 1,358 0%STI Kit (Non-Ulcerative)
11/12 -% 30,000 1,358 - 1,358 30,100 100 - - - 30,000 Cefidoxal
3002 - 4/18/2014 4:46:24PM Page 39 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
804 673 2,247 1,898 - 25 20,941 14,248 52,999 25 (16)%VCT
1 /10 (100)% - - - - 268 70 46 - - - VCT Concordant Couple (HIV-Negative)
8 /13 -% - - - - 4 4 - - - - VCT Concordant Couple (HIV-Positive)
12/09 (14)% 1,895 25 - 25 52,649 14,156 2,193 20,941 672 803 VCT Individual (HIV-Negative)
12/09 (63)% 3 - - - 78 18 8 - 1 1 VCT Individual (HIV-Positive)
Namibia - - -
- 17,856 546,234 - - - - 9,064,577 19,460,930 - (100)%Free Condom
1 /08 -% - - - - 9,526,977 6,048,000 - - - - Camouflage Free
1 /08 (100)% - - - - 9,933,953 3,016,577 546,234 - 17,856 - Smile
- - 4,724 - - - - 51,545 316,734 - (100)%Free Female Condom
2 /07 (100)% - - - - 316,734 51,545 4,724 - - - Femidom Free
- - 12,517 - - - - 26,585 272,855 - (100)%LLINs
7 /08 (100)% - - - - 113,536 7,868 7,859 - - - Generic Permanet
12/05 (100)% - - - - 159,319 18,717 4,658 - - - Supanet Plus
- - 217,620 - - - - 380,181 734,719 - (100)%Lubricant A
8 /11 (100)% - - - - 734,719 380,181 217,620 - - - Condom Lubricant (Water Based)
- - 9,557 - - - - 10,037 2,109,240 - (100)%PUR
5 /11 (100)% - - - - 2,109,240 10,037 9,557 - - - PUR Sachets for Social Marketing
South Africa 408,953 40,452 449,406
7,377,033 5,044,146 18,190,992 16,873,023 23,551 241,666 71,977,680 68,851,774 483,396,265 218,115 (7)%Condom
10/92 (16)% 2,048,881 29,345 2,860 26,486 142,416,897 9,737,575 2,430,158 10,197,360 678,376 889,602 Lovers Plus
1 /08 (16)% 1,670,328 23,924 2,331 21,592 37,906,545 8,046,141 1,983,384 8,326,080 606,480 491,688 Lovers Plus C&F
9 /13 -% 174,386 2,498 243 2,254 298,965 124,579 - 1,116,000 46,368 110,306 Lovers Plus Extra Play
4 /07 (9)% 913,464 13,083 1,275 11,808 26,130,867 4,342,384 998,496 4,289,040 336,792 269,208 Lovers Plus R&S
3002 - 4/18/2014 4:46:24PM Page 40 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
5 /01 (18)% 5,949,492 85,212 8,304 76,908 139,514,401 23,624,177 7,219,618 24,303,600 1,566,434 3,007,453 Trust
4 /04 10% 6,116,472 87,604 8,537 79,067 137,128,590 22,976,918 5,559,336 23,745,600 1,809,695 2,608,776 Trust Studded
9,396 21,968 - 43,188 60 583 129,600 203,308 246,496 522 0%Female Condom
9 /13 -% 43,188 583 60 522 246,496 203,308 - 129,600 21,968 9,396 LP Condom - Inner Condom
3,660,000 5,300,000 21,964,800 11,928,000 16,649 170,840 84,527,100 82,302,000 710,536,760 154,192 (46)%Free Condom
3 /13 (100)% - - - - 1,800,000 1,800,000 784,800 - - - Military Condom
1 /04 (44)% 11,928,000 170,840 16,649 154,192 708,736,760 80,502,000 21,180,000 84,527,100 5,300,000 3,660,000 Public Distribution
23,000 49,333 372,500 137,500 192 1,855 1,080,250 1,014,000 1,610,500 1,663 (63)%Free Female Condom
5 /12 (88)% 25,000 337 35 302 1,075,000 758,000 208,000 - 15,000 - FC2 Female Condom
10/13 -% 112,500 1,518 157 1,361 144,000 31,500 - 1,080,250 34,333 23,000 Female Condom GOSA
10/11 (100)% - - - - 391,500 224,500 164,500 - - - Female Condom SANDF
100,000 (33,333,333) 100,000,000 (99,900,000) - - - 100,000,000 100,000 - (200)%Lubricant A
3 /13 (200)%(99,900,000) - - - 100,000 100,000,000 100,000,000 - (33,333,333) 100,000 Lovers Plus Lube Natural (5mL)
6,240 5,264 6,672 16,332 - - 72,000 59,676 76,008 - 145%Lubricant E
1 /13 46% 5,748 - - - 31,620 25,872 3,936 36,000 2,276 1,356 Lovers Plus Lube Natural (100mL)
1 /13 287% 10,584 - - - 44,388 33,804 2,736 36,000 2,988 4,884 Lovers Plus Lube Natural (50mL)
4,048 766 6,009 5,373 - 19,522 37,357 33,961 71,395 19,522 (11)%Male Circumcision
3 /09 (12)% 5,201 18,978 - 18,978 70,360 33,449 5,935 36,794 729 3,885 Bepelopele (MC HIV-Negative)
3 /09 132% 172 544 - 544 1,035 512 74 563 37 163 Bepelopele (MC HIV-Unknown)
9,735 9,325 27,462 33,315 - 14,940 117,580 106,891 664,163 14,940 21%VCT
12/09 26% 1,828 525 - 525 26,536 5,094 1,448 5,603 459 596 VCT Concordant Couple (HIV-Negative)
12/09 70% 68 206 - 206 2,016 980 40 1,078 5 52 VCT Concordant Couple (HIV-Positive)
12/09 (62)% 18 12 - 12 804 181 47 199 5 6 VCT Discordant Couple (HIV-Negative)
12/09 (62)% 18 59 - 59 804 181 47 199 5 6 VCT Discordant Couple (HIV-Positive)
12/09 20% 29,516 8,481 - 8,481 577,311 96,037 24,586 105,641 8,275 8,836 VCT Individual (HIV-Negative)
3002 - 4/18/2014 4:46:24PM Page 41 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
12/09 44% 1,867 5,656 - 5,656 56,692 4,418 1,294 4,860 576 239 VCT Individual (HIV-Positive)
Swaziland 70,939 8,823 79,762
143,424 163,536 - 634,032 1,942 12,111 1,330,560 996,936 14,871,319 10,169 0%Condom
2 /01 -% 198,576 3,793 608 3,185 1,494,898 20,736 - 73,440 66,192 - Lovers Plus
1 /05 -% 22,464 429 69 360 235,984 23,352 - 64,800 6,336 3,456 Lovers Plus C&F
5 /10 -% 15,552 297 48 249 159,624 30,096 - 43,200 4,608 1,728 Lovers Plus R&S
5 /01 -% 95,040 1,815 291 1,524 6,167,593 226,368 - 285,120 25,920 17,280 Trust
1 /05 -% 302,400 5,776 926 4,850 6,813,220 696,384 - 864,000 60,480 120,960 Trust Studded
39 52 151 134 - 1,007 1,200 788 1,776 1,007 (11)%Early Infant MC (HIV-Negative)
7 /11 (11)% 134 1,007 - 1,007 1,776 788 151 1,200 52 39 Early Infant MC (HIV-Negative)
19 25 553 64 - 453 800 957 1,817 453 (88)%Early Infant MC (HIV-Unknown)
7 /11 (88)% 64 453 - 453 1,817 957 553 800 25 19 Early Infant MC (HIV-Unknown)
5,000 5,333 34,000 20,000 61 361 150,000 120,000 464,227 300 (41)%Female Condom
7 /06 (41)% 20,000 361 61 300 464,227 120,000 34,000 150,000 5,333 5,000 Female Condom
1,036,800 411,024 720,000 2,226,672 6,820 42,534 5,320,000 4,791,984 15,646,944 35,714 209%Free Condom
4 /05 209% 2,226,672 42,534 6,820 35,714 15,646,944 4,791,984 720,000 5,320,000 411,024 1,036,800 Generic
24,000 4,000 18,000 32,000 - - - 90,000 130,557 - 78%Lubricant A
8 /11 78% 32,000 - - - 130,557 90,000 18,000 - 4,000 24,000 Assegai Branded (5 mL)
- 800 - 2,400 - - - 288 2,688 - 0%Lubricant E
-% 2,400 - - - 2,688 288 - - 800 - Lovers Plus Lube Natural (50mL)
565 277 1,046 1,080 - 7,149 9,960 8,403 48,714 7,149 3%Male Circumcision
6 /09 35% 985 6,627 - 6,627 41,722 7,437 730 9,000 252 524 Male Circumcision (HIV-Negative)
6 /09 (70)% 95 521 - 521 6,992 966 316 960 25 41 Male Circumcision (HIV-Unknown)
2 2 490 8 - 1 1,391 1,444 2,676 1 (98)%STI Kit (Non-Ulcerative)
3 /10 (96)% 7 1 - 1 1,068 496 163 634 2 2 Urethral Discharge
3002 - 4/18/2014 4:46:24PM Page 42 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
3 /10 (100)% 1 - - - 1,608 948 327 757 - - Vaginal Discharge
- 1 6 4 - 2 63 46 289 2 (33)%STI Kit (Ulcerative)
3 /10 -% - - - - 20 1 - 1 - - Genital Herpes
3 /10 (33)% 4 2 - 2 269 45 6 62 1 - Genital Ulcer Syndrome
10,039 7,140 15,509 25,698 - 16,144 98,300 88,262 274,747 16,144 66%VCT
12/09 47% 832 423 - 423 5,394 2,154 566 1,600 263 250 VCT Concordant Couple (HIV-Negative)
12/09 (18)% 36 96 - 96 742 124 44 100 10 10 VCT Concordant Couple (HIV-Positive)
12/09 (13)% 40 47 - 47 506 134 46 300 10 13 VCT Discordant Couple (HIV-Negative)
12/09 (13)% 40 124 - 124 506 134 46 300 10 13 VCT Discordant Couple (HIV-Positive)
12/09 76% 23,415 11,900 - 11,900 240,234 79,896 13,305 81,600 6,499 9,221 VCT Individual (HIV-Negative)
12/09 (11)% 1,335 3,554 - 3,554 27,365 5,820 1,502 14,400 348 532 VCT Individual (HIV-Positive)
Zambia 201,207 162,863 364,070
39 28 - 91 35 35 - 470 561 - 0%Cervical Cancer-VIA and Cryotherapy
4 /13 -% 91 35 35 - 561 470 - - 28 39 Cervical Cancer-VIA and Cryotherapy
2,676,309 2,772,799 6,212,874 4,908,259 23,577 88,541 31,400,000 32,809,792 146,304,369 64,964 (21)%Condom
10/06 (25)% 4,509,631 81,350 21,663 59,688 133,240,234 31,820,584 6,008,574 30,800,000 2,720,419 2,371,317 Maximum Classic
8 /04 95% 398,628 7,191 1,915 5,276 13,064,135 989,208 204,300 600,000 52,380 304,992 Maximum Scented
214,064 60,261 69,168 321,664 1,545 5,525 300,000 297,776 4,084,575 3,980 365%Female Condom
10/97 365% 321,664 5,525 1,545 3,980 4,084,575 297,776 69,168 300,000 60,261 214,064 Care
124,000 15,800 7,000 127,700 613 2,304 400,000 157,500 1,893,500 1,690 1724%Free Condom
1 /08 1,724% 127,700 2,304 613 1,690 1,893,500 157,500 7,000 400,000 15,800 124,000 Generic
- - 93,300 - - - 110,000 96,000 186,700 - (100)%Free Female Condom
1 /12 (100)% - - - - 186,700 96,000 93,300 110,000 - - Free Female Condoms
- - 330 - - - - 330 12,000 - (100)%Implant 4 Distribution
3 /12 (100)% - - - - 12,000 330 330 - - - Sino Implant
3002 - 4/18/2014 4:46:24PM Page 43 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
(2,894) (1,559) (6,138)(8,586) (18,609) (18,609) 37,200 (13,760) 64,507 - 0%Implant 5 Distribution
-%(15,836) (34,323)(34,323) - (60,176)(44,340)(10,828) - (4,449)(5,604) PSI Implant 5 Distributed Inserted (1)
11/08 55% 7,250 15,714 15,714 - 124,683 30,580 4,690 37,200 2,890 2,710 Jadelle
5,604 4,449 10,828 15,836 36,514 36,514 37,200 44,340 60,176 - 46%Implant 5 Insertion
46% 15,836 36,514 36,514 - 60,176 44,340 10,828 37,200 4,449 5,604 PSI Implant 5 Inserted
- 193 - 305 45 45 - 2,172 10,845 - 0%Injectable 3
1 /08 -% 305 45 45 - 10,845 2,172 - - 193 - My Choice Inj 3
(229) (194) (460)(1,612) (4,229) (4,229) 24,800 804 56,871 - 0%IUD 10 Distribution
-%(4,202) (11,025)(11,025) - (18,708)(14,506)(3,466) - (1,191)(1,469) PSI IUD 10 Distributed Inserted (1)
11/08 (14)% 2,590 6,795 6,795 - 75,579 15,310 3,006 24,800 997 1,240 MyChoice IUD-10
1,469 1,191 3,466 4,202 11,728 11,728 24,800 14,506 18,708 - 21%IUD 10 Insertion
21% 4,202 11,728 11,728 - 18,708 14,506 3,466 24,800 1,191 1,469 PSI IUD 10 Inserted
11,586 120,035 25 159,836 89,455 89,455 1,400,000 1,022,947 5,481,567 - 639244%LLINs
1 /02 639,244% 159,836 89,455 89,455 - 4,829,467 370,847 25 1,400,000 120,035 11,586 Mama Safenite
10/13 -% - - - - 652,100 652,100 - - - - Mama Safenite MOH (SI)
8,044 16,070 20,237 28,096 - 96,998 110,000 170,304 403,059 96,998 39%Male Circumcision
4 /07 42% 17,615 63,194 - 63,194 240,120 108,652 12,417 - 11,226 5,003 Male Circumcision (HIV-Negative)
4 /07 34% 10,481 33,804 - 33,804 162,939 61,652 7,820 110,000 4,844 3,041 Male Circumcision (HIV-Unknown)
- - - - - - - 119,988 119,988 - 0%Misoprostol for PPH
4 /13 -% - - - - 119,988 119,988 - - - - Misoprostol
159,912 186,919 461,628 365,697 13,905 13,905 2,600,000 2,477,306 21,479,358 - (21)%OCs
8 /07 67% 31,536 1,199 1,199 - 1,248,020 77,868 18,828 100,000 10,524 13,176 MyChoice OCs
12/96 (25)% 334,161 12,706 12,706 - 20,231,338 2,399,438 442,800 2,500,000 176,395 146,736 Safeplan
214,848 146,276 645,552 515,340 8,283 8,283 3,000,000 2,845,932 31,473,311 - (20)%Safe Water Solution
11/98 (20)% 515,340 8,283 8,283 - 31,473,311 2,845,932 645,552 3,000,000 146,276 214,848 Clorin
3002 - 4/18/2014 4:46:24PM Page 44 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
30,959 22,261 73,322 85,455 - 33,576 280,539 313,196 1,023,739 33,576 17%VCT
12/09 (24)% 13,438 3,161 - 3,161 179,842 61,172 17,624 44,934 3,146 4,218 VCT Concordant Couple (HIV-Negative)
12/09 (18)% 848 2,004 - 2,004 16,658 5,676 1,040 8,425 241 332 VCT Concordant Couple (HIV-Positive)
12/09 4% 343 195 - 195 6,107 1,368 329 5,617 99 132 VCT Discordant Couple (HIV-Negative)
12/09 4% 343 885 - 885 6,107 1,368 329 5,317 99 132 VCT Discordant Couple (HIV-Positive)
12/09 33% 65,431 15,391 - 15,391 733,085 222,113 49,014 185,354 17,259 24,229 VCT Individual (HIV-Negative)
12/09 1% 5,052 11,939 - 11,939 81,940 21,499 4,986 30,892 1,416 1,916 VCT Individual (HIV-Positive)
Zimbabwe 271,226 887,139 1,158,365
141 49 - 239 66 66 1,800 134 373 - 0%Cervical Cancer-VIA and Cryotherapy
11/13 -% 239 66 66 - 373 134 - 1,800 49 141 Cervical Cancer-VIA and Cryotherapy
2,687,520 2,141,800 7,183,960 6,229,920 18,292 104,285 28,778,966 28,077,040 219,202,890 85,993 (13)%Condom
1 /08 (15)% 6,104,520 102,186 17,924 84,262 219,077,490 28,077,040 7,183,960 28,778,966 2,141,800 2,562,120 Protector Plus
3 /14 -% 125,400 2,099 368 1,731 125,400 - - - - 125,400 Protector Plus Strawberry
8,308 7,401 14,864 12,394 225 225 118,272 123,332 515,948 - (17)%Emergency Contraception
5 /04 (100)% - - - - 262,883 1,620 770 - - - Postinor II
9 /10 (12)% 12,394 225 225 - 253,065 121,712 14,094 118,272 7,401 8,308 Pregnon
152,780 111,513 320,220 369,160 1,084 5,847 1,667,388 1,589,720 19,441,154 4,763 15%Female Condom
6 /97 15% 369,160 5,847 1,084 4,763 19,441,154 1,589,720 320,220 1,667,388 111,513 152,780 Care
35,000 12,333 - 72,000 211 1,140 - 37,000 137,000 929 0%Free Female Condom
12/11 -% 72,000 1,140 211 929 137,000 37,000 - - 12,333 35,000 Care (Free Distribution)
- 933 1,700 1,500 1,987 1,987 35,498 8,400 60,107 - (12)%Implant 5 Distribution
9 /09 (12)% 1,500 1,987 1,987 - 60,107 8,400 1,700 35,498 933 - Jadelle
3,599 2,363 5,298 7,240 658 658 20,544 24,836 109,162 - 37%Injectable 3
9 /09 37% 7,240 658 658 - 109,162 24,836 5,298 20,544 2,363 3,599 Petogen
350 150 200 650 1,042 1,042 1,600 1,100 1,950 - 225%IUD 10 Distribution
3002 - 4/18/2014 4:46:24PM Page 45 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
4 /12 225% 650 1,042 1,042 - 1,950 1,100 200 1,600 150 350 TCU 380A IUCD Copper T
- 233,247 - 699,740 862,704 862,704 1,908,090 768,098 2,888,217 - 0%LLINs
10/10 -% 699,740 862,704 862,704 - 2,888,217 768,098 - 1,908,090 233,247 - Interceptor
14,320 10,338 14,902 34,341 - 134,333 170,000 101,923 228,339 134,333 130%Male Circumcision
1 /09 130% 34,341 134,333 - 134,333 228,339 101,923 14,902 170,000 10,338 14,320 Male Circumcision (HIV-Negative)
15,840 6,720 31,740 27,360 636 636 117,453 69,900 161,280 - (14)%OCs
4 /12 16% 20,160 469 469 - 95,040 37,500 17,340 80,573 3,840 12,960 Control Combined OC
4 /12 (50)% 7,200 167 167 - 66,240 32,400 14,400 36,880 2,880 2,880 Secure POP
- 35,853 90,946 17,964 224 224 - 357,861 1,049,801 - (80)%Safe Water Solution
9 /10 (80)% 17,964 224 224 - 1,049,801 357,861 90,946 - 35,853 - WaterGuard
40,428 32,453 106,424 113,855 - 45,208 400,000 417,469 1,655,283 45,208 7%VCT
12/09 (25)% 11,660 2,998 - 2,998 215,474 50,562 15,538 47,977 3,621 3,914 VCT Concordant Couple (HIV-Negative)
12/09 (49)% 556 1,074 - 1,074 19,332 2,966 1,090 2,841 188 176 VCT Concordant Couple (HIV-Positive)
12/09 (57)% 439 271 - 271 9,032 2,288 1,014 2,421 146 135 VCT Discordant Couple (HIV-Negative)
12/09 (57)% 439 952 - 952 9,032 2,288 1,014 2,421 146 135 VCT Discordant Couple (HIV-Positive)
12/09 17% 92,396 23,759 - 23,759 1,231,436 325,631 78,973 312,022 25,846 33,186 VCT Individual (HIV-Negative)
12/09 (5)% 8,365 16,154 - 16,154 170,977 33,734 8,795 32,318 2,506 2,882 VCT Individual (HIV-Positive)
36,000 349,800 3,672,000 36,000 9 9 - 13,107,400 99,214,900 - (99)%Water Treatment Tablets
1 /08 -% 36,000 9 9 - 74,203,500 24,000 - - 7,200 36,000 Aquatab
1 /08 (100)% - - - - 25,011,400 13,083,400 3,672,000 - 342,600 - WaterGuard Tablets
3002 - 4/18/2014 4:46:24PM Page 46 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
SouSouthern Africa
Botswana $222,896 $223,186 $75,933 2.94
Condom2.95Lovers Plus 03/2014 1,000,000 $222,896 100%0 281 $75,675 4,370,172 10.440% $223,186 418,5101,000,281
NATrust 03/2014 0 $0 NA0 0 $258 781,404 663.89NA $0 1,1770
Lesotho $0 $542 $0 NA
CondomNALovers Plus C&F 03/2014 0 $0 NA0 0 $0 0 NANA $125 00
NATrust 03/2014 0 $0 NA0 0 $0 0 NANA $98 00
NATrust Studded 03/2014 0 $0 NA0 0 $0 0 NANA $320 00
Female CondomNAFemale Condom 03/2014 0 $0 NA88,000 1,000 $0 561,000 7.98100% $0 70,33389,000
NAGeneric 03/2014 0 $0 NA0 0 NA 2,880,000 NANA $0 NA0
Free CondomNABlue & Gold Workplace 03/2014 0 $0 NA1,239,000 120,000 $0 11,229,000 9.88100% $0 1,137,0001,359,000
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 68 $0 NA0 0 $0 0 NA0% $0 6568
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 200 $0 NA0 0 $0 0 NA0% $0 183200
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 20 $0 NA0 0 $0 0 NA0% $0 2220
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 13 $0 NA0 0 $0 0 NA0% $0 1413
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 13 $0 NA0 0 $0 0 NA0% $0 1413
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 8,804 $0 NA0 0 $0 0 NA0% $0 8,1698,804
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 1,149 $0 NA0 0 $0 0 NA0% $0 1,1621,149
Madagascar $35,022 $40,784 $32,875 1.24
CondomNAProtector Plus 03/2014 961,584 $5,510 0%7,680 0 $4,388 2,547,179 3.361% $0 757,648969,264
Female CondomNAFeeling 03/2014 23,100 $331 0%6 0 $120 66,942 8.020% $0 8,35223,106
Page 23 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Madagascar $35,022 $40,784 $32,875 1.24
Free CondomNAGeneric 03/2014 0 $0 NA116,556 0 $0 501,992 11.65100% $0 43,085116,556
Lubricant ANALubricant 03/2014 0 $0 NA4,400 0 $0 27,968 9.07100% $0 3,0834,400
STI Kit (Non-Ulcerative)NACefidoxal 03/2014 0 $0 NA30,000 0 $0 210,890 21.09100% $0 10,00030,000
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 803 $0 NA0 0 $0 0 NA0% $0 632803
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 1 $0 NA0 0 $0 0 NA0% $0 11
LLINNAInterceptor Blue 03/2014 0 $0 NA0 0 $0 12 NANA $0 00
NAInterceptor White 03/2014 0 $0 NA0 0 $0 1,067 NANA $0 00
NANet Protect 03/2014 0 $0 NA0 0 $0 151,446 113,584.50NA $0 10
NAOlyset Net Blue 03/2014 0 $0 NA0 0 $0 25,370 54.36NA $0 4670
NAOlyset Net White 03/2014 0 $0 NA0 0 $0 125,162 421.89NA $0 2970
NAPermaNet-White 03/2014 0 $0 NA0 0 $0 26,110 NANA $0 00
NARoyal Sentry Blue (Generic Net)-Bl 03/2014 0 $0 NA0 0 $0 33 NANA $0 00
NASuper Moustiquaire-Blue 03/2014 0 $0 NA0 0 $0 227 NANA $537 00
NASuper Moustiquaire-White 03/2014 0 $0 NA0 0 $0 529 NANA $0 00
NAYorkool White (Generic Net)-Whit 03/2014 0 $0 NA0 0 $0 13 NANA $0 00
Malaria PPT (ACT)NAArtesunate Amodiaquine 25 mg 03/2014 31,869 $259 0%0 0 $150 118,293 6.610% $0 17,88431,869
NAArtesunate Amodiaquine combo 50 03/2014 66,806 $546 0%0 0 $426 223,999 4.380% $0 51,10266,806
Malaria RDKNARDT Malaria 03/2014 0 $0 NA115,669 0 $0 548,936 5.90100% $0 92,989115,669
Diarrhea Treatment KitNAViasur 03/2014 6,745 $980 0%13,850 0 $1,308 6,332 0.4267% $0 14,97720,595
Micronutrient PowderNAZAZATOMADY (ZZT) 03/2014 25,350 $182 0%5,730 4,380 $158 3,804,780 114.0218% $0 33,37035,460
Safe Water Solution0.04Sur Eau 40 mL 03/2014 24,220 $755 4%85 0 $780 12,088 0.490% $32 24,56124,305
0.02Sur Eau Vaovao 03/2014 172,680 $11,113 0%120 0 $7,066 64,187 0.590% $157 108,507172,800
Page 24 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Madagascar $35,022 $40,784 $32,875 1.24
Emergency ContraceptionNANorlevo 03/2014 0 $0 NA420 0 $0 11,040 16.90100% $0 653420
Implant 3NAImplanon 03/2014 289 $62 0%45 0 $43 5,500 23.4713% $0 234334
Implant 4NAImplant Zarin 03/2014 60 $13 0%99 0 $4 199 3.0362% $0 66159
Injectable 32.39Confiance Injectable 03/2014 125,010 $6,502 79%2,240 0 $8,219 437,987 3.012% $19,651 145,368127,250
IUD 10NACopper T 03/2014 2,395 $515 0%1 0 $372 16,614 9.730% $0 1,7082,396
NAIUD 1 x 5 03/2014 10 $3 0%0 0 $2 3,315 497.250% $0 710
OCs2.51Pilplan 03/2014 222,176 $6,352 83%0 288 $8,136 2,418,313 9.250% $20,406 261,548222,464
SDM (Cycle Beads)NARojo 03/2014 870 $18 0%0 0 $17 38,406 46.680% $0 823870
Pneumonia PPTNAPneumostop 03/2014 11,370 $1,882 0%7,735 0 $1,684 68,046 5.1140% $0 13,32619,105
Namibia $0 $0 $9 NA
Free CondomNASmile 03/2014 0 $0 NA281,952 0 $0 62,280 0.15100% $0 419,881281,952
Free Female CondomNAFemidom Free 03/2014 0 $0 NA4,500 0 $0 30,500 5.51100% $0 5,5334,500
Lubricant ANACondom Lubricant (Water Based) 03/2014 0 $0 NA24,000 0 $0 2,810,444 41.41100% $0 67,87624,000
LLINNASupanet Plus-Rectangular 03/2014 0 $0 NA0 0 $6 1 0.33NA $0 30
PURNAPUR Sachets for Social Marketing 03/2014 0 $0 NA0 0 $0 0 NANA $0 00
South Africa $0 $0 $0 NA
Male Circumcision (HIV-Negative)NABepelopele (MC HIV-Negative) 03/2014 3,885 $0 NA0 0 $0 0 NA0% $0 1,7343,885
Male Circumcision (HIV-Unknown)NABepelopele (MC HIV-Unknown) 03/2014 163 $0 NA0 0 $0 0 NA0% $0 57163
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 596 $0 NA0 0 $0 0 NA0% $0 609596
Page 25 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
South Africa $0 $0 $0 NA
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 52 $0 NA0 0 $0 0 NA0% $0 2352
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 6 $0 NA0 0 $0 0 NA0% $0 66
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 6 $0 NA0 0 $0 0 NA0% $0 66
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 8,836 $0 NA0 0 $0 0 NA0% $0 9,8398,836
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 239 $0 NA0 0 $0 0 NA0% $0 622239
Swaziland $0 -$2,497 $0 NA
Other RevenuesNAVCT Fees 03/2014 0 $0 NA0 10,044 $0 0 NANA $0 5,22410,044
CondomNALovers Plus 03/2014 0 $0 NA0 0 $0 0 NANA -$903 00
NALovers Plus C&F 03/2014 0 $0 NA0 0 $0 0 NANA $1,883 00
NALovers Plus R&S 03/2014 0 $0 NA0 0 $0 0 NANA -$131 00
NATrust 03/2014 0 $0 NA0 0 $0 0 NANA -$1,109 00
NATrust Studded 03/2014 0 $0 NA0 0 $0 0 NANA -$2,319 00
Early Infant MC (HIV-Negative)NAEarly Infant MC (HIV-Negative) 03/2014 0 $0 NA39 0 $0 0 NA100% $0 4539
Early Infant MC (HIV-Unknown)NAEarly Infant MC (HIV-Unknown) 03/2014 0 $0 NA19 0 $0 0 NA100% $0 2119
Female CondomNACare 03/2014 0 $0 NA0 0 $0 2,700 NANA $0 00
NAFemale Condom 03/2014 5,000 $0 NA0 0 $0 25,000 3.750% $82 6,6675,000
Free CondomNAGeneric 03/2014 1,036,800 $0 NA0 0 $0 1,123,200 1.510% $0 742,2241,036,800
Lubricant ANAAssegai Branded (5 mL) 03/2014 0 $0 NA24,000 0 $0 371,243 34.80100% $0 10,66724,000
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 524 $0 NA0 0 $0 0 NA0% $0 328524
Male Circumcision (HIV-Unknown)NAMale Circumcision (HIV-Unknown) 03/2014 41 $0 NA0 0 $0 0 NA0% $0 3241
Page 26 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Swaziland $0 -$2,497 $0 NA
STI Kit (Non-Ulcerative)NAUrethral Discharge 03/2014 0 $0 NA2 0 $0 0 NA100% $0 22
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 250 $0 NA0 0 $0 0 NA0% $0 277250
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 10 $0 NA0 0 $0 0 NA0% $0 1210
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 13 $0 NA0 0 $0 0 NA0% $0 1313
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 13 $0 NA0 0 $0 0 NA0% $0 1313
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 9,221 $0 NA0 0 $0 0 NA0% $0 7,8059,221
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 532 $0 NA0 0 $0 0 NA0% $0 445532
Zambia $0 $0 $0 NA
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 5,003 $0 NA0 0 $0 0 NA0% $0 5,8725,003
Male Circumcision (HIV-Unknown)NAMale Circumcision (HIV-Unknown) 03/2014 3,041 $0 NA0 0 $0 0 NA0% $0 3,4943,041
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 4,218 $0 NA0 0 $0 0 NA0% $0 4,4794,218
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 332 $0 NA0 0 $0 0 NA0% $0 283332
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 132 $0 NA0 0 $0 0 NA0% $0 114132
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 132 $0 NA0 0 $0 0 NA0% $0 114132
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 24,229 $0 NA0 0 $0 0 NA0% $0 21,81024,229
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 1,916 $0 NA0 0 $0 0 NA0% $0 1,6841,916
Cervical Cancer-VIA and CryotherapyNACervical Cancer-VIA and Cryother 03/2014 39 $0 NA0 0 $0 0 NA0% $0 3039
Page 27 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Zimbabwe $0 $0 $0 NA
TB CasesNATB Cases 03/2014 55 $0 NA0 0 $0 0 NA0% $0 4155
Male Circumcision (HIV-Negative)NAMale Circumcision (HIV-Negative) 03/2014 14,320 $0 NA0 0 $0 0 NA0% $0 11,44714,320
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 3,914 $0 NA0 0 $0 0 NA0% $0 3,8873,914
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 176 $0 NA0 0 $0 0 NA0% $0 185176
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 135 $0 NA0 0 $0 0 NA0% $0 146135
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 135 $0 NA0 0 $0 0 NA0% $0 146135
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 33,186 $0 NA0 0 $0 0 NA0% $0 30,79933,186
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 2,882 $0 NA0 0 $0 0 NA0% $0 2,7882,882
Cervical Cancer-VIA and CryotherapyNACervical Cancer-VIA and Cryother 03/2014 141 $0 NA0 0 $0 0 NA0% $0 80141
Page 28 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Latin America & the Caribbean
POPULATION SERVICES INTERNATIONAL
CYPs, Cases, and Deaths by Country
1/2014 - 3/2014
Cases CYP*
HIV & TB Reproductive Health
Maternal
Deaths
Unintended
Pregnancies
Malaria
Cases
Malaria
Deaths
Diarrhea
Cases
Diarrhea
Deaths
Malaria Control Child Survival
Sum of
All Deaths
Pneumonia
Cases
Pneumonia
Deaths
STI
Deaths
TB
Deaths
Nutrition
Deaths
IDU
Deaths
Americas 352 191,475 47 35,663 - 12 37 - 96 - - - - - -
Belize 6 380 - 77 - - - - - - - - - - -
Caribbean 3 792 - 110 - - - - - - - - - - -
Costa Rica 2 2,234 - 281 - - - - - - - - - - -
Dominican Republic 118 35,091 5 6,213 - - - - 5 - - - - - -
Dominican Republic - Panama Warehouse - - - - - - - - - - - - - - -
El Salvador 17 13,515 2 1,489 - - - - 2 - - - - - -
Guatemala 64 44,338 5 9,382 - - - - 5 - - - - - -
Haiti 68 33,367 27 7,071 - 12 37 - 76 - - - - - -
Honduras 22 7,344 1 1,438 - - - - 1 - - - - - -
Mexico - - - - - - - - - - - - - - -
Nicaragua 6 22,128 2 3,810 - - - - 2 - - - - - -
Panama 41 11,530 1 1,777 - - - - 1 - - - - - -
Paraguay 4 20,757 3 4,014 - - - - 3 - - - - - -
3001 - 4/18/2014 4:45:11PM Page 4 of 5
* Using USAID CYP conversion factors
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Americas - Caribbean 172 244 71
Condom 18,587 26,861 - 76,667 58 196 575,000 -% 225,885 1,886,592 139
Emergency Contraception - - - - - - - -% 1 2 -
Free Condom 5,539 5,800 996 12,018 9 31 55,500 1,107% 54,513 300,679 22
Free Female Condom 84 1,164 133 3,038 2 7 4,000 2,184% 3,992 62,114 5
Injectable 1 - 3 - 4 - - 50 -% 5 14 -
Injectable 2 - 3 - 3 - - - -% 6 17 -
Injectable 3 - 5 - 10 - - - -% 27 2,772 -
IUD 10 Insertion - 4 - 5 2 2 10 -% 14 19 -
Lubricant A 2,480 5,607 16 14,503 - - 9,000 90,544% 18,881 57,916 -
Lubricant E 583 46 - 656 - - - -% 382 1,941 -
OCs - 10 - 18 - - 150 -% 23 18,813 -
VCT 125 204 2 386 - 6 310 19,200% 678 1,370 6
3003 - 4/18/2014 4:49:12PM Page 7 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Americas - Central America 8,430 19,418 10,988
Condom 2,442,029 1,934,431 5,883,472 7,088,003 5,883 14,109 27,072,726 20% 25,108,117 243,824,046 8,226
Female Condom - - 2,000 - - - - (100)% 2,000 107,562 -
Free Condom - 158 40 - - - 4,300 (100)% 1,355 56,391 -
Free Female Condom - 30 - - - - - -% 263 14,528 -
Implant 3 Distribution (62) - - (62) (22) (22) - -% - (62) -
Implant 3 Insertion 545 - - 545 203 203 - -% - 545 -
Implant 5 Distribution 1,296 133 519 1,178 609 609 1,470 127% 2,256 15,807 -
Implant 5 Insertion 84 463 1,006 1,053 532 532 8,040 5% 5,187 6,240 -
Injectable 1 13,989 6,651 11,006 31,050 349 349 55,000 182% 49,433 96,260 -
Injectable 2 - - - - - - - -% 1 2 -
Injectable 3 - - - - - - - -% 1 4 -
IUD 10 Distribution 94 175 5,368 (701) (478) (478) 25,050 (113)% 21,260 160,816 -
IUD 10 Insertion 2,283 2,016 5,683 6,570 3,568 3,568 26,750 16% 29,392 35,962 -
Lubricant A 50,806 43,450 137,001 168,147 - - 386,249 23% 457,683 2,258,516 -
Lubricant E 8,750 4,997 16,366 21,761 - - 68,191 33% 62,773 330,508 -
Misoprostol for PAC (Oral) 650 1,000 - 3,650 21 21 30,000 -% 7,000 10,650 -
Misoprostol for PPH - 2 377 - - - 1,260 (100)% 1,092 3,446 -
OCs 8,318 15,997 39,962 49,964 324 324 199,839 25% 186,821 679,775 -
Pregnancy Test - - - - - - - -% 2,760 2,760 -
Tubal Ligation - - - - - - 2,619 -% 76 76 -
Vasectomy - - - - - - 220 -% 10 10 -
3003 - 4/18/2014 4:49:12PM Page 8 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
VCT 1,949 1,017 2,843 4,059 - 204 20,295 43% 20,102 64,893 204
3003 - 4/18/2014 4:49:12PM Page 9 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Americas - Other 9,964 22,942 12,978
Condom 2,215,965 1,443,767 3,772,485 5,107,725 3,545 12,912 19,547,000 35% 20,208,033 303,235,227 9,368
Emergency Contraception 23,471 22,917 66,757 68,529 308 308 286,000 3% 269,267 1,432,732 -
Female Condom - - - - - - - -% 1,704 951,749 -
Free Condom 94,800 75,260 189,624 251,380 147 526 1,500,000 33% 1,305,978 45,726,099 380
Implant 3 Insertion 523 - - 523 96 96 900 -% 58 581 -
Injectable 3 17,200 17,600 84,100 49,100 1,916 1,916 245,000 (42)% 234,090 2,577,812 -
IUD 10 Distribution 85 262 - 460 317 317 1,710 -% 410 870 -
IUD 10 Insertion 43 36 - 43 15 15 1,000 -% 126 169 -
Lubricant A 5,300 1,967 - 10,200 - - - -% 9,287 80,277 -
Lubricant E - - - - - - - -% 29,618 392,850 -
Malaria PPT (Non-ACT) - 11,967 38,700 12,500 1,065 1,065 66,825 (68)% 76,600 268,300 -
Malaria PPT (Non-ACT) P - - 33,333 - - - 40,095 (100)% 44,700 44,700 -
Malaria RDK - - - - - - 360,000 -% - 90 -
Multivitamin 200,160 164,490 508,110 567,270 47 47 2,160,000 12% 1,927,920 28,019,760 -
Needle & Syringe - - - - - - - -% 138,400 162,800 -
OCs 135,570 116,691 413,092 378,493 3,006 3,006 1,493,300 (8)% 1,363,106 9,602,563 -
ORS 19,440 19,120 80,400 63,600 740 740 311,500 (21)% 253,680 8,798,096 -
PUR - - - - - - - -% 947,280 16,208,400 -
Safe Water Solution 63,000 120,000 376,810 243,000 1,778 1,778 1,940,400 (36)% 1,861,810 2,536,614 -
VCT 1,400 739 2,464 3,167 - 216 12,201 29% 14,785 25,282 216
3003 - 4/18/2014 4:49:12PM Page 10 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Americas - Caribbean 172 71 244
Caribbean 172 71 244
18,587 26,861 - 76,667 58 196 575,000 225,885 1,886,592 139 0%Condom
10/09 -% 76,667 196 58 139 1,886,592 225,885 - 575,000 26,861 18,587 GIGI (Got it? Get it!) Condom
- - - - - - - 1 2 - 0%Emergency Contraception
9 /12 -% - - - - 2 1 - - - - GIGI (Got it? Get it!) EC
5,539 5,800 996 12,018 9 31 55,500 54,513 300,679 22 1107%Free Condom
10/09 1,107% 12,018 31 9 22 300,679 54,513 996 55,500 5,800 5,539 GIGI (Got it? Get it!) Free Condom
84 1,164 133 3,038 2 7 4,000 3,992 62,114 5 2184%Free Female Condom
10/09 2,184% 3,038 7 2 5 62,114 3,992 133 4,000 1,164 84 GIGI (Got it? Get it!) Free Female Cond
- 3 - 4 - - 50 5 14 - 0%Injectable 1
2 /12 -% 4 - - - 14 5 - 50 3 - GIGI (Got it? Get it!) Inj 1 M
- 3 - 3 - - - 6 17 - 0%Injectable 2
2 /12 -% 3 - - - 17 6 - - 3 - GIGI (Got it? Get it!) Inj 2 M
- 5 - 10 - - - 27 2,772 - 0%Injectable 3
2 /12 -% 10 - - - 2,772 27 - - 5 - GIGI (Got it? Get it!) Inj 3 M
- 4 - 5 2 2 10 14 19 - 0%IUD 10 Insertion
-% 5 2 2 - 19 14 - 10 4 - Non-PSI IUD 10 Inserted
2,480 5,607 16 14,503 - - 9,000 18,881 57,916 - 90544%Lubricant A
10/09 90,544% 14,503 - - - 57,916 18,881 16 9,000 5,607 2,480 GIGI (Got it? Get it!) Lube Sachet
583 46 - 656 - - - 382 1,941 - 0%Lubricant E
4 /11 -% 656 - - - 1,941 382 - - 46 583 Vive Lub (tube)
- 10 - 18 - - 150 23 18,813 - 0%OCs
2 /12 -% 18 - - - 18,813 23 - 150 10 - GIGI (Got it? Get it!) OC
125 204 2 386 - 6 310 678 1,370 6 19200%VCT
3002 - 4/18/2014 4:46:24PM Page 47 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
12/10 19,150% 385 4 - 4 1,352 675 2 300 203 125 VCT Individual (HIV-Negative)
12/10 -% 1 2 - 2 18 3 - 10 1 - VCT Individual (HIV-Positive)
3002 - 4/18/2014 4:46:24PM Page 48 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Americas - Central America 8,430 10,988 19,418
Belize 305 37 342
24,696 11,228 12,958 45,036 37 327 232,000 206,757 1,827,831 290 248%Condom
4 /05 (100)% - - - - 2,233 217 216 - - - Combo Pack
3 /10 -% 44,892 326 37 289 723,000 161,994 - 182,000 10,456 24,696 GIGI (Got it? Get it!) Condom
8 /98 -% - - - - 391,621 464 - 50,000 111 - Vive
8 /04 (100)% - - - - 137,440 2,540 432 - 105 - Vive Amor
6 /03 (97)% 144 1 - 1 394,377 26,578 4,174 - 390 - Vive Colors/Mas Colors
8 /04 (100)% - - - - 69,185 9,381 6,768 - - - Vive Mas Fuerte /Retardante
8 /04 (100)% - - - - 49,665 1,926 648 - 6 - Vive Mas Natural /Sensitivo
8 /04 (100)% - - - - 60,310 3,657 720 - 160 - Vive Mas/Texturizado
- 158 40 - - - 4,300 1,355 56,391 - (100)%Free Condom
3 /10 (100)% - - - - 56,391 1,355 40 4,300 158 - GIGI (Got it? Get it!) Free Condom
- 30 - - - - - 263 14,528 - 0%Free Female Condom
3 /10 -% - - - - 14,528 263 - - 30 - GIGI (Got it? Get it!) Free Female Cond
- 1 - - - - - 3 7 - 0%Injectable 1
6 /12 -% - - - - 7 3 - - 1 - GIGI (Got it? Get it!) Inj 1 M
- - - - - - - 1 2 - 0%Injectable 2
9 /12 -% - - - - 2 1 - - - - GIGI (Got it? Get it!) Inj 2 M
- - - - - - - 1 4 - 0%Injectable 3
6 /12 -% - - - - 4 1 - - - - GIGI (Got it? Get it!) Inj 3 M
- 1 - 1 - - - 2 3 - 0%IUD 10 Insertion
-% 1 - - - 3 2 - - 1 - Non-PSI IUD 10 Inserted
- 37 263 - - - - 9,367 38,283 - (100)%Lubricant A
3 /10 -% - - - - 5,489 338 - - 31 - GIGI (Got it? Get it!) Lube Sachet
3002 - 4/18/2014 4:46:24PM Page 49 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
4 /05 (100)% - - - - 32,794 9,029 263 - 6 - Vive Lub (sachet)
- - 19 - - - - 97 3,144 - (100)%Lubricant E
4 /05 (100)% - - - - 3,144 97 19 - - - Vive Lub (tube)
- - - - - - - 3 23 - 0%OCs
6 /12 -% - - - - 23 3 - - - - GIGI (Got it? Get it!) OC
203 122 521 351 - 15 3,185 1,868 3,991 15 (33)%VCT
12/10 (32)% 350 13 - 13 3,964 1,857 516 3,121 122 202 VCT Individual (HIV-Negative)
12/10 (80)% 1 2 - 2 27 11 5 64 1 1 VCT Individual (HIV-Positive)
Costa Rica 116 143 259
82,692 99,828 336,138 268,120 143 237 1,414,779 1,286,450 11,960,254 95 (20)%Condom
5 /05 -% - - - - 36,250 - - 9,024 - - Combo Pack
6 /12 23% 411 - - - 4,110 1,727 335 2,986 28 351 Combo-Mix Lub Fresa
6 /12 213% 610 1 - - 1,922 690 195 - 157 233 Combo-Mix Lub Natural
10/10 (38)% 1,455 1 1 1 23,222 7,729 2,328 - 747 862 Combo-Pack Lub Fresa
12/97 (15)% 25,950 23 14 9 3,814,999 77,701 30,441 82,683 7,804 4,089 Vive
6 /04 (30)% 112,887 100 60 40 4,831,970 772,100 160,599 822,557 56,864 32,460 Vive Amor
5 /03 (17)% 65,441 58 35 23 2,244,135 252,203 78,457 278,169 17,253 25,844 Vive Colors/Mas Colors
6 /04 2% 18,555 16 10 7 377,652 61,531 18,213 77,575 4,865 7,155 Vive Mas Fuerte /Retardante
6 /04 (48)% 21,695 19 12 8 381,450 95,403 41,922 119,500 5,625 9,278 Vive Mas Natural /Sensitivo
6 /04 479% 21,116 19 11 7 244,544 17,366 3,648 22,285 6,484 2,420 Vive Mas/Texturizado
676 1,015 2,735 3,271 - - 46,504 44,167 145,921 - 20%Lubricant A
3 /05 (100)% - - - - 92,207 1,946 1,430 34,156 - - Vive Lub (sachet)
5 /11 23% 1,061 - - - 20,811 11,528 861 12,348 395 151 Vive Lub Natural (sachet)
5 /12 398% 2,210 - - - 32,903 30,693 444 - 620 525 Vive Lub Sachet Fresa 5 mL
3002 - 4/18/2014 4:46:24PM Page 50 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
555 670 1,215 1,740 - - 6,870 6,227 34,027 - 43%Lubricant E
3 /05 2% 1,065 - - - 30,942 4,572 1,045 5,009 453 312 Vive Lub (tube)
5 /11 297% 675 - - - 3,085 1,655 170 1,861 217 243 Vive Lub Natural (tube)
117 85 159 373 - 21 - 548 1,573 21 135%VCT
12/11 132% 366 1 - 1 1,548 546 158 - 84 114 VCT Individual (HIV-Negative)
12/11 600% 7 20 - 20 25 2 1 - 1 3 VCT Individual (HIV-Positive)
El Salvador 979 1,005 1,984
249,792 158,563 728,944 671,200 399 1,284 2,900,758 2,348,472 26,577,555 886 (8)%Condom
12/06 -% - - - - - - - 5,100 - - Combo Pack
10/10 (88)% 112 - - - 16,608 8 968 9,082 43 - Combo-Mix Lub Fresa
10/10 (88)% 96 - - - 9,552 1,160 768 - 32 - Combo-Mix Lub Natural
5 /12 (100)% - - - - 4,232 608 200 - - - Combo-Pack Lub Fresa
4 /98 (18)% 240,240 460 143 317 11,391,884 883,104 294,528 1,049,768 68,704 49,296 Vive
7 /04 (1)% 236,352 452 140 312 8,754,457 876,432 238,416 976,200 47,488 119,184 Vive Amor
10/03 (4)% 118,608 227 70 157 4,701,954 369,816 123,216 598,877 25,488 50,232 Vive Colors/Mas Colors
7 /04 28% 42,576 81 25 56 736,988 101,136 33,144 - 9,680 15,888 Vive Mas Fuerte /Retardante
7 /04 (28)% 13,560 26 8 18 433,240 45,624 18,792 - 2,592 6,792 Vive Mas Natural /Sensitivo
7 /04 4% 19,656 38 12 26 528,640 70,584 18,912 261,731 4,536 8,400 Vive Mas/Texturizado
- - 2,000 - - - - 2,000 107,562 - (100)%Female Condom
10/03 (100)% - - - - 107,562 2,000 2,000 - - - Femidom
47 2 67 52 14 14 - 55 2,507 - (22)%Implant 5 Distribution
-%(25) (7)(7) - (100)(75)(33) - (9)(5) PSI Implant 5 Distributed Inserted (1)
12/08 (23)% 77 21 21 - 2,607 130 100 - 11 52 Jadelle
5 9 33 25 7 7 - 75 100 - (24)%Implant 5 Insertion
3002 - 4/18/2014 4:46:24PM Page 51 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
(24)% 25 7 7 - 100 75 33 - 9 5 PSI Implant 5 Inserted
123 27 561 2 1 1 4,000 1,551 35,401 - (100)%IUD 10 Distribution
-%(798) (259)(259) - (2,750)(1,952)(503) - (225)(217) PSI IUD 10 Distributed Inserted (1)
12/08 (25)% 800 259 259 - 38,151 3,503 1,064 4,000 252 340 Copper T 380
477 375 1,229 1,301 449 449 4,600 4,955 6,256 - 6%IUD 10 Insertion
59% 798 275 275 - 2,750 1,952 503 4,000 225 217 PSI IUD 10 Inserted
11/13 (31)% 503 174 174 - 3,506 3,003 726 600 150 260 Non-PSI IUD 10 Inserted
19,550 5,750 17,250 36,100 - - 122,211 93,856 467,853 - 109%Lubricant A
12/06 279% 23,300 - - - 348,757 45,403 6,150 122,211 3,533 12,700 Vive Lub (sachet)
1 /10 15% 12,800 - - - 119,096 48,453 11,100 - 2,217 6,850 Vive Lub Natural (sachet)
1,345 464 1,594 2,700 - - 6,932 7,199 34,300 - 69%Lubricant E
12/06 67% 1,962 - - - 28,414 5,117 1,174 6,932 318 1,032 Vive Lub (tube)
1 /10 76% 738 - - - 5,886 2,082 420 - 145 313 Vive Lub Natural (tube)
650 1,000 - 3,650 21 21 30,000 7,000 10,650 - 0%Misoprostol for PAC (Oral)
10/13 -% 3,650 21 21 - 10,650 7,000 - 30,000 1,000 650 Misoprostol for PAC (oral)
1,637 7,990 3,658 24,523 115 115 38,339 14,958 55,429 - 570%OCs
5 /12 1,289% 18,339 86 86 - 21,000 2,417 1,320 18,339 6,113 - Marvelon 28
2 /12 164% 6,184 29 29 - 34,429 12,541 2,338 20,000 1,877 1,637 Segura Plus
620 325 513 1,371 - 93 5,138 6,426 26,488 93 167%VCT
11/13 -% 4 - - - 6 2 - - 1 - VCT Concordant Couple (HIV-Negative)
12/09 160% 1,336 11 - 11 26,278 6,387 513 5,112 319 600 VCT Individual (HIV-Negative)
12/09 -% 31 82 - 82 204 37 - 26 5 20 VCT Individual (HIV-Positive)
Guatemala 3,383 6,437 9,819
1,033,352 586,565 1,742,520 2,528,696 2,986 6,332 10,548,000 10,396,420 91,826,277 3,346 45%Condom
4 /05 68% 12,064 30 14 16 249,128 40,888 7,200 55,000 1,557 7,648 Combo Pack
3002 - 4/18/2014 4:46:24PM Page 52 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
4 /98 110% 869,680 2,178 1,027 1,151 40,533,885 3,219,300 414,144 3,330,000 192,272 333,760 Vive
7 /04 17% 1,236,240 3,096 1,460 1,636 38,055,423 5,718,384 1,059,648 5,450,000 295,504 552,624 Vive Amor
4 /02 52% 288,384 722 341 382 10,135,654 917,088 190,128 1,090,000 65,184 105,024 Vive Colors/Mas Colors
7 /04 92% 80,064 200 95 106 1,553,168 265,056 41,616 342,262 17,752 28,224 Vive Mas Fuerte /Retardante
7 /04 35% 23,016 58 27 30 683,749 138,672 17,064 181,469 8,192 3,576 Vive Mas Natural /Sensitivo
7 /04 51% 19,248 48 23 25 615,270 97,032 12,720 99,269 6,104 2,496 Vive Mas/Texturizado
(62) - - (62) (22) (22) - - (62) - 0%Implant 3 Distribution
-%(62) (22)(22) - (62) - - - - (62) PSI Implant 3 Distributed Inserted (1)
545 - - 545 203 203 - - 545 - 0%Implant 3 Insertion
-% 62 23 23 - 62 - - - - 62 PSI Implant 3 Inserted
-% 483 180 180 - 483 - - - - 483 Non-PSI Implant 3 Inserted
1,211 6 (48) 1,102 587 587 1,000 (174) 9,703 - 0%Implant 5 Distribution
-%(188) (100)(100) - (1,405)(1,217)(241) - (83) - PSI Implant 5 Distributed Inserted (1)
12/08 568% 1,290 687 687 - 11,108 1,043 193 1,000 89 1,211 Jadelle
- 330 843 752 426 426 7,640 4,442 5,194 - (11)%Implant 5 Insertion
(22)% 188 107 107 - 1,405 1,217 241 1,000 83 - PSI Implant 5 Inserted
(6)% 564 320 320 - 3,789 3,225 602 6,640 247 - Non-PSI Implant 5 Inserted
13,989 6,650 11,006 31,050 349 349 55,000 49,430 96,253 - 182%Injectable 1
5 /11 182% 31,050 349 349 - 96,253 49,430 11,006 55,000 6,650 13,989 Cyclofem
179 (231) 464 (810) (522) (522) 14,000 748 54,207 - (275)%IUD 10 Distribution
-%(2,169) (1,399)(1,399) - (14,689)(12,520)(2,299) - (678)(688) PSI IUD 10 Distributed Inserted (1)
12/08 (51)% 1,359 877 877 - 68,896 13,268 2,763 14,000 447 867 Copper T 380
1,069 1,097 2,608 3,309 2,270 2,270 15,250 15,901 19,210 - 27%IUD 10 Insertion
(6)% 2,169 1,488 1,488 - 14,689 12,520 2,299 13,000 678 688 PSI IUD 10 Inserted
269% 1,140 782 782 - 4,521 3,381 309 2,250 419 381 Non-PSI IUD 10 Inserted
3002 - 4/18/2014 4:46:24PM Page 53 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
23,580 3,924 39,291 33,726 - - 75,060 82,721 605,867 - (14)%Lubricant A
4 /05 (24)% 27,651 - - - 541,691 67,349 36,602 53,960 2,227 22,499 Vive Lub (sachet)
1 /10 126% 6,075 - - - 64,176 15,372 2,689 21,100 1,697 1,081 Vive Lub Natural (sachet)
4,032 1,351 2,456 8,001 - - 21,000 17,118 94,868 - 226%Lubricant E
4 /05 192% 4,512 - - - 72,110 9,686 1,543 12,100 875 1,923 Vive Lub (tube)
1 /10 282% 3,489 - - - 22,758 7,432 913 8,900 476 2,109 Vive Lub Natural (tube)
- 2 377 - - - 1,260 1,092 3,446 - (100)%Misoprostol for PPH
12/11 (100)% - - - - 2,914 560 377 1,260 - - Cytotec
7 /13 -% - - - - 532 532 - - 2 - Misoprostol for PPH
5,415 4,791 30,214 16,934 158 158 104,000 123,945 227,344 - (44)%OCs
8 /10 (44)% 16,934 158 158 - 227,344 123,945 30,214 104,000 4,791 5,415 Oralcon-F (28 tablets Blister)
- - - - - - - 2,760 2,760 - 0%Pregnancy Test
4 /13 -% - - - - 2,760 2,760 - - - - SD Bioline Hcg
- - - - - - 2,619 76 76 - 0%Tubal Ligation
7 /12 -% - - - - 76 76 - 2,619 - - Tubal Ligation
- - - - - - 220 10 10 - 0%Vasectomy
7 /12 -% - - - - 10 10 - 220 - - Vasectomy
816 210 1,092 1,279 - 37 7,050 6,938 19,328 37 17%VCT
12/09 17% 1,268 11 - 11 19,183 6,898 1,085 7,000 208 808 VCT Individual (HIV-Negative)
12/09 57% 11 26 - 26 145 40 7 50 2 8 VCT Individual (HIV-Positive)
Honduras 1,159 706 1,865
359,256 257,059 747,184 881,280 706 1,865 3,818,278 3,601,104 32,159,952 1,159 18%Condom
4 /05 9% 1,880 4 2 2 141,184 5,008 1,728 17,086 645 192 Combo Pack
10/10 227% 680 1 1 1 7,256 808 208 3,528 227 40 Combo-Mix Lub Fresa
10/10 222% 592 1 - 1 5,440 872 184 - 189 48 Combo-Mix Lub Natural
3002 - 4/18/2014 4:46:24PM Page 54 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
10/10 45% 1,264 3 1 2 15,824 3,128 872 - 357 272 Combo-Pack Lub Natural
9 /00 42% 307,344 650 246 404 11,242,483 917,088 215,808 989,755 63,904 153,696 Vive
8 /04 20% 401,616 850 322 528 13,427,864 1,956,432 335,520 2,054,253 148,048 144,336 Vive Amor
4 /02 (17)% 138,936 294 111 183 6,168,238 610,224 167,160 640,735 34,528 53,904 Vive Colors/Mas Colors
8 /04 (35)% 14,016 30 11 18 510,048 68,424 21,600 71,845 4,176 5,808 Vive Mas Fuerte /Retardante
8 /04 572% 8,544 18 7 11 319,370 19,200 1,272 20,160 2,896 456 Vive Mas Natural /Sensitivo
8 /04 126% 6,408 14 5 8 322,245 19,920 2,832 20,916 2,088 504 Vive Mas/Texturizado
3,750 21,690 29,900 68,700 - - - 96,311 436,440 - 130%Lubricant A
3 /05 164% 64,170 - - - 381,440 79,552 24,270 - 20,800 1,770 Vive Lub (sachet)
1 /10 (20)% 4,530 - - - 55,000 16,759 5,630 - 890 1,980 Vive Lub Natural (sachet)
2,020 745 3,551 4,244 - - - 11,345 54,647 - 20%Lubricant E
3 /05 (2)% 2,232 - - - 41,735 7,440 2,274 - 304 1,330 Vive Lub (tube)
1 /10 58% 2,012 - - - 12,912 3,905 1,277 - 441 690 Vive Lub Natural (tube)
Nicaragua 288 2,024 2,312
355,449 452,852 1,456,072 1,310,071 976 1,256 4,705,326 4,270,954 53,645,663 280 (10)%Condom
2 /04 (74)% 43,210 41 32 9 10,601,006 539,178 168,560 802,056 30,547 5,184 Bodyguard
5 /11 (22)% 1,032 1 1 - 26,008 7,168 1,328 - 413 456 Combo-Pack Lub Fresa
10/10 (23)% 272 - - - 12,864 2,624 352 - 88 240 Combo-Pack Lub Natural
4 /98 (3)% 976,186 936 727 209 33,698,019 2,776,400 1,009,383 2,919,039 319,603 273,936 Vive
4 /02 1% 209,004 200 156 45 7,458,269 657,373 207,423 749,600 68,280 56,664 Vive Colors/Mas Colors
6 /04 (17)% 40,330 39 30 9 778,091 162,115 48,548 117,489 18,837 10,032 Vive Mas Fuerte /Retardante
6 /04 234% 22,291 21 17 5 557,143 65,450 6,669 59,943 7,981 5,769 Vive Mas Natural /Sensitivo
6 /04 29% 17,746 17 13 4 514,263 60,646 13,809 57,199 7,101 3,168 Vive Mas/Texturizado
38 44 96 24 8 8 470 413 1,635 - (75)%Implant 5 Distribution
3002 - 4/18/2014 4:46:24PM Page 55 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
-%(276) (93)(93) - (946)(670)(130) - (124)(79) PSI Implant 5 Distributed Inserted (1)
12/08 33% 300 101 101 - 2,581 1,083 226 470 168 117 Jadelle
79 124 130 276 99 99 400 670 946 - 112%Implant 5 Insertion
112% 276 99 99 - 946 670 130 400 124 79 PSI Implant 5 Inserted
(208) 27 (305) 107 44 44 7,050 (4,045) 48,202 - 0%IUD 10 Distribution
-%(1,959) (797)(797) - (10,493)(8,534)(1,846) - (543)(737) PSI IUD 10 Distributed Inserted (1)
12/08 34% 2,066 841 841 - 58,695 4,489 1,541 7,050 570 529 Copper T 380
737 543 1,846 1,959 848 848 6,900 8,534 10,493 - 6%IUD 10 Insertion
6% 1,959 848 848 - 10,493 8,534 1,846 6,900 543 737 PSI IUD 10 Inserted
2,950 6,200 30,723 12,000 - - 68,536 73,243 344,134 - (61)%Lubricant A
3 /05 (70)% 5,500 - - - 222,445 41,602 18,182 - 3,033 1,350 Vive Lub (sachet)
1 /10 (48)% 6,500 - - - 121,689 31,641 12,541 68,536 3,167 1,600 Vive Lub Natural (sachet)
28 1,060 6,083 2,184 - - 26,861 15,366 74,330 - (64)%Lubricant E
3 /05 (38)% 2,184 - - - 51,800 12,564 3,518 - 1,060 28 Vive Lub (tube)
1 /10 (100)% - - - - 22,530 2,802 2,565 26,861 - - Vive Lub Natural (tube)
1,266 3,216 6,090 8,507 50 50 57,500 47,915 396,979 - 40%OCs
7 /08 40% 8,507 50 50 - 396,979 47,915 6,090 57,500 3,216 1,266 Marvelon
63 26 - 141 - 8 1,826 1,234 5,529 8 0%VCT
12/09 -% 139 - - - 5,501 1,228 - 1,825 26 61 VCT Individual (HIV-Negative)
12/09 -% 2 8 - 8 28 6 - 1 - 2 VCT Individual (HIV-Positive)
Panama 2,200 637 2,837
336,792 368,336 859,656 1,383,600 637 2,808 3,453,585 2,997,960 25,826,514 2,171 61%Condom
7 /00 70% 1,186,704 2,408 546 1,862 21,624,587 2,505,552 696,912 2,840,617 310,992 294,192 Vive
3 /05 18% 102,672 208 47 161 2,533,227 252,264 87,312 321,876 32,184 18,528 Vive Colors/Mas Colors
3 /05 46% 49,344 100 23 77 788,527 130,776 33,744 291,092 13,880 12,168 Vive Mas Fuerte /Retardante
3002 - 4/18/2014 4:46:24PM Page 56 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
3 /05 25% 25,344 51 12 40 466,157 62,688 20,208 - 5,568 8,640 Vive Mas Natural /Sensitivo
3 /05 (9)% 19,536 40 9 31 414,016 46,680 21,480 - 5,712 3,264 Vive Mas/Texturizado
300 4,833 16,839 14,350 - - 73,938 58,018 220,018 - (15)%Lubricant A
2 /09 (15)% 14,300 - - - 196,216 57,966 16,839 73,938 4,833 250 Vive Lub (sachet)
5 /11 -% 50 - - - 23,802 52 - - - 50 Vive Lub Natural (sachet)
770 707 1,448 2,892 - - 6,528 5,421 35,192 - 100%Lubricant E
2 /09 98% 2,242 - - - 27,718 5,095 1,134 6,528 566 545 Vive Lub (tube)
5 /11 107% 650 - - - 7,474 326 314 - 142 225 Vive Lub Natural (tube)
130 247 558 544 - 30 3,096 3,088 7,984 30 (3)%VCT
7 /13 -% - - - - 4 4 - - - - VCT Concordant Couple (HIV-Negative)
12/11 (1)% 529 5 - 5 7,850 3,044 537 3,024 244 123 VCT Individual (HIV-Negative)
12/11 (29)% 15 24 - 24 130 40 21 72 3 7 VCT Individual (HIV-Positive)
3002 - 4/18/2014 4:46:24PM Page 57 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Americas - Other 9,964 12,978 22,942
Dominican Republic 6,089 2,460 8,549
1,724,780 1,055,425 2,316,480 3,778,860 2,203 7,912 14,000,000 15,016,738 143,626,339 5,709 63%Condom
9 /03 50% 3,477,920 7,282 2,027 5,255 142,711,317 14,402,656 2,314,880 14,000,000 894,240 1,723,600 Pante
3 /13 24,848% 99,790 209 58 151 263,409 163,619 400 - 48,645 1,130 Pante Banana
3 /13 1,125% 4,900 10 3 7 129,332 124,432 400 - 14,833 - Pante Clásico
3 /13 25,438% 102,150 214 60 154 269,068 166,918 400 - 49,935 50 Pante Strawberry
3 /13 23,425% 94,100 197 55 142 253,213 159,113 400 - 47,771 - Pante Vanilla
94,800 75,260 189,624 251,380 147 526 1,500,000 1,127,669 3,182,049 380 33%Free Condom
4 /10 33% 251,380 526 147 380 3,182,049 1,127,669 189,624 1,500,000 75,260 94,800 No Logo
523 - - 523 96 96 900 58 581 - 0%Implant 3 Insertion
11/13 -% 523 96 96 - 581 58 - 900 - 523 Non-PSI Implant 3 Inserted
43 - - 43 15 15 300 17 60 - 0%IUD 10 Insertion
11/13 -% 43 15 15 - 60 17 - 300 - 43 Non-PSI IUD 10 Inserted
5,300 1,967 - 10,200 - - - 2,000 12,200 - 0%Lubricant A
3 /13 -% 10,200 - - - 12,200 2,000 - - 1,967 5,300 No Logo Lubricant (4.5 gram sachet)
- - - - - - 5,000 4,441 4,441 - 0%VCT
9 /13 -% - - - - 4,440 4,440 - 4,850 - - VCT Individual (HIV-Negative)
9 /13 -% - - - - 1 1 - 150 - - VCT Individual (HIV-Positive)
Dominican Republic - Panama Warehouse - - -
- - - - - - - 947,280 16,208,400 - 0%PUR
11/06 -% - - - - 16,208,400 947,280 - - - - PuR
Haiti 3,652 8,666 12,319
250,920 197,160 678,240 705,960 890 4,327 2,847,000 2,714,004 131,127,042 3,436 4%Condom
11/90 4% 705,960 4,327 890 3,436 131,127,042 2,714,004 678,240 2,847,000 197,160 250,920 Pante
3002 - 4/18/2014 4:46:24PM Page 58 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
- - - - - - - 1,704 951,749 - 0%Female Condom
12/96 -% - - - - 951,749 1,704 - - - - Realite
17,200 17,600 84,100 49,100 1,916 1,916 245,000 234,090 2,577,812 - (42)%Injectable 3
12/96 (42)% 49,100 1,916 1,916 - 2,577,812 234,090 84,100 245,000 17,600 17,200 Confiance Injectable
85 225 - 460 317 317 1,710 301 761 - 0%IUD 10 Distribution
-% - - - - (109)(109) - - (36) - PSI IUD 10 Distributed Inserted (1)
12/13 -% 460 317 317 - 870 410 - 1,710 262 85 Confiance Plus IUD
- 36 - - - - 700 109 109 - 0%IUD 10 Insertion
12/13 -% - - - - 109 109 - 700 36 - PSI IUD 10 Inserted
- 11,967 38,700 12,500 1,065 1,065 66,825 76,600 268,300 - (68)%Malaria PPT (Non-ACT)
3 /12 (68)% 12,500 1,065 1,065 - 268,300 76,600 38,700 66,825 11,967 - Chloroquine
- - 33,333 - - - 40,095 44,700 44,700 - (100)%Malaria PPT (Non-ACT) P
7 /12 (100)% - - - - 44,700 44,700 33,333 40,095 - - Primaquine Tablet
- - - - - - 360,000 - 90 - 0%Malaria RDK
3 /12 -% - - - - 90 - - 360,000 - - Malaria Test Kit
69,500 59,733 243,000 196,400 1,960 1,960 713,300 679,690 4,659,613 - (19)%OCs
12/96 (19)% 196,400 1,960 1,960 - 4,659,613 679,690 243,000 713,300 59,733 69,500 Pilplan
19,440 19,120 80,400 63,600 740 740 311,500 253,680 8,798,096 - (21)%ORS
10/99 (21)% 63,600 740 740 - 8,798,096 253,680 80,400 311,500 19,120 19,440 Sel Lavi
63,000 120,000 376,810 243,000 1,778 1,778 1,940,400 1,861,810 2,536,614 - (36)%Safe Water Solution
4 /07 (36)% 243,000 1,778 1,778 - 2,536,614 1,861,810 376,810 1,940,400 120,000 63,000 Dlo Lavi
1,400 739 2,464 3,167 - 216 7,201 10,344 20,841 216 29%VCT
4 /10 28% 3,103 87 - 87 20,355 10,090 2,420 7,200 729 1,359 VCT Individual (HIV-Negative)
4 /10 45% 64 129 - 129 486 254 44 1 10 41 VCT Individual (HIV-Positive)
Mexico - - -
3002 - 4/18/2014 4:46:24PM Page 59 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
- - - - - - - 178,309 42,544,050 - 0%Free Condom
11/11 -% - - - - 41,775,500 163,744 - - - - POSSES
11/06 -% - - - - 176,131 5,600 - - - - SSA/C. CONDESA
11/06 -% - - - - 592,419 8,965 - - - - SSA/CENSIDA
- - - - - - - 7,287 68,077 - 0%Lubricant A
11/11 -% - - - - 68,077 7,287 - - - - LUBRI GEL (8 grams sachet)
- - - - - - - 29,618 392,850 - 0%Lubricant E
11/11 -% - - - - 392,850 29,618 - - - - LUBRI GEL (60 grams tube)
- - - - - - - 138,400 162,800 - 0%Needle & Syringe
12/11 -% - - - - 162,800 138,400 - - - - BD Ultra-Fine
Paraguay 222 1,852 2,074
240,265 191,183 777,765 622,905 452 674 2,700,000 2,477,291 28,481,846 222 (20)%Condom
8 /98 (20)% 622,893 674 452 222 28,481,834 2,477,291 777,765 2,000,000 191,183 240,253 Pantera
2 /14 -% 3 - - - 3 - - 100,000 - 3 Pantera Chocolate
2 /14 -% 3 - - - 3 - - 400,000 - 3 Pantera Retardant
2 /14 -% 3 - - - 3 - - 100,000 - 3 Pantera Ribbed
2 /14 -% 3 - - - 3 - - 100,000 - 3 Pantera Strawberry
23,471 22,917 66,757 68,529 308 308 286,000 269,267 1,432,732 - 3%Emergency Contraception
2 /04 3% 68,529 308 308 - 1,432,732 269,267 66,757 286,000 22,917 23,471 Pronta
200,160 164,490 508,110 567,270 47 47 2,160,000 1,927,920 28,019,760 - 12%Multivitamin
11/00 12% 567,270 47 47 - 28,019,760 1,927,920 508,110 2,160,000 164,490 200,160 VitalDia
66,070 56,958 170,092 182,093 1,046 1,046 780,000 683,416 4,942,950 - 7%OCs
4 /01 6% 177,601 1,020 1,020 - 4,901,441 668,386 168,322 720,000 55,800 63,860 Segura
3 /11 154% 4,492 26 26 - 41,509 15,030 1,770 60,000 1,157 2,210 Segura Plus
3002 - 4/18/2014 4:46:24PM Page 60 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
AmAmericas - Caribbean
Caribbean $0 $0 $0 NA
CondomNAGIGI (Got it? Get it!) Condom 03/2014 18,587 $0 NA0 0 $0 0 NA0% $0 25,55618,587
Free CondomNAGIGI (Got it? Get it!) Free Condom 03/2014 0 $0 NA5,539 0 $0 0 NA100% $0 4,0065,539
Free Female CondomNAGIGI (Got it? Get it!) Free Female 03/2014 0 $0 NA84 0 $0 0 NA100% $0 1,01384
Lubricant ANAGIGI (Got it? Get it!) Lube Sachet 03/2014 0 $0 NA2,480 0 $0 0 NA100% $0 4,8342,480
Lubricant ENAVive Lub (tube) 03/2014 0 $0 NA583 0 $0 0 NA100% $0 219583
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 125 $0 NA0 0 $0 0 NA0% $0 128125
Page 30 of 47 4/15/2014 11:13:26 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
AmAmericas - Central America
Belize $0 $2,656 $11 247.80
CondomNAGIGI (Got it? Get it!) Condom 03/2014 24,696 $0 NA0 0 $0 0 NA0% $109 14,96424,696
NAVive 03/2014 0 $0 NA0 0 $0 62,874 NANA $0 00
NAVive Amor 03/2014 0 $0 NA0 0 $0 23,007 NANA $301 00
65.33Vive Colors/Mas Colors 03/2014 0 $0 NA0 0 $11 71,884 1,497.58NA $700 480
NAVive Mas Fuerte /Retardante 03/2014 0 $0 NA0 0 $0 15,555 NANA $539 00
NAVive Mas Natural /Sensitivo 03/2014 0 $0 NA0 0 $0 18,369 NANA $302 00
NAVive Mas/Texturizado 03/2014 0 $0 NA0 1,662 $0 14,085 NANA $539 01,662
Lubricant ANAVive Lub (sachet) 03/2014 0 $0 NA0 0 $0 32,129 NANA $0 00
Lubricant ENAVive Lub (tube) 03/2014 0 $0 NA0 0 $0 396 NANA $166 00
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 202 $0 NA0 0 $0 0 NA0% $0 117202
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 1 $0 NA0 0 $0 0 NA0% $0 01
Costa Rica $22,820 $44,924 $21,815 2.06
Condom0.35Combo-Mix Lub Fresa 03/2014 351 $352 14%0 0 $137 761 5.550% $48 137351
1.85Combo-Mix Lub Natural 03/2014 228 $214 100%5 0 $216 1,312 6.452% $400 203233
4.40Combo-Pack Lub Fresa 03/2014 854 $836 86%8 0 $500 1,289 2.661% $2,200 485862
2.03Vive 03/2014 3,801 $877 93%288 0 $1,924 289,524 33.477% $3,912 8,6504,089
1.06Vive Amor 03/2014 31,884 $4,181 52%576 0 $4,893 808,689 21.492% $5,175 37,62932,460
2.30Vive Colors/Mas Colors 03/2014 24,687 $8,353 76%1,157 0 $6,303 220,690 10.124% $14,475 21,81425,844
2.39Vive Mas Fuerte /Retardante 03/2014 6,861 $2,320 81%294 0 $2,153 93,285 15.084% $5,145 6,1857,155
2.84Vive Mas Natural /Sensitivo 03/2014 9,246 $3,062 96%32 3,400 $2,543 167,295 23.130% $7,217 7,23212,678
0.74Vive Mas/Texturizado 03/2014 2,040 $687 62%380 0 $1,032 8,208 1.1716% $762 7,0392,420
Lubricant A0.84Vive Lub Natural (sachet) 03/2014 125 $25 100%26 800 $53 13,503 38.1817% $44 354951
0.48Vive Lub Sachet Fresa 5 mL 03/2014 525 $126 47%0 900 $160 12,241 16.620% $77 7371,425
Page 31 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Costa Rica $22,820 $44,924 $21,815 2.06
Lubricant E2.89Vive Lub (tube) 03/2014 311 $997 87%1 17 $1,159 5,175 14.580% $3,349 355329
2.86Vive Lub Natural (tube) 03/2014 242 $790 80%1 0 $743 1,502 6.680% $2,121 225243
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 114 $0 NA0 0 $0 0 NA0% $0 122114
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 3 $0 NA0 0 $0 0 NA0% $0 23
El Salvador $45,654 $63,926 $40,718 1.57
Other Revenues9.32IUD Insertion Kits 03/2014 1 $22 0%0 0 $19 207 207.000% $179 11
Condom2.66Combo-Mix Lub Fresa 03/2014 0 $0 NA0 0 $26 6,376 170.79NA $69 370
NACombo-Mix Lub Natural 03/2014 0 $0 NA0 0 $21 3,640 113.75NA $0 320
NACombo-Pack Lub Fresa 03/2014 0 $0 NA0 0 $0 3,264 NANA $0 00
2.01Vive 03/2014 44,976 $6,442 31%4,320 0 $11,024 1,253,952 15.669% $22,149 80,08049,296
0.99Vive Amor 03/2014 119,184 $13,212 13%0 0 $8,766 1,518,624 19.280% $8,719 78,784119,184
1.50Vive Colors/Mas Colors 03/2014 50,232 $10,659 41%0 0 $8,750 869,568 21.990% $13,163 39,53650,232
1.68Vive Mas Fuerte /Retardante 03/2014 15,888 $3,258 39%0 0 $3,140 186,960 13.170% $5,273 14,19215,888
1.13Vive Mas Natural /Sensitivo 03/2014 6,792 $1,420 35%0 0 $1,018 122,328 27.060% $1,150 4,5206,792
1.69Vive Mas/Texturizado 03/2014 8,400 $1,891 49%0 0 $1,535 135,696 20.710% $2,596 6,5528,400
Lubricant A2.00Vive Lub (sachet) 03/2014 12,700 $1,523 25%0 0 $970 26,758 3.450% $1,937 7,76712,700
0.67Vive Lub Natural (sachet) 03/2014 6,850 $808 4%0 0 $539 30,810 7.220% $363 4,2676,850
Lubricant E1.04Vive Lub (tube) 03/2014 1,032 $2,130 0%0 0 $1,391 17,587 26.890% $1,453 6541,032
1.35Vive Lub Natural (tube) 03/2014 313 $646 2%0 0 $512 19,186 77.990% $688 246313
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 600 $0 NA0 0 $0 0 NA0% $0 445600
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 20 $0 NA0 0 $0 0 NA0% $0 1020
Misoprostol for PAC (Oral)3.00Misoprostol for PAC (oral) 03/2014 500 $1,372 100%150 0 $457 0 NA23% $1,372 1,217650
Page 32 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
El Salvador $45,654 $63,926 $40,718 1.57
Implant 5NAJadelle 03/2014 0 $0 NA52 0 $0 1,512 58.91100% $0 2652
IUD 101.54Copper T 380 03/2014 325 $526 0%15 0 $439 8,835 33.134% $674 267340
OCs1.97Segura Plus 03/2014 1,637 $1,745 0%0 0 $2,104 101,009 49.000% $4,141 2,0611,637
Guatemala $174,989 $231,130 $130,345 1.77
Condom2.51Combo Pack 03/2014 7,624 $2,842 97%24 0 $1,573 19,120 4.750% $3,949 4,0217,648
2.39Vive 03/2014 328,272 $35,602 90%5,488 48,080 $31,690 2,490,048 8.592% $75,882 289,893381,840
1.72Vive Amor 03/2014 546,384 $46,146 49%6,240 0 $38,614 7,588,560 18.421% $66,504 412,080552,624
2.34Vive Colors/Mas Colors 03/2014 101,616 $18,211 89%3,408 0 $17,360 2,005,752 20.873% $40,707 96,128105,024
2.45Vive Mas Fuerte /Retardante 03/2014 26,904 $5,157 68%1,320 0 $4,919 203,640 7.635% $12,049 26,68828,224
2.33Vive Mas Natural /Sensitivo 03/2014 3,168 $606 79%408 0 $1,431 87,864 11.4511% $3,342 7,6723,576
2.56Vive Mas/Texturizado 03/2014 2,352 $454 83%144 0 $1,168 127,080 19.816% $2,995 6,4162,496
Lubricant A0.26Vive Lub (sachet) 03/2014 22,378 $4,116 5%121 24,040 $1,740 82,204 8.921% $454 9,21746,539
1.91Vive Lub Natural (sachet) 03/2014 1,005 $204 58%76 0 $377 25,852 12.777% $720 2,0251,081
Lubricant E2.09Vive Lub (tube) 03/2014 1,917 $4,015 99%6 0 $3,336 5,746 3.820% $6,986 1,5041,923
2.28Vive Lub Natural (tube) 03/2014 2,098 $4,387 99%11 0 $2,508 8,803 7.571% $5,727 1,1632,109
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 808 $0 NA0 0 $0 0 NA0% $0 423808
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 8 $0 NA0 0 $0 0 NA0% $0 48
Implant 50.08Jadelle 03/2014 1,210 $24,387 3%1 30 $8,735 1,723 4.010% $664 4301,241
Injectable 10.53Cyclofem 03/2014 11,299 $23,459 14%2,690 0 $12,281 31,768 3.0719% $6,462 10,35013,989
IUD 10NACopper T 380 03/2014 862 $2,161 0%5 0 $1,155 46,372 102.371% $0 453867
OCs1.36Oralcon-F (28 tablets Blister) 03/2014 4,685 $3,243 49%730 0 $3,458 2,434 0.4313% $4,689 5,6455,415
Page 33 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Honduras $58,655 $48,347 $52,134 0.93
Other RevenuesNAAldo Dog Tags 03/2014 0 $0 NA0 0 $0 16,000 24.00NA $0 6670
Condom0.26Combo Pack 03/2014 192 $132 33%0 0 $411 5,744 9.170% $105 627192
2.34Combo-Mix Lub Fresa 03/2014 40 $43 44%0 0 $213 2,344 10.340% $499 22740
2.36Combo-Mix Lub Natural 03/2014 48 $55 71%0 0 $195 2,936 14.880% $461 19748
1.62Combo-Pack Lub Natural 03/2014 272 $192 53%0 0 $257 4,984 11.830% $417 421272
1.08Vive 03/2014 153,696 $16,326 61%0 14,400 $11,969 1,383,120 13.500% $12,930 102,448168,096
0.38Vive Amor 03/2014 144,336 $17,346 27%0 0 $15,214 2,974,032 22.220% $5,826 133,872144,336
1.30Vive Colors/Mas Colors 03/2014 53,904 $17,329 32%0 0 $14,733 1,193,280 25.770% $19,199 46,31253,904
1.47Vive Mas Fuerte /Retardante 03/2014 5,808 $1,961 59%0 0 $1,541 126,192 27.010% $2,266 4,6725,808
1.16Vive Mas Natural /Sensitivo 03/2014 456 $165 42%0 0 $882 46,440 16.310% $1,027 2,848456
1.49Vive Mas/Texturizado 03/2014 504 $181 39%0 0 $681 125,520 58.760% $1,012 2,136504
Lubricant A0.01Vive Lub (sachet) 03/2014 1,770 $217 4%0 3,600 $2,741 128,652 6.010% $22 21,3905,370
0.17Vive Lub Natural (sachet) 03/2014 1,980 $245 0%0 3,600 $193 75,670 50.110% $32 1,5105,580
Lubricant E1.61Vive Lub (tube) 03/2014 1,330 $2,940 76%0 0 $1,636 17,199 23.120% $2,634 7441,330
1.31Vive Lub Natural (tube) 03/2014 690 $1,525 88%0 0 $1,467 6,292 9.380% $1,918 671690
Nicaragua $51,787 $106,145 $68,348 1.55
HIV Test KitNADetermine 03/2014 0 $0 NA0 0 $0 100 NANA $0 00
Condom4.04Bodyguard 03/2014 5,184 $728 92%0 0 $1,343 2,076,418 144.160% $5,427 14,4035,184
1.61Combo-Pack Lub Fresa 03/2014 456 $314 94%0 0 $244 1,944 5.650% $393 344456
1.82Combo-Pack Lub Natural 03/2014 232 $160 92%8 0 $60 736 8.123% $109 91240
1.60Vive 03/2014 204,000 $29,841 60%69,936 0 $39,831 2,138,370 6.5726% $63,540 325,395273,936
1.00Vive Colors/Mas Colors 03/2014 51,720 $11,482 68%4,944 0 $13,680 800,573 11.499% $13,659 69,66856,664
1.23Vive Mas Fuerte /Retardante 03/2014 8,064 $1,876 97%1,968 0 $2,660 103,979 7.7320% $3,276 13,44310,032
2.02Vive Mas Natural /Sensitivo 03/2014 5,304 $1,207 98%465 0 $1,564 58,658 7.898% $3,155 7,4305,769
1.57Vive Mas/Texturizado 03/2014 2,760 $632 100%408 0 $1,270 131,846 22.2913% $1,989 5,9153,168
Page 34 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Nicaragua $51,787 $106,145 $68,348 1.55
Lubricant A1.44Vive Lub (sachet) 03/2014 1,350 $184 100%0 0 $246 13,906 7.590% $354 1,8331,350
0.77Vive Lub Natural (sachet) 03/2014 1,600 $230 100%0 0 $308 26,329 12.150% $236 2,1671,600
Lubricant E0.02Vive Lub (tube) 03/2014 28 $53 0%0 0 $1,004 69 0.090% $17 72828
NAVive Lub Natural (tube) 03/2014 0 $0 NA0 0 $0 0 NANA $205 00
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 61 $0 NA0 0 $0 0 NA0% $0 4661
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 2 $0 NA0 0 $0 0 NA0% $0 12
Implant 51.99Jadelle 03/2014 117 $3,531 81%0 0 $3,014 0 NA0% $5,998 100117
Injectable 1NANorigynon 03/2014 0 $0 NA0 0 $0 0 NANA $2,845 00
Injectable 3NAMegestron 03/2014 0 $0 NA0 0 $0 0 NANA $708 00
IUD 101.70Copper T 380 03/2014 529 $623 93%0 0 $941 17,903 26.000% $1,600 689529
OCs1.21Marvelon 03/2014 1,241 $929 95%25 0 $2,183 37,577 13.252% $2,631 2,8361,266
Panama $59,621 $200,300 $85,415 2.35
HIV Test KitNASD HIV ½ 3.0 Prueba Rápida 03/2014 0 $0 NA0 0 $0 260 NANA $0 00
NAUni Gold Kit 03/2014 0 $0 NA120 0 $0 480 3.43100% $0 140120
Condom2.38Vive 03/2014 290,448 $45,442 94%3,744 0 $62,773 2,542,998 6.431% $149,663 395,568294,192
2.31Vive Colors/Mas Colors 03/2014 18,528 $5,252 99%0 0 $9,793 598,065 17.480% $22,643 34,22418,528
2.31Vive Mas Fuerte /Retardante 03/2014 12,168 $3,732 99%0 0 $5,703 112,032 6.810% $13,169 16,44812,168
2.32Vive Mas Natural /Sensitivo 03/2014 8,640 $2,640 100%0 0 $2,895 118,356 14.010% $6,707 8,4488,640
1.82Vive Mas/Texturizado 03/2014 3,264 $1,053 100%0 0 $2,203 61,920 9.510% $4,000 6,5123,264
Lubricant A0.59Vive Lub (sachet) 03/2014 250 $80 100%0 0 $361 7,760 1.630% $212 4,767250
3.00Vive Lub Natural (sachet) 03/2014 50 $16 100%0 0 $5 18,498 1,109.880% $16 1750
Page 35 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Panama $59,621 $200,300 $85,415 2.35
Lubricant E2.49Vive Lub (tube) 03/2014 545 $954 99%0 0 $1,274 5,758 7.700% $3,165 747545
1.77Vive Lub Natural (tube) 03/2014 225 $452 67%0 0 $410 10,775 49.730% $724 217225
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 123 $0 NA0 0 $0 0 NA0% $0 176123
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 7 $0 NA0 0 $0 0 NA0% $0 57
Page 36 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
AmAmericas - Other
Dominican Republic $43,858 $16,563 $31,042 0.53
Condom0.53Pante 03/2014 1,465,760 $43,858 38%257,840 0 $31,042 12,828,492 11.0715% $16,563 1,159,3071,723,600
NAPante Banana 03/2014 0 $0 NA1,130 0 $0 3,982,094 119.71100% $0 33,2631,130
NAPante Clásico 03/2014 0 $0 NA0 0 $0 4,315,271 2,642.00NA $0 1,6330
NAPante Strawberry 03/2014 0 $0 NA50 0 $0 3,988,138 117.13100% $0 34,05050
NAPante Vanilla 03/2014 0 $0 NA0 0 $0 4,162,072 132.69NA $0 31,3670
Free CondomNANo Logo 03/2014 0 $0 NA94,800 0 $0 1,482,951 17.70100% $0 83,79394,800
Lubricant ANANo Logo Lubricant (4.5 gram sach 03/2014 0 $0 NA5,300 0 $0 1,207,800 355.24100% $0 3,4005,300
Haiti $36,016 $0 $35,439 NA
CondomNAPante 03/2014 250,920 $7,897 0%0 87 $7,511 3,276,741 13.920% $0 235,320251,007
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 1,359 $0 NA0 0 $0 0 NA0% $0 1,0341,359
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 41 $0 NA0 0 $0 0 NA0% $0 2141
Malaria PPT (Non-ACT)NAChloroquine 03/2014 0 $0 NA0 50,800 $0 82,800 19.87NA $0 4,16750,800
Malaria PPT (Non-ACT) PNAPrimaquine Tablet 03/2014 0 $0 NA0 0 $0 19,550 NANA $0 00
ORSNASel Lavi 03/2014 19,440 $3,190 0%0 0 $3,556 348,371 16.430% $0 21,20019,440
Safe Water SolutionNADlo Lavi 03/2014 63,000 $642 0%0 0 $845 3,948,190 48.740% $0 81,00063,000
Injectable 3NAConfiance Injectable 03/2014 17,200 $8,185 0%0 0 $7,888 128,177 7.830% $0 16,36717,200
IUD 10NAConfiance Plus IUD 03/2014 0 $353 0%85 15 $596 569 3.71100% $0 153100
OCsNAPilplan 03/2014 69,500 $15,749 0%0 0 $15,042 429,616 6.560% $0 65,46769,500
Page 37 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Paraguay $182,434 $412,567 $168,261 2.45
Condom1.86Pantera 03/2014 238,848 $31,199 70%1,405 44 $26,503 1,550,614 7.471% $49,418 207,631240,297
NAPantera Chocolate 03/2014 0 $0 NA3 0 NA 287,997 NA100% $0 NA3
NAPantera Retardant 03/2014 0 $0 NA3 9 NA 719,988 NA100% $0 NA12
NAPantera Ribbed 03/2014 0 $0 NA3 0 NA 287,997 NA100% $0 NA3
NAPantera Strawberry 03/2014 0 $0 NA3 0 NA 287,997 NA100% $0 NA3
Multivitamin2.75VitalDia 03/2014 188,940 $14,220 90%11,220 0 $13,488 129,330 0.686% $37,094 189,090200,160
Emergency Contraception2.76Pronta 03/2014 23,463 $59,414 96%8 31 $57,374 32,331 1.420% $158,136 22,84323,502
OCs2.37Segura 03/2014 63,860 $75,498 76%0 102 $69,518 767,636 12.970% $165,068 59,20063,962
2.07Segura Plus 03/2014 1,790 $2,102 93%420 0 $1,378 110,848 74.0319% $2,852 1,4972,210
Page 38 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Asia & Eastern Europe
POPULATION SERVICES INTERNATIONAL
CYPs, Cases, and Deaths by Country
1/2014 - 3/2014
Cases CYP*
HIV & TB Reproductive Health
Maternal
Deaths
Unintended
Pregnancies
Malaria
Cases
Malaria
Deaths
Diarrhea
Cases
Diarrhea
Deaths
Malaria Control Child Survival
Sum of
All Deaths
Pneumonia
Cases
Pneumonia
Deaths
STI
Deaths
TB
Deaths
Nutrition
Deaths
IDU
Deaths
Asia and Eastern Europe 705 1,078,588 452 224,211 - 177 227 - 1,810 - 201 17 662 - 75
Cambodia 129 133,398 46 24,094 - 116 13 - 219 - 43 - - - -
China - - - - - - - - - - - - - - -
India 25 88,701 58 14,398 - - 113 - 172 - - - - - -
Kazakhstan - 60 - 8 - - - - 48 - - - - - 48
Kyrgyzstan - 41 - 6 - - - - - - - - - - -
Laos 17 6,372 3 1,697 - - - - 4 - - 1 - - -
Myanmar 263 116,436 32 14,809 - 58 99 - 948 - 157 16 585 - -
Nepal - 1,487 5 672 - 3 - - 8 - - - - - -
Pakistan 167 723,864 305 167,264 - - - - 382 - - - 77 - -
Papua New Guinea 26 2,190 1 527 - - - - 1 - - - - - -
Tajikistan 5 1,442 - 261 - - - - 27 - - - - - 27
Thailand 72 4,596 - 475 - - - - - - - - - - -
Viet Nam - - - - - - - - - - - - - - -
54,254 4,274,120 3,165 1,148,882 - 107,644 - 1,700 114,185 Total - 885 54 662 - 75
3001 - 4/18/2014 4:45:11PM Page 5 of 5
* Using USAID CYP conversion factors
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
Asia and Eastern Europe - Asia 85,972 443,348 357,376
Antiretroviral Treatment 151 457 365 482 - 236 4,050 32% 2,775 3,257 236
BCC (Behavior Change) - - 7,543 - - - - (100)% 22,801 101,359 -
Cervical Cancer-VIA and Cryotherapy 1 20 113 26 7 7 200 (77)% 522 556 -
Clean Delivery Kit 5,000 - 8,212 5,000 565 565 12,100 (39)% 8,217 379,086 -
Condom 26,318,681 20,308,115 65,781,067 41,406,006 102,806 135,174 380,158,080 (37)% 309,193,382 5,540,125,181 32,368
Diarrhea Treatment Kit 81,162 45,021 239,105 162,605 8,185 8,185 916,200 (32)% 1,140,085 4,012,388 -
Emergency Contraception 296,063 117,833 473,901 493,930 8,485 8,485 3,360,000 4% 1,893,669 11,023,837 -
Female Condom 19,836 34,162 111,827 74,830 86 363 277,200 (33)% 350,092 1,789,022 277
Free Condom 387,024 158,470 540,098 736,472 637 4,679 2,798,040 36% 7,140,570 37,181,468 4,042
Free Female Condom - 93 7,930 220 - 1 65,000 (97)% 30,414 101,987 -
Implant 3 Distribution (33) (21) - (95) (29) (29) - -% - (95) -
Implant 3 Insertion 33 36 296 95 31 31 - (68)% 612 707 -
Implant 4 Distribution (140) (97) 161 (431) (460) (460) - (368)% 458 4,207 -
Implant 4 Insertion 140 143 476 431 489 489 - (9)% 1,784 2,215 -
Implant 5 Distribution 6,209 70 1,944 5,915 7,675 7,675 22,493 204% 19,368 52,988 -
Implant 5 Insertion 390 554 1,843 1,656 825 825 7,895 (10)% 5,709 7,365 -
Injectable 1 26,605 7,722 50,100 38,788 1,036 1,036 235,000 (23)% 145,986 2,542,270 -
Injectable 2 44,160 14,960 150,480 62,160 3,602 3,602 780,000 (59)% 533,775 5,803,403 -
Injectable 3 185,714 165,034 431,774 466,772 24,131 24,131 2,306,700 8% 2,113,228 12,031,639 -
Iron Folic Acid Tablet - - 192,000 - - - - (100)% 1,109,910 48,233,970 -
IUD 10 Distribution (1,356) 2,024 6,294 (6,864) (9,590) (9,590) 79,034 (209)% 66,448 243,284 -
3003 - 4/18/2014 4:49:12PM Page 11 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
IUD 10 Insertion 3,896 4,601 8,330 11,703 13,397 13,397 47,467 40% 46,383 58,087 -
IUD 5 Distribution 69,337 8,657 350,980 52,955 53,095 53,095 700,228 (85)% 865,361 4,126,520 -
IUD 5 Insertion 18,550 18,680 40,248 55,786 65,292 65,292 1,692 39% 211,382 267,167 -
LLINs 170,390 7 93,243 170,411 629 629 1,069,718 83% 1,580,238 3,908,224 -
Lubricant A 389,500 429,170 587,846 1,339,665 - - 4,624,032 128% 4,616,049 23,438,046 -
Lubricant B 7,751 9,027 21,052 23,870 - - 105,400 13% 109,089 532,418 -
Malaria PPT (ACT) 12,529 23,576 356,135 57,778 9,680 9,680 1,021,001 (84)% 1,053,742 1,953,856 -
Malaria RDK 55,308 47,745 163,110 114,892 - - 1,319,000 (30)% 883,277 4,471,989 -
Medical Abortion 42,660 30,887 165,572 110,345 3,502 3,502 516,353 (33)% 506,434 1,652,511 -
Micronutrient Powder - - 33,600 - - - - (100)% 88,600 8,536,522 -
Misoprostol for PAC (Oral) - - - - - - 40,000 -% 20,000 20,000 -
Misoprostol for PPH - - 5,004 - - - 5,000 (100)% 16,560 22,215 -
Naloxone 80 3,102 1,932 3,104 - 4,216 7,246 61% 13,141 23,667 4,216
Needle & Syringe 653,710 245,869 280,425 1,166,002 - 9,109 4,229,974 316% 1,473,455 3,985,008 9,109
OCs 763,840 868,500 3,896,271 2,345,072 29,042 29,042 12,965,000 (40)% 23,648,325 184,710,066 -
ORS 71,297 181,950 335,875 403,397 11,389 11,389 2,046,000 20% 1,095,207 22,771,797 -
Pneumonia PPT 15,859 16,909 44,433 44,284 17,200 17,200 230,000 -% 225,756 643,970 -
Pregnancy Test 6,984 13,305 9,126 27,025 - - - 196% 95,154 457,051 -
Retreatment IconMaxx 21,519 - 361,420 21,519 3,243 3,243 - (94)% 361,420 2,576,546 -
Retreatment KO123 - - 15 - - - - (100)% 76 306,592 -
Safe Water Solution 5,760 5,298 40,226 12,792 26 26 100,000 (68)% 124,700 3,763,117 -
SDM (Cycle Beads) 6 - - 6 3 3 - -% - 6 -
3003 - 4/18/2014 4:49:12PM Page 12 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Region and Product
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
SALES
YTD DALY
HIV2014
STI Kit (Non-Ulcerative) 7,791 12,189 12,292 36,548 - 745 102,000 197% 75,230 501,748 745
STI Kit (Ulcerative) 828 805 1,994 2,207 - 256 7,000 11% 6,692 47,261 256
TB DOTS 2,171 1,808 4,332 5,667 - 33,678 23,860 31% 24,605 195,425 33,678
Tubal Ligation - 194 1,144 582 2,065 2,065 16,000 (49)% 5,888 211,920 -
VCT 3,813 3,754 9,483 11,339 - 1,044 51,060 20% 41,327 120,771 1,044
Water Treatment Tablets 65,780 6,567 364,200 67,780 17 17 99,150 (81)% 1,769,500 7,787,310 -
Zinc - 12,400 6,000 30,300 315 315 31,100 405% 49,230 138,642 -
3003 - 4/18/2014 4:49:12PM Page 13 of 13
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
Asia and Eastern Europe - Asia 85,972 357,376 443,348
Cambodia 6,537 31,028 37,565
482,388 884,658 1,768,710 2,333,214 2,412 8,950 15,490,000 13,021,590 331,485,811 6,537 32%Condom
12/94 (16)% 451,944 1,734 467 1,266 249,709,453 3,769,848 536,472 4,990,000 168,888 100,008 Number One
2 /04 53% 1,881,270 7,216 1,945 5,271 81,776,358 9,251,742 1,232,238 10,500,000 715,770 382,380 OK Condom
9,130 14,160 8,320 45,050 1,181 1,181 125,000 108,800 506,040 - 441%Diarrhea Treatment Kit
3 /09 441% 45,050 1,181 1,181 - 506,040 108,800 8,320 125,000 14,160 9,130 Orasel Kit
520 560 - 1,440 9 9 105,000 39,010 40,450 - 0%Emergency Contraception
8 /13 -% 1,440 9 9 - 40,450 39,010 - 105,000 560 520 NEXT 72 EC
- - 10,008 - - - 510,000 10,008 6,239,040 - (100)%Free Condom
4 /11 (100)% - - - - 6,106,344 10,008 10,008 10,000 - - Number One Condom (STF)
12/12 -% - - - - 132,696 - - 500,000 - - OK Condom (STF)
(33) (36) (296)(95) (29) (29) - (612) (707) - 0%Implant 3 Distribution
-%(95) (29)(29) - (707)(612)(296) - (36)(33) PSI Implant 3 Distributed Inserted (1)
33 36 296 95 31 31 - 612 707 - (68)%Implant 3 Insertion
(68)% 95 31 31 - 707 612 296 - 36 33 PSI Implant 3 Inserted
116 (88) 262 (225) (105) (105) 14,649 3,482 18,109 - (186)%Implant 5 Distribution
-%(1,652) (771)(771) - (6,366)(4,714)(1,412) - (533)(390) PSI Implant 5 Distributed Inserted (1)
5 /09 (68)% 531 248 248 - 21,939 6,556 1,674 11,669 146 342 Implant 5
9 /13 -% 896 418 418 - 2,536 1,640 - 2,980 299 164 Jadelle - NORAD
390 533 1,412 1,652 820 820 6,800 4,714 6,366 - 17%Implant 5 Insertion
17% 1,652 820 820 - 6,366 4,714 1,412 6,800 533 390 PSI Implant 5 Inserted
27,300 22,767 103,060 80,160 2,565 2,565 663,000 692,470 3,956,604 - (22)%Injectable 3
2 /02 (22)% 80,160 2,565 2,565 - 3,956,604 692,470 103,060 663,000 22,767 27,300 OK Injection-3
590 1,056 (3,421)(320) (181) (181) 40,010 10,922 62,810 - 0%IUD 10 Distribution
3002 - 4/18/2014 4:46:24PM Page 61 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
-%(4,850) (2,739)(2,739) - (22,000)(17,150)(4,698) - (1,671)(1,835) PSI IUD 10 Distributed Inserted (1)
1 /10 255% 4,530 2,558 2,558 - 84,810 28,072 1,277 40,010 2,727 2,425 IUD Copper T
1,835 1,671 4,698 4,850 2,914 2,914 15,310 17,150 22,000 - 3%IUD 10 Insertion
3% 4,850 2,914 2,914 - 22,000 17,150 4,698 15,310 1,671 1,835 PSI IUD 10 Inserted
- 72,080 148,620 90,540 - - 2,000,000 1,056,430 6,335,960 - (39)%Lubricant A
6 /09 (39)% 90,540 - - - 6,335,960 1,056,430 148,620 2,000,000 72,080 - OK Plus Lubricant
9,072 6,956 26,916 14,796 5,048 5,048 100,000 107,688 167,316 - (45)%Malaria PPT (ACT)
8 /12 (47)% 1,728 590 590 - 20,424 11,844 3,264 6,500 672 936 DHA-PIP For Adolescent
8 /12 (46)% 11,424 3,898 3,898 - 130,512 86,916 21,084 87,000 5,832 7,320 DHA-PIP For Adult
8 /12 (36)% 1,644 561 561 - 16,380 8,928 2,568 6,500 452 816 DHA-PIP For Children
29,900 21,947 79,470 44,350 - - 430,000 475,670 3,157,260 - (44)%Malaria RDK
2 /03 (44)% 44,350 - - - 3,157,260 475,670 79,470 430,000 21,947 29,900 MalaCheck
14,910 9,443 31,395 42,165 1,105 1,105 180,000 174,375 506,545 - 34%Medical Abortion
11/09 34% 42,165 1,105 1,105 - 506,545 174,375 31,395 180,000 9,443 14,910 Medabon
171,475 300,396 1,916,186 1,013,733 8,297 8,297 4,910,000 4,917,968 36,742,731 - (47)%OCs
12/12 -% 5,745 47 47 - 89,010 58,255 (17,530) 155,000 1,540 2,875 Marvelon
5 /13 -% - - - - 1 1 - - - - Mid-Range Oral Contraceptives
9 /97 (48)% 1,007,988 8,250 8,250 - 36,653,720 4,859,712 1,933,716 4,755,000 298,856 168,600 OK Pills
3,570 3,220 9,780 10,400 3,717 3,717 50,000 36,410 47,060 - 6%Pneumonia PPT
11/12 6% 10,400 3,717 3,717 - 47,060 36,410 9,780 50,000 3,220 3,570 Pneumox 250 (10's)
21,519 - 361,420 21,519 3,243 3,243 - 361,420 2,576,546 - (94)%Retreatment IconMaxx
10/09 (94)% 21,519 3,243 3,243 - 2,576,546 361,420 361,420 - - 21,519 Super Malatab
- 5,067 59,200 - - - - 1,361,200 7,019,900 - (100)%Water Treatment Tablets
10/09 (100)% - - - - 7,019,900 1,361,200 59,200 - 5,067 - Safe Water
China - - -
3002 - 4/18/2014 4:46:24PM Page 62 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
- - 62,758 - - - - 182,857 13,557,149 - (100)%Condom
8 /04 (100)% - - - - 13,557,149 182,857 62,758 - - - Hu Xiang Hao
- - - - - - - 10 52,470 - 0%Female Condom
8 /04 -% - - - - 52,470 10 - - - - Hu Xiang Hao (FC)
- - 46,000 - - - - 347,500 836,756 - (100)%Free Condom
11/11 (100)% - - - - 836,756 347,500 46,000 - - - Condom No Logo
- - 10,000 - - - - 366,500 763,605 - (100)%Lubricant A
1 /06 (100)% - - - - 763,605 366,500 10,000 - - - Hu Xiang Hao Lube Female (sachet)
- - 52 - - - - 433 1,421 - (100)%VCT
12/09 (100)% - - - - 1,374 413 52 - - - VCT Individual (HIV-Negative)
1 /10 -% - - - - 47 20 - - - - VCT Individual (HIV-Positive)
India 1,338 35,153 36,491
- - 7,543 - - - - 22,801 101,359 - (100)%BCC (Behavior Change)
11/05 (100)% - - - - 101,359 22,801 7,543 - - - STI Treatment BCC
350,520 7,956,880 21,365,597 788,520 1,727 3,065 200,822,548 134,375,642 2,690,047,690 1,338 (96)%Condom
9 /88 (96)% 788,520 3,065 1,727 1,338 1,869,180,338 134,371,272 21,365,597 103,326,560 7,956,880 350,520 Masti
5 /88 -% - - - - 820,867,352 4,370 - 97,495,988 - - Nirodh
(38,067) 6,192 86,112 (30,491) (1,783) (1,783) 11,200 254,609 312,915 - (135)%Diarrhea Treatment Kit
7 /13 -% 12,400 725 725 - 33,260 20,860 - 10,000 7,800 - Neotral Zinc Kit
9 /12 (150)%(42,891) (2,508)(2,508) - 279,655 233,749 86,112 1,200 (1,608)(38,067)ORS + Zinc (Generic)
- - (3,226) - - - - (6,819) 438,091 - 0%Emergency Contraception
7 /08 -% - - - - 438,091 (6,819)(3,226) - - - Emergency Goli
- - - - - - - 4,009 537,429 - 0%Female Condom
11/09 -% - - - - 537,429 4,009 - - - - Female Condom
4,100 2,933 - 9,720 659 659 43,500 34,247 43,967 - 0%Injectable 3
3002 - 4/18/2014 4:46:24PM Page 63 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
7 /13 -% 9,720 659 659 - 43,967 34,247 - 43,500 2,933 4,100 Freedom Inject (3-month)
- - 192,000 - - - - 1,109,910 48,233,970 - (100)%Iron Folic Acid Tablet
8 /02 (100)% - - - - 48,233,970 1,109,910 192,000 - - - Vitalet-Preg
7,800 5,433 49,592 7,800 6,695 6,695 132,900 192,015 733,446 - (84)%IUD 5 Distribution
7 /08 (84)% 7,800 6,695 6,695 - 733,446 192,015 49,592 132,900 5,433 7,800 Freedom 5
18,600 20,643 110,877 59,030 2,117 2,117 286,336 286,589 987,193 - (47)%Medical Abortion
11/09 (47)% 59,030 2,117 2,117 - 987,193 286,589 110,877 286,336 20,643 18,600 Safe Abort kit
367,200 353,800 1,284,999 809,400 14,036 14,036 4,350,000 15,646,267 110,447,303 - (37)%OCs
5 /97 (100)% - - - - 67,161,660 11,525,347 1,281,000 - - - Mala-D
1 /02 20,140% 809,400 14,036 14,036 - 43,285,643 4,120,920 3,999 4,350,000 353,800 367,200 Pearl 3
71,100 181,950 334,675 403,200 11,386 11,386 2,045,000 1,094,007 22,756,542 - 20%ORS
7 /98 20% 403,200 11,386 11,386 - 22,756,542 1,094,007 334,675 2,045,000 181,950 71,100 Neotral Orange 1000ml
- - - - - - - (368) 193,891 - 0%STI Kit (Non-Ulcerative)
8 /04 -% - - - - 193,891 (368) - - - - ACT 1
- 12,400 - 30,300 315 315 21,100 29,930 60,230 - 0%Zinc
7 /13 -% 30,300 315 315 - 60,230 29,930 - 21,100 12,400 - NeoZinc (50ml zinc acetate syrup)
Kazakhstan 2,889 6 2,896
1,440 1,920 2,880 7,200 6 20 24,000 54,115 145,555 13 150%Free Condom
7 /10 150% 7,200 20 6 13 145,555 54,115 2,880 24,000 1,920 1,440 Generic Condom
- 2,667 - 2,000 - 2,710 2,000 6,600 10,200 2,710 0%Naloxone
11/11 -% 2,000 2,710 - 2,710 10,200 6,600 - 2,000 2,667 - Naloxone
15,000 3,333 20,000 25,000 - 166 25,000 41,682 86,682 166 25%Needle & Syringe
11/11 25% 25,000 166 - 166 86,682 41,682 20,000 25,000 3,333 15,000 Needle/Syringe
Kyrgyzstan 7 6 13
- 2,128 3,430 4,656 6 12 15,000 16,330 226,932 6 36%Free Condom
3002 - 4/18/2014 4:46:24PM Page 64 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
8 /10 36% 4,656 12 6 6 226,932 16,330 3,430 15,000 2,128 - Generic Condom
- 93 - 220 - 1 - 352 572 - 0%Free Female Condom
7 /13 -% 220 1 - - 572 352 - - 93 - Cupid (Free Female Condom)
- - 1,890 - - - - 2,690 19,965 - (100)%IUD 10 Distribution
11/08 (100)% - - - - 19,965 2,690 1,890 - - - Copper T 380
- 67 - 140 - - - 345 485 - 0%Lubricant A
7 /13 -% 140 - - - 485 345 - - 67 - Personal lubricants water based 4.5 g
- - 1,182 - - - - 3,324 5,544 - (100)%Naloxone
11/11 (100)% - - - - 5,544 3,324 1,182 - - - Naloxone
- - 17,290 - - - - 86,590 162,118 - (100)%Needle & Syringe
11/11 (100)% - - - - 162,118 86,590 17,290 - - - Needle/Syringe
Laos 1,043 1,013 2,057
- 269,282 1,468,460 749,670 990 1,896 4,365,532 4,677,569 15,337,551 906 (49)%Condom
11/10 2,941% 748,896 1,894 989 905 2,559,190 1,479,284 24,626 1,145,532 269,024 - No 1 Condom Grp
8 /08 (100)% 243 1 - - 7,701,645 1,134,288 1,054,701 2,320,000 81 - No 1 Condom Strw
4 /08 (100)% 531 1 1 1 5,076,716 2,063,997 389,133 900,000 177 - Number One Rose
- - 7 - - - - 1,007 17,776 - (100)%Female Condom
5 /09 (100)% - - - - 17,776 1,007 7 - - - Female Condom
- 167 550 500 20 20 5,200 5,475 6,825 - (9)%Injectable 3
9 /11 (9)% 500 20 20 - 6,825 5,475 550 5,200 167 - OK Injection-3
- 2 - - - - - 210 210 - 0%IUD 10 Distribution
8 /13 -% - - - - 210 210 - - 2 - Pregna T Cu 380A
- - (725) - - - - (245) 954 - 0%IUD 5 Distribution
-% - - - - (856)(856)(856) - - - PSI IUD 5 Distributed Inserted (1)
7 /12 (100)% - - - - 1,810 611 131 - - - IUD Cu375
3002 - 4/18/2014 4:46:24PM Page 65 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
- - 856 - - - - 856 856 - (100)%IUD 5 Insertion
(100)% - - - - 856 856 856 - - - PSI IUD 5 Inserted
- 7 - 21 3 3 5,200 - 22,231 - 0%LLINs
6 /09 -% 13 2 2 - 11,736 - - 5,200 4 - Power Net Family
6 /09 -% 8 1 1 - 10,495 - - - 3 - Power Net Single
- 269,024 24,626 748,896 - - 1,145,532 1,479,284 2,559,190 - 2941%Lubricant A
11/10 2,941% 748,896 - - - 2,559,190 1,479,284 24,626 1,145,532 269,024 - Number One Lubricant Grape
- 1,087 474 - - - 10,400 13,169 13,468 - (100)%Lubricant B
7 /12 (100)% - - - - 13,468 13,169 474 5,200 1,087 - Number One Lubricant (20 cc)
1 /13 -% - - - - - - - 5,200 - - Number One Lubricant 20cc Tube (Grape)
- - - - - - 40,000 20,000 20,000 - 0%Misoprostol for PAC (Oral)
8 /13 -% - - - - 20,000 20,000 - 40,000 - - Misoprostol for PAC (oral)
- (5,280) 4 - - - 20,000 15,853 317,930 - (100)%OCs
11/01 (100)% - - - - 317,930 15,853 4 20,000 (5,280) - OK Pills
- 4,708 1 14,124 - 107 27,000 28 139,241 107 1412300%STI Kit (Non-Ulcerative)
12/11 -% 14,124 107 - 107 14,124 - - - 4,708 - One Stop Kit
3 /06 (100)% - - - - 125,117 28 1 27,000 - - STI Kit
- - 4 - - - 20 17 94 - (100)%TB DOTS
11/11 (100)% - - - - 94 17 4 20 - - TB DOTS
176 186 1,081 470 - 30 2,060 3,417 7,697 30 (57)%VCT
2 /10 (57)% 458 2 - 2 7,628 3,389 1,073 2,000 183 171 VCT Individual (HIV-Negative)
4 /10 50% 12 28 - 28 69 28 8 60 3 5 VCT Individual (HIV-Positive)
Myanmar 45,301 39,200 84,501
151 457 365 482 - 236 4,050 2,775 3,257 236 32%Antiretroviral Treatment
1 /13 (100)% - - - - 2,054 2,054 362 - 151 - ART Regimen 1 (patient-month)
3002 - 4/18/2014 4:46:24PM Page 66 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
1 /13 333% 13 6 - 6 121 108 3 400 28 2 ART Regimen 2 (patient-month)
11/13 -% 469 230 - 230 1,055 586 - 3,650 269 149 ART Regimen 3 (patient-month)
12/13 -% - - - - 27 27 - - 9 - ART Regimen 4 (patient-month)
1 20 113 26 7 7 200 522 556 - (77)%Cervical Cancer-VIA and Cryotherapy
11/12 (77)% 26 7 7 - 556 522 113 200 20 1 Cervical Cancer-VIA and Cryotherapy
- - 12 - - - - 17 18,954 - (100)%Clean Delivery Kit
7 /10 (100)% - - - - 18,954 17 12 - - - Clean Delivery Kit
1,258,333 1,416,455 7,281,045 3,839,792 3,217 16,665 19,000,000 26,070,321 330,367,125 13,448 (47)%Condom
7 /96 22% 399,056 1,732 334 1,398 171,173,589 2,966,924 327,136 17,700,000 221,207 34,748 Aphaw
8 /12 (19)% 518,580 2,251 434 1,816 4,622,670 2,633,178 638,940 - 120,020 218,340 Aphaw - Natural Touch
10/01 (59)% 2,188,988 9,500 1,834 7,666 145,042,710 17,756,027 5,303,573 - 889,934 693,285 Aphaw Flavors
7 /12 (41)% 564,360 2,449 473 1,977 5,795,208 2,393,760 955,620 - 137,780 252,600 Aphaw Studded
1 /08 -% 88,216 383 74 309 122,928 34,712 - - 19,683 29,168 Generic Male Condom
5 /03 44% 80,592 350 68 282 3,610,020 285,720 55,776 1,300,000 27,832 30,192 OK Condom
110,099 24,669 144,673 148,046 8,787 8,787 780,000 776,676 3,193,433 - 2%Diarrhea Treatment Kit
2 /09 2% 148,046 8,787 8,787 - 3,193,433 776,676 144,673 780,000 24,669 110,099 Orasel DTK
2,523 2,440 4,599 7,070 37 37 30,000 27,407 129,839 - 54%Emergency Contraception
8 /07 54% 7,070 37 37 - 129,839 27,407 4,599 30,000 2,440 2,523 OK EC
19,388 17,997 77,680 55,285 46 228 220,000 255,040 994,363 182 (29)%Female Condom
5 /08 (29)% 55,285 228 46 182 994,363 255,040 77,680 220,000 17,997 19,388 Generic Female Condom
- - 57,256 - - - - 208,348 4,285,491 - (100)%Free Condom
8 /01 (100)% - - - - 4,285,491 208,348 57,256 - - - Generic
- 1 - 2 1 1 - 10,090 18,591 - 0%Implant 5 Distribution
12/08 -% 2 1 1 - 18,591 10,090 - - 1 - OK Implant
5 55 225 88 1 1 - 946 1,319,458 - (61)%Injectable 1
3002 - 4/18/2014 4:46:24PM Page 67 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
12/02 (61)% 88 1 1 - 1,319,458 946 225 - 55 5 OK-1 Injection
74,434 69,709 220,213 193,972 5,029 5,029 910,000 860,540 6,853,775 - (12)%Injectable 3
9 /01 (12)% 193,972 5,029 5,029 - 6,853,775 860,540 220,213 910,000 69,709 74,434 OK-3 Injection
1,239 1,059 6,311 4,302 1,412 1,412 15,000 51,534 177,094 - (32)%IUD 5 Distribution
5 /03 (32)% 4,302 1,412 1,412 - 177,094 51,534 6,311 15,000 1,059 1,239 OK IUD
5,194 - 53,392 5,194 467 467 - 90,590 95,784 - (90)%LLINs
12/12 (90)% 5,194 467 467 - 95,784 90,590 53,392 - - 5,194 PowerNet
- 71,416 180,320 70,840 - - 1,000,000 908,208 10,571,796 - (61)%Lubricant A
8 /03 (61)% 70,840 - - - 6,143,738 908,208 180,320 - 71,416 - Aphaw Gel
10/06 -% - - - - 4,428,058 - - 1,000,000 - - Aphaw Gel - Sachet
7,751 7,940 20,578 23,870 - - 95,000 95,920 518,950 - 16%Lubricant B
10/06 16% 23,870 - - - 518,950 95,920 20,578 95,000 7,940 7,751 Aphaw Gel - Tube 20 cc
3,457 16,620 329,219 42,982 4,632 4,632 913,001 935,171 1,775,657 - (87)%Malaria PPT (ACT)
7 /12 (8)% 662 71 71 - 7,379 2,759 716 2,125 239 190 AL 1
7 /12 (27)% 727 78 78 - 7,930 3,472 996 2,674 238 255 AL 2
1 /11 (73)% 759 82 82 - 37,934 8,201 2,837 6,317 343 178 AL 3
1 /11 (77)% 1,600 172 172 - 200,416 40,097 6,853 30,884 791 722 AL 4
9 /09 (100)% - - - - 26,502 549 549 - - - Coartem 1
9 /09 (100)% - - - - 26,743 35 29 - - - Coartem 2
9 /12 (79)% 3,250 350 350 - 86,763 55,231 15,388 54,919 1,053 90 Supa Arte 1
9 /12 (80)% 3,190 344 344 - 87,003 55,526 15,612 55,213 1,033 90 Supa Arte 2
9 /12 (84)% 3,860 416 416 - 157,593 106,563 23,977 105,962 1,257 90 Supa Arte 3
9 /12 (90)% 26,109 2,814 2,814 - 1,059,425 637,505 259,837 633,907 10,419 1,246 Supa Arte 4
6 /11 16% 2,825 304 304 - 77,969 25,233 2,425 21,000 1,246 596 Vivax Treatment Kit
25,408 25,799 83,640 70,542 - - 870,000 376,704 1,283,826 - (16)%Malaria RDK
3002 - 4/18/2014 4:46:24PM Page 68 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
3 /11 (16)% 70,542 - - - 1,283,826 376,704 83,640 870,000 25,799 25,408 Malaria RDT (Diagnosis)
- - 5,004 - - - 5,000 16,560 22,215 - (100)%Misoprostol for PPH
8 /11 (100)% - - - - 22,215 16,560 5,004 5,000 - - Misoprostol
117,825 161,244 297,390 313,799 2,081 2,081 1,600,000 1,676,302 8,418,273 - 6%OCs
9 /01 6% 313,799 2,081 2,081 - 8,418,273 1,676,302 297,390 1,600,000 161,244 117,825 OK Pills
12,289 13,689 34,653 33,884 13,483 13,483 180,000 189,346 596,910 - (2)%Pneumonia PPT
2 /11 788% 13,114 5,218 5,218 - 229,104 58,960 1,477 55,000 5,238 4,803 Pneumox 125 mg (15 tabs)
2 /11 (37)% 20,770 8,265 8,265 - 367,806 130,386 33,176 125,000 8,451 7,486 Pneumox 250 mg (15 tabs)
6,984 13,305 9,126 27,025 - - - 95,154 457,051 - 196%Pregnancy Test
4 /05 196% 27,025 - - - 457,051 95,154 9,126 - 13,305 6,984 OK Test
- - 15 - - - - 76 306,592 - (100)%Retreatment KO123
7 /11 (100)% - - - - 306,592 76 15 - - - Supa Tab 3
- - 34,440 - - - - 42,459 2,764,492 - (100)%Safe Water Solution
7 /04 (100)% - - - - 2,764,492 42,459 34,440 - - - WaterGuard
7,791 7,426 12,291 22,260 - 634 75,000 72,464 354,927 634 81%STI Kit (Non-Ulcerative)
8 /09 62% 19,847 558 - 558 346,604 70,374 12,220 60,000 6,974 6,464 Cure U for Urethritis & Cervicitis
5 /11 3,299% 2,413 76 - 76 8,323 2,090 71 15,000 453 1,327 Cure U Vaginitis
828 805 1,994 2,207 - 256 7,000 6,692 47,261 256 11%STI Kit (Ulcerative)
8 /09 11% 2,207 256 - 256 47,261 6,692 1,994 7,000 805 828 Cure U for Non-Herpetic Ulcer
1,828 1,507 3,677 4,761 - 29,532 20,240 21,391 142,714 29,532 29%TB DOTS
12/04 29% 4,761 29,532 - 29,532 142,714 21,391 3,677 20,240 1,507 1,828 TB DOTS
3,637 3,568 8,350 10,869 - 1,014 49,000 37,477 111,653 1,014 30%VCT
12/09 (40)% 52 1 - 1 1,838 244 86 252 24 14 VCT Concordant Couple (HIV-Negative)
12/09 -% 38 42 - 42 1,510 160 38 162 11 18 VCT Concordant Couple (HIV-Positive)
12/09 (50)% 11 - - - 642 69 22 72 4 3 VCT Discordant Couple (HIV-Negative)
3002 - 4/18/2014 4:46:24PM Page 69 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
12/09 (50)% 11 12 - 12 642 69 22 72 4 3 VCT Discordant Couple (HIV-Positive)
12/09 34% 10,010 124 - 124 95,525 34,098 7,498 44,676 3,274 3,352 VCT Individual (HIV-Negative)
12/09 9% 747 834 - 834 11,496 2,837 684 3,766 252 247 VCT Individual (HIV-Positive)
Nepal 3 1,557 1,560
- (19) (158)(4) (5) (5) 844 (198) 2,142 - 0%Implant 5 Distribution
-%(4) (5)(5) - (969)(965)(428) - (19) - PSI Implant 5 Distributed Inserted (1)
8 /09 (100)% - - - - 3,111 767 270 844 - - Jadelle
- 22 431 4 5 5 1,095 995 999 - (99)%Implant 5 Insertion
(99)% 4 5 5 - 969 965 428 1,062 19 - PSI Implant 5 Inserted
(100)% - - - - 30 30 3 33 3 - Non-PSI Implant 5 Inserted
(1,946) (996) (416)(6,544) (9,409) (9,409) 39,024 7,314 114,988 - 0%IUD 10 Distribution
-%(6,544) (9,409)(9,409) - (34,705)(28,162)(3,543) - (2,830)(1,946) PSI IUD 10 Distributed Inserted (1)
6 /13 -% - - - - 1,096 1,096 - 1,206 - - IUCD Disposable Kit
8 /03 (100)% - - - - 117,344 3,127 3,127 - - - IUD
6 /13 -% - - - - 31,253 31,253 - 37,818 1,833 - OK IUCD-Tcu380
2,061 2,930 3,632 6,853 10,483 10,483 32,157 29,233 36,087 - 89%IUD 10 Insertion
85% 6,544 10,010 10,010 - 34,705 28,162 3,543 30,978 2,830 1,946 PSI IUD 10 Inserted
247% 310 474 474 - 1,381 1,072 89 1,179 101 115 Non-PSI IUD 10 Inserted
(102) 184 (135)(344) (355) (355) 2,328 634 6,023 - 0%IUD 5 Distribution
-%(344) (355)(355) - (1,827)(1,482)(186) - (149)(102) PSI IUD 5 Distributed Inserted (1)
5 /11 (100)% - - - - 5,785 51 51 - - - IUCD CU 375
6 /13 -% - - - - 2,065 2,065 - 2,328 333 - OK cu375
108 154 191 361 396 396 1,692 1,539 1,899 - 89%IUD 5 Insertion
85% 344 378 378 - 1,827 1,482 186 1,630 149 102 PSI IUD 5 Inserted
3002 - 4/18/2014 4:46:24PM Page 70 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
247% 16 18 18 - 73 56 5 62 5 6 Non-PSI IUD 5 Inserted
165,196 - 39,851 165,196 159 159 1,064,518 1,489,648 3,790,209 - 315%LLINs
3 /06 315% 165,196 159 159 - 3,790,209 1,489,648 39,851 1,064,518 - 165,196 Supanet (Public Distribution)
9,150 800 23,300 9,150 279 279 50,017 45,470 158,773 - (61)%Medical Abortion
12/08 -% 7,350 224 224 - 18,521 - - - - 7,350 Medabon
7 /10 (92)% 1,800 55 55 - 140,252 45,470 23,300 50,017 800 1,800 Medabon (PSI-PLC/Nepal)
- - 410 - - - - 28,800 474,750 - (100)%Safe Water Solution
7 /10 (100)% - - - - 474,750 28,800 410 - - - WaterGuard (PSI-PLC/Nepal)
6 - - 6 3 3 - - 6 - 0%SDM (Cycle Beads)
3 /14 -% 6 3 3 - 6 - - - - 6 Cycle Beads
- 55 - 164 - 3 - 2,738 7,580 3 0%STI Kit (Non-Ulcerative)
4 /12 -% 121 3 - 3 4,292 1,399 - - 40 - CLEAR STI Kit for Male Urethral Discharge Syndrome
12/11 -% 43 1 - 1 3,288 1,339 - - 14 - CLEAR STI Kit for Vaginal Discharge Syndrome
Pakistan 13,018 248,223 261,241
5,000 - 8,200 5,000 565 565 12,100 8,200 360,132 - (39)%Clean Delivery Kit
10/03 (39)% 5,000 565 565 - 360,132 8,200 8,200 12,100 - 5,000 Clean Delivery Kit
24,167,172 9,716,496 30,673,694 33,451,500 93,963 102,834 140,000,000 123,326,610 2,114,929,840 8,871 9%Condom
1 /87 8% 29,007,540 89,173 81,480 7,693 1,916,161,686 109,592,268 26,741,934 124,000,000 8,765,376 21,225,492 Sathi
4 /96 13% 4,443,960 13,661 12,483 1,179 198,768,154 13,734,342 3,931,760 16,000,000 951,120 2,941,680 Touch
293,020 114,833 469,302 485,420 8,439 8,439 3,225,000 1,827,252 10,853,548 - 3%Emergency Contraception
6 /01 3% 485,420 8,439 8,439 - 10,853,548 1,827,252 469,302 3,225,000 114,833 293,020 Postinor II
(140) (143) (315)(431) (460) (460) - (1,326) 2,423 - 0%Implant 4 Distribution
-%(431) (460)(460) - (2,215)(1,784)(476) - (143)(140) PSI Implant 4 Distributed Inserted (1)
7 /11 (100)% - - - - 4,638 458 161 - - - Femplant
140 143 476 431 489 489 - 1,784 2,215 - (9)%Implant 4 Insertion
3002 - 4/18/2014 4:46:24PM Page 71 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
(9)% 431 489 489 - 2,215 1,784 476 - 143 140 PSI Implant 4 Inserted
6,093 46 - 6,142 7,784 7,784 7,000 315 8,467 - 0%Implant 5 Distribution
12/11 -% 6,142 7,784 7,784 - 8,467 315 - 7,000 46 6,093 Jadelle
26,600 7,667 49,875 38,700 1,035 1,035 235,000 145,040 1,222,812 - (22)%Injectable 1
6 /03 (22)% 38,700 1,035 1,035 - 1,222,812 145,040 49,875 235,000 7,667 26,600 Femi-ject
44,160 14,960 150,480 62,160 3,602 3,602 780,000 533,775 5,803,403 - (59)%Injectable 2
12/96 (59)% 62,160 3,602 3,602 - 5,803,403 533,775 150,480 780,000 14,960 44,160 Novaject
79,880 69,458 107,951 182,420 15,858 15,858 685,000 520,496 1,170,468 - 69%Injectable 3
7 /11 69% 182,420 15,858 15,858 - 1,170,468 520,496 107,951 685,000 69,458 79,880 Depo-Provera
60,400 (4,285) 255,694 41,197 45,342 45,342 550,000 410,098 2,997,677 - (84)%IUD 5 Distribution
-%(55,425) (61,002)(61,002) - (264,412)(208,987)(39,201) - (18,525)(18,442) PSI IUD 5 Distributed Inserted (1)
12/95 (67)% 96,622 106,344 106,344 - 3,262,089 619,085 294,895 550,000 14,240 78,842 Multiload
18,442 18,525 39,201 55,425 64,896 64,896 - 208,987 264,412 - 41%IUD 5 Insertion
41% 55,425 64,896 64,896 - 264,412 208,987 39,201 - 18,525 18,442 PSI IUD 5 Inserted
- - 33,600 - - - - 33,600 8,481,522 - (100)%Micronutrient Powder
11/05 (100)% - - - - 8,481,522 33,600 33,600 - - - Baby Active
107,340 58,340 397,692 208,140 4,628 4,628 2,085,000 1,391,935 28,783,829 - (48)%OCs
12/96 (48)% 208,140 4,628 4,628 - 28,783,829 1,391,935 397,692 - 58,340 107,340 Nova
1 /08 -% - - - - - - - 2,085,000 - - Novadol
343 302 651 906 - 4,146 3,600 3,197 52,617 4,146 39%TB DOTS
4 /05 39% 906 4,146 - 4,146 52,617 3,197 651 3,600 302 343 TB DOTS
- 194 1,144 582 2,065 2,065 16,000 5,888 211,920 - (49)%Tubal Ligation
6 /01 (49)% 582 2,065 2,065 - 211,920 5,888 1,144 16,000 194 - VSC
65,000 1,500 287,000 67,000 17 17 89,150 390,300 457,300 - (77)%Water Treatment Tablets
2 /12 (90)% 22,000 3 3 - 325,600 303,600 229,200 56,100 1,333 20,000 Aquatabs 33 mg (10 L)
3002 - 4/18/2014 4:46:24PM Page 72 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
2 /12 (22)% 45,000 14 14 - 131,700 86,700 57,800 33,050 167 45,000 Aquatabs 67 mg (20 L)
Papua New Guinea 1,363 540 1,903
60,268 64,344 101,643 243,310 497 1,764 480,000 454,171 5,983,470 1,268 139%Condom
1 /08 25% 126,924 920 259 661 5,867,084 454,171 101,643 480,000 34,136 34,504 Seif Raida
8 /13 -% 116,386 844 238 606 116,386 - - - 30,207 25,764 Seif Raida Orange Plus
448 16,166 18,840 19,545 40 135 27,200 62,626 155,464 95 4%Female Condom
2 /09 4% 19,545 135 40 95 155,464 62,626 18,840 27,200 16,166 448 Stap Seif
- - - - - - 50,000 - 12,778 - 0%Free Female Condom
1 /08 -% - - - - 12,778 - - 50,000 - - Female Condom Free
- - - - - - 8,000 10,883 10,883 - 0%Malaria PPT (ACT)
10/13 -% - - - - 10,883 10,883 - 8,000 - - Lumartem
- - - - - - 19,000 30,903 30,903 - 0%Malaria RDK
10/13 -% - - - - 30,903 30,903 - 19,000 - - Carestart Malaria HRP2/pLDH (pf/PAN)
197 - 1,200 197 3 3 1,000 1,200 15,255 - (84)%ORS
12/11 (84)% 197 3 3 - 15,255 1,200 1,200 1,000 - 197 ORS
780 - 18,000 780 - - 10,000 18,000 310,110 - (96)%Water Treatment Tablets
12/11 (96)% 780 - - - 310,110 18,000 18,000 10,000 - 780 Aquatab
- - 6,000 - - - 10,000 19,300 78,412 - (100)%Zinc
12/11 (100)% - - - - 78,412 19,300 6,000 10,000 - - Zinc 20 mg
Tajikistan 3,113 293 3,406
18,700 67,639 122,854 173,036 293 538 749,040 521,920 892,722 245 41%Free Condom
8 /10 41% 173,036 538 293 245 892,722 521,920 122,854 749,040 67,639 18,700 Generic Condom
80 435 750 1,104 - 1,506 5,246 3,217 7,923 1,506 47%Naloxone
1 /11 47% 1,104 1,506 - 1,506 7,923 3,217 750 5,246 435 80 Naloxone
10,260 36,497 95,000 108,512 - 1,362 208,800 317,760 543,716 1,362 14%Needle & Syringe
3002 - 4/18/2014 4:46:24PM Page 73 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
1 /11 14% 108,512 1,362 - 1,362 543,716 317,760 95,000 208,800 36,497 10,260 Needle/Syringe
Thailand 5,188 332 5,520
366,884 86,784 297,670 551,580 332 4,109 1,500,000 1,619,931 3,556,846 3,777 85%Free Condom
11/09 85% 551,580 4,109 332 3,777 3,556,846 1,619,931 297,670 1,500,000 86,784 366,884 Male Condom Free
- - 2,000 - - - 15,000 23,000 31,895 - (100)%Free Female Condom
11/09 (100)% - - - - 31,895 23,000 2,000 15,000 - - Female Condom Free
389,500 16,583 68,500 429,249 - - 478,500 435,000 1,516,054 - 527%Lubricant A
11/09 527% 429,249 - - - 1,516,054 435,000 68,500 478,500 16,583 389,500 Lube Sachet Free
52,450 47,305 148,135 155,490 - 1,410 595,741 541,583 1,829,652 1,410 5%Needle & Syringe
8 /09 5% 155,490 1,410 - 1,410 1,829,652 541,583 148,135 595,741 47,305 52,450 Needle/Syringe
Viet Nam 6,171 26 6,196
- - 3,059,160 - - - - 7,084,622 38,416,545 - (100)%Condom
9 /13 -% - - - - 109,440 109,440 - - - - Karol
1 /07 (100)% - - - - 38,307,105 6,975,182 3,059,160 - - - Number One
- - 15,300 - - - 30,000 27,400 31,520 - (100)%Female Condom
10/12 (100)% - - - - 31,520 27,400 15,300 30,000 - - Dream
- - - - - - - 4,362,418 20,998,126 - 0%Free Condom
9 /08 -% - - - - 20,998,126 4,362,418 - - - - Protector Plus Free Condom
- - 5,930 - - - - 7,062 56,742 - (100)%Free Female Condom
1 /10 (100)% - - - - 56,742 7,062 5,930 - - - Female Condom Free
- - 155,780 - - - - 370,282 1,690,956 - (100)%Lubricant A
3 /08 (100)% - - - - 1,690,956 370,282 155,780 - - - Number One Lubricant
- - - - - - - 55,000 55,000 - 0%Micronutrient Powder
9 /13 -% - - - - 55,000 55,000 - - - - Lyzivita
576,000 158,733 - 877,000 - 6,171 3,400,433 485,840 1,362,840 6,171 0%Needle & Syringe
3002 - 4/18/2014 4:46:24PM Page 74 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
POPULATION SERVICES INTERNATIONAL
Monthly Distribution by Country
Period: 3
Year: 2014
DISTRIBUTION
3/2014
MONTHLY
AVG PREV 3
MONTHS
YTD
DISTRIBUTION
2014
YTD
DISTRIBUTION
2013
YTD DALY
Non-HIV 2014
YTD DALY
2014
DISTRIBUTION
TARGET
2014
LAUNCH
DATE
YTD %
CHANGE
TOTAL
DISTRIBUTION
2013
CUMULATIVE
DISTRIBUTION YTD DALY
HIV2014
9 /13 -% 876,000 6,164 - 6,164 1,360,800 484,800 - 3,375,000 158,400 576,000 B-braun Omnican 40 (U-40 Insulin/40I.U.)
4 /13 -% 1,000 7 - 7 2,040 1,040 - 25,433 333 - Needle & Syringe (LDS)
5,760 5,298 5,376 12,792 26 26 100,000 53,441 523,875 - 138%Safe Water Solution
11/05 138% 12,792 26 26 - 523,875 53,441 5,376 100,000 5,298 5,760 SafeWat
3002 - 4/18/2014 4:46:24PM Page 75 of 75
(1) DALY credit is given separately for product distribution and product insertion. To avoid double-counting when a PSI product is both distributed AND inserted, this line subtracts
DALYS for product distribution.
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
AsiAsia and Eastern Europe - Asia
India $39,190 $0 $48,444 NA
CondomNAMasti 03/2014 350,400 $5,618 0%120 0 $4,122 2,357,950 8.970% $0 262,840350,520
Clean Delivery KitNANewBorn 03/2014 0 $0 NA0 0 NA 900 NANA $0 NA0
Diarrhea Treatment KitNANeotral Zinc Kit 03/2014 0 $0 NA0 0 $774 266,540 64.49NA $0 4,1330
NAORS + Zinc (Generic) 03/2014 -38,067 -$13,913 0%0 0 -$5,161 200,551 -14.030% $0 -14,297-38,067
Iron Folic Acid TabletNAVitalet-Preg 03/2014 0 $0 NA0 0 $0 1,462,790 NANA $0 00
Medical AbortionNASafe Abort kit 03/2014 18,600 $20,025 0%0 0 $22,393 41,079 2.090% $0 19,67718,600
ORSNANeotral 200ml 03/2014 0 $0 NA0 0 NA 12,144 NANA $0 NA0
NANeotral Orange 1000ml 03/2014 71,100 $4,657 0%0 0 $9,194 32,710 0.240% $0 134,40071,100
ZincNANeoZinc (50ml zinc acetate syrup) 03/2014 0 $0 NA0 0 $2,609 39,770 3.94NA $0 10,1000
Emergency ContraceptionNAEmergency Goli 03/2014 0 $0 NA0 0 $0 115,630 NANA $0 00
Injectable 3NAFreedom Inject (3-month) 03/2014 4,100 $2,655 0%0 0 $2,101 36,076 11.130% $0 3,2404,100
IUD 5NAFreedom 5 03/2014 7,800 $6,333 0%0 0 $2,111 812 0.310% $0 2,6007,800
OCsNAMala-D 03/2014 0 $0 NA0 0 $0 854,907 NANA $0 00
NAPearl 3 03/2014 367,200 $13,817 0%0 0 $10,300 3,100,389 11.490% $0 269,800367,200
Kazakhstan $0 $0 $0 NA
Free CondomNAGeneric Condom 03/2014 0 $0 NA1,440 0 $0 62,695 26.12100% $0 2,4001,440
Needle & SyringeNANeedle/Syringe 03/2014 0 $0 NA15,000 0 $0 0 NA100% $0 8,33315,000
Kyrgyzstan $0 $0 $0 NA
Free CondomNAGeneric Condom 03/2014 0 $0 NA0 0 $0 14,124 9.10NA $0 1,5520
Page 40 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Kyrgyzstan $0 $0 $0 NA
Free Female CondomNACupid (Free Female Condom) 03/2014 0 $0 NA0 0 $0 2,428 33.11NA $0 730
Lubricant ANAPersonal lubricants water based 4. 03/2014 0 $0 NA0 0 $0 515 11.04NA $0 470
Laos $1,870 $74,519 $25,154 2.96
Condom2.17No 1 Condom Grp 03/2014 0 $0 NA0 0 $7,501 396,636 1.59NA $16,300 249,6320
NANo 1 Condom Strw 03/2014 0 $0 NA0 0 $0 0 NANA $13,576 810
297,141,624.00Number One Rose 03/2014 0 $0 100%0 0 $0 0 NANA $9,905 1770
Female CondomNAFemale Condom 03/2014 0 $0 NA0 0 $0 281 NANA $0 00
Lubricant A2.17Number One Lubricant Grape 03/2014 0 $0 NA0 0 $7,501 396,636 1.59NA $16,300 249,6320
Lubricant BNANumber One Lubricant (20 cc) 03/2014 0 $0 NA0 0 $0 0 NANA $287 00
STI Kit (Non-Ulcerative)1.71One Stop Kit 03/2014 0 $0 NA0 0 $9,497 35,700 7.58NA $16,282 4,7080
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 171 $0 NA0 0 $0 0 NA0% $0 153171
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 5 $0 NA0 0 $0 0 NA0% $0 45
Misoprostol for PAC (Oral)3.00Misoprostol for PAC (oral) 03/2014 0 $1,870 100%0 2,000 $623 98,000 NANA $1,870 02,000
Injectable 3NAOK Injection-3 03/2014 0 $0 NA0 0 $31 11,175 67.05NA $0 1670
IUD 10NAPregna T Cu 380A 03/2014 0 $0 NA0 5 $0 4,785 NANA $0 05
IUD 5NAIUD Cu375 03/2014 0 $0 NA0 0 $0 3,740 NANA $0 00
Myanmar $102,526 $0 $83,085 NA
Other RevenuesNAVCT Fees 03/2014 249 $87 0%0 -249 $90 0 NA0% $0 1690
TB CasesNATB Cases 03/2014 1,812 $0 NA0 0 $0 0 NA0% $0 1,2271,812
Page 41 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Myanmar $102,526 $0 $83,085 NA
Antiretroviral TreatmentNAART Regimen 2 (patient-month) 03/2014 2 $12 0%0 -2 $26 0 NA0% $0 40
NAART Regimen 3 (patient-month) 03/2014 149 $908 0%0 -149 $953 0 NA0% $0 1560
CondomNAAphaw 03/2014 5,580 $189 0%29,168 1 $1,811 58,355 0.4484% $0 133,01934,749
NAAphaw - Natural Touch 03/2014 218,040 $9,263 0%300 0 $7,304 2,777,102 16.070% $0 172,860218,340
NAAphaw Flavors 03/2014 227,640 $8,747 0%465,645 0 $9,394 7,704,024 10.5667% $0 729,663693,285
NAAphaw Studded 03/2014 252,300 $10,821 0%300 33 $8,077 6,528,523 34.700% $0 188,120252,633
NAGeneric Male Condom 03/2014 0 $0 NA29,168 -29,168 $0 0 NA100% $0 29,4050
NAOK Condom 03/2014 29,904 $254 0%288 0 $228 1,296,612 48.271% $0 26,86430,192
Female CondomNAGeneric Female Condom 03/2014 0 $0 NA19,388 0 $0 307,215 16.67100% $0 18,42819,388
Lubricant BNAAphaw Gel - Tube 20 cc 03/2014 7,681 $3,122 0%70 0 $3,191 89,816 11.291% $0 7,9577,751
STI Kit (Non-Ulcerative)NACure U for Urethritis & Cervicitis 03/2014 5,963 $2,991 0%501 0 $2,962 10,084 1.528% $0 6,6166,464
NACure U Vaginitis 03/2014 1,327 $671 0%0 -3,000 $407 3,674 4.570% $0 804-1,673
STI Kit (Ulcerative)NACure U for Non-Herpetic Ulcer 03/2014 811 $405 0%17 0 $361 3,575 4.862% $0 736828
VCT Concordant Couple (HIV-Negative)NAVCT Concordant Couple (HIV-Neg 03/2014 14 $0 NA0 0 $0 0 NA0% $0 1714
VCT Concordant Couple (HIV-Positive)NAVCT Concordant Couple (HIV-Posi 03/2014 18 $0 NA0 0 $0 0 NA0% $0 1318
VCT Discordant Couple (HIV-Negative)NAVCT Discordant Couple (HIV-Nega 03/2014 3 $0 NA0 0 $0 0 NA0% $0 43
VCT Discordant Couple (HIV-Positive)NAVCT Discordant Couple (HIV-Posit 03/2014 3 $0 NA0 0 $0 0 NA0% $0 43
VCT Individual (HIV-Negative)NAVCT Individual (HIV-Negative) 03/2014 3,352 $0 NA0 0 $0 0 NA0% $0 3,3373,352
VCT Individual (HIV-Positive)NAVCT Individual (HIV-Positive) 03/2014 247 $0 NA0 0 $0 0 NA0% $0 249247
LLINNAPowerNet 03/2014 0 $0 NA5,194 0 $0 4,206 2.43100% $0 1,7315,194
Page 42 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Myanmar $102,526 $0 $83,085 NA
Malaria PPT (ACT)NAAL 1 03/2014 124 $6 0%66 1,190 $4 1,096 4.9735% $0 2211,380
NAAL 2 03/2014 32 $3 0%223 652 $8 1,098 4.5387% $0 242907
NAAL 3 03/2014 34 $5 0%144 2,512 $11 2,153 8.5181% $0 2532,690
NAAL 4 03/2014 415 $84 0%307 22,321 $59 36,331 68.1243% $0 53323,043
NASupa Arte 1 03/2014 0 $0 NA90 4,821 $0 60,768 56.09100% $0 1,0834,911
NASupa Arte 2 03/2014 0 $0 NA90 6,585 $0 59,755 56.20100% $0 1,0636,675
NASupa Arte 3 03/2014 0 $0 NA90 28,398 $0 120,801 93.89100% $0 1,28728,488
NASupa Arte 4 03/2014 0 $0 NA1,246 483,623 $0 946,799 108.79100% $0 8,703484,869
NAVivax Treatment Kit 03/2014 136 $14 0%460 0 $32 16,131 17.1377% $0 942596
Malaria RDKNAMalaria RDT (Diagnosis) 03/2014 7,015 $713 0%18,393 0 $720 958,574 40.7772% $0 23,51425,408
Clean Delivery KitNAClean Delivery Kit 03/2014 0 $0 NA0 0 $0 9,039 NANA $0 00
Diarrhea Treatment KitNAOrasel DTK 03/2014 110,040 $21,425 0%59 0 $9,525 54,315 1.100% $0 49,349110,099
Pregnancy TestNAOK Test 03/2014 6,805 $692 0%179 3,000 $380 85,631 9.513% $0 9,0089,984
Emergency ContraceptionNAOK EC 03/2014 2,480 $630 0%43 20 $587 66,921 28.402% $0 2,3572,543
Implant 5NAOK Implant 03/2014 0 $0 NA0 0 $0 19 28.50NA $0 10
Injectable 1NAOK-1 Injection 03/2014 0 $0 NA5 0 $3 1,778 60.61100% $0 295
Injectable 3NAOK-3 Injection 03/2014 74,350 $15,111 0%84 32 $13,109 770,576 11.920% $0 64,65774,466
IUD 5NAOK IUD 03/2014 1,238 $629 0%1 0 $415 15,709 10.950% $0 1,4341,239
OCsNAOK Pills 03/2014 117,660 $22,729 0%165 2 $20,653 340,918 3.260% $0 104,600117,827
Cervical Cancer-VIA and CryotherapyNACervical Cancer-VIA and Cryother 03/2014 1 $0 NA0 0 $0 0 NA0% $0 91
Page 43 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Myanmar $102,526 $0 $83,085 NA
Pneumonia PPTNAPneumox 125 mg (15 tabs) 03/2014 4,803 $732 0%0 0 $666 29,400 6.730% $0 4,3714,803
NAPneumox 250 mg (15 tabs) 03/2014 7,486 $2,282 0%0 0 $2,109 8,289 1.200% $0 6,9237,486
TB DOTSNATB DOTS 03/2014 1,828 $0 NA0 0 $0 0 NA0% $0 1,5871,828
Pakistan $784,738 $896,320 $365,834 2.45
TB CasesNATB Cases 03/2014 913 $0 NA0 0 $0 0 NA0% $0 740913
Condom2.65Sathi 03/2014 21,225,492 $399,234 100%0 0 $179,624 174,379,115 18.030% $476,875 9,669,18021,225,492
2.39Touch 03/2014 2,941,680 $204,488 100%0 0 $101,669 4,111,170 2.780% $242,973 1,481,3202,941,680
Clean Delivery KitNAClean Delivery Kit 03/2014 5,000 $0 NA0 0 $0 10,516 6.310% $8 1,6675,000
Micronutrient PowderNABaby Active 03/2014 0 $0 NA0 0 $0 47,308 NANA $5,748 00
Water Treatment Tablets268.01Aquatabs 33 mg (10 L) 03/2014 20,000 $0 NA0 0 $32 1,674,400 228.330% $8,586 7,33320,000
NAAquatabs 67 mg (20 L) 03/2014 45,000 $0 NA0 0 $0 380,300 25.350% $3,837 15,00045,000
Emergency Contraception2.23Postinor II 03/2014 293,020 $33,400 100%0 0 $18,314 85,590 0.530% $40,928 161,807293,020
Implant 4NAFemplant 03/2014 0 $0 NA0 0 $0 217 NANA $0 00
Implant 5NAJadelle 03/2014 6,093 $39,235 0%0 0 $13,139 1,533 0.750% $0 2,0476,093
Injectable 11.80Femi-ject 03/2014 26,600 $10,996 69%0 0 $4,981 315,522 24.460% $8,956 12,90026,600
Injectable 22.51Novaject 03/2014 44,160 $22,828 100%0 0 $10,542 1,051,123 50.730% $26,426 20,72044,160
Injectable 31.84Depo-Provera 03/2014 79,880 $29,471 91%0 0 $15,929 303,800 5.000% $29,389 60,80779,880
IUD 52.65Multiload 03/2014 78,842 $30,136 91%0 0 $12,318 320,608 9.950% $32,618 32,20778,842
OCs2.15Nova 03/2014 107,340 $14,950 99%0 1,000,000 $9,285 184,636 2.660% $19,977 69,3801,107,340
Page 44 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Pakistan $784,738 $896,320 $365,834 2.45
TB DOTSNATB DOTS 03/2014 343 $0 NA0 0 $0 0 NA0% $0 302343
Papua New Guinea $0 $5,677 $675 8.41
Condom330.78Seif Raida 03/2014 25,424 $0 NA9,080 34,150 $14 926,808 21.9126% $4,788 42,30868,654
NASeif Raida Orange Plus 03/2014 17,820 $0 NA7,944 0 $660 945,210 24.3631% $0 38,79525,764
Female CondomNAStap Seif 03/2014 360 $0 NA88 0 $0 1,035,729 158.9820% $888 6,515448
Lubricant ANAGlide Lubricant 03/2014 0 $0 NA0 0 $0 13,974 NANA $0 00
Malaria PPT (ACT)NALumartem 03/2014 0 $0 NA0 0 $0 6,775 NANA $0 00
Malaria RDKNACarestart Malaria HRP2/pLDH (pf/ 03/2014 0 $0 NA0 0 $0 10,547 NANA $0 00
ORSNAORS 03/2014 0 $0 NA197 0 $0 0 NA100% $0 66197
Water Treatment TabletsNAAquatab 03/2014 0 $0 NA780 0 $0 346,170 1,331.42100% $0 260780
ZincNAZinc 20 mg 03/2014 0 $0 NA0 0 $0 19,280 NANA $0 00
PSI-PLC/Nepal $0 $11,504 $0 NA
Medical AbortionNAMedabon (PSI-PLC/Nepal) 03/2014 1,800 $0 NA0 0 $0 11,677 19.460% $319 6001,800
Safe Water SolutionNAWaterGuard (PSI-PLC/Nepal) 03/2014 0 $0 NA0 0 $0 391 NANA $10,516 00
Implant 5NAJadelle 03/2014 0 $0 NA0 0 $0 19,202 NANA $0 00
IUD 10NAIUCD Disposable Kit-IUD 03/2014 0 $0 NA0 0 $0 704 NANA $0 00
NAOK IUCD-Tcu380-IUD 03/2014 0 $0 NA0 0 $0 16,931 NANA $549 00
IUD 5NAOK cu375 03/2014 0 $0 NA0 0 $0 2,102 NANA $120 00
Page 45 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria
Credit\Receivables and Inventory Report SA-003
Brand Name\Var. SalesQty
Date Samples%
SampleQty Out
Sales SalesOutstanding
Credit
03/2014 03/2014-
OtherQty Out Total Value % Credit Monthly Sales
AvgOutst Credit/
Mo. Sales AvgInventory
Ending BalMos. Inv in Stock
Monthly SalesAvg (Qty)Out
Total Qty
Tajikistan $0 $0 $0 NA
Free CondomNAGeneric Condom 03/2014 0 $0 NA18,700 0 $0 0 NA100% $0 57,67918,700
Needle & SyringeNANeedle/Syringe 03/2014 0 $0 NA10,260 0 $0 27,856 0.77100% $0 36,17110,260
NaloxoneNANaloxone 03/2014 0 $0 NA80 0 $0 9 0.02100% $0 36880
Thailand $0 $0 $0 NA
Free CondomNAMale Condom Free 03/2014 0 $0 NA366,884 0 $0 621,803 3.38100% $0 183,860366,884
Free Female CondomNAFemale Condom Free 03/2014 0 $0 NA0 0 $0 6,329 NANA $0 00
Lubricant ANALube Sachet Free 03/2014 0 $0 NA389,500 0 $0 245,248 1.71100% $0 143,083389,500
Needle & SyringeNANeedle/Syringe 03/2014 0 $0 NA52,450 0 $0 22,792 0.44100% $0 51,83052,450
Viet Nam $1,229 $0 $941 NA
CondomNANumber One 03/2014 0 $0 NA0 0 $0 9,758,519 NANA $0 00
Female CondomNADream 03/2014 0 $0 NA0 0 $0 5,490 NANA $0 00
Lubricant ANANumber One Lubricant 03/2014 0 $0 NA0 0 $0 674,988 NANA $0 00
Needle & SyringeNAB-braun Omnican 40 (U-40 Insulin/ 03/2014 0 $0 NA576,000 -576,000 $0 0 NA100% $0 292,0000
NANeedle & Syringe (LDS) 03/2014 0 $0 NA0 0 $32 32,910 98.73NA $0 3330
Safe Water SolutionNASafeWat 03/2014 5,760 $1,229 0%0 0 $910 10,469 2.460% $0 4,2645,760
Page 46 of 47 4/15/2014 11:13:27 AM(Landscape)03/201403/2014
Criteria